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Abstract 
P2X4 receptors (P2X4R) are ligand-gated ion channels activated by ATP and with a high 
permeability to Ca2+. They are predominantly localised to lysosomes and from there can 
traffic to the cell surface. ATP levels within the lysosome are high but P2X4Rs are inhibited 
by the acidic pH. Previously, it was shown that the alkalinisation of lysosomes using 
pharmacological reagents was sufficient to activate P2X4Rs, which promoted homotypic 
lysosome fusion. The main aim of this study was to identify physiological regulators of 
lysosomal P2X4Rs and to examine their role in lysosome Ca2+ signalling and fusion.  
The first candidate I investigated was P2X7R, which is typically co-expressed with P2X4R 
in immune and epithelial cells, and which has already been shown to induce changes in 
lysosome properties upon activation. I co-expressed these two receptors in normal rat 
kidney (NRK) cells and in HeLa cells and looked for a synergistic interaction between them 
in promoting lysosome fusion, as assessed by measuring the size of lysosomes. My 
results showed a significant increase in lysosome size following activation of P2X7R but 
only in the presence of P2X4R. Neither receptor alone was sufficient to promote lysosome 
fusion in response to the agonist BzATP. LAMP-GECO was used to measure changes in 
cytosolic [Ca2+] within the vicinity of the lysosome. Fusion of the Ca2+ reporter (GECO) to 
the C-terminus of LAMP-1 targets GECO to the cytosolic surface of the lysosome. Co-
expression of P2X4R with P2X7R augmented the P2X7R-induced Ca2+ signal suggesting 
that P2X4Rs mediate lysosomal Ca2+ efflux downstream of P2X7R stimulation. Next, I 
showed that the expression of P2X4R was sufficient to potentiate the cytosolic Ca2+ 
response to the activation of endogenous histamine H1 receptors and to promote 
lysosome fusion. Similar results were obtained with P2Y2R stimulation, which also couples 
to the phospholipase C pathway. Therefore, lysosomal P2X4Rs can be recruited 
downstream of P2X7R and Gq-coupled GPCRs activation to modulate lysosome function.  
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Further experiments were conducted to look at differences in the trafficking behaviour of 
human and rat P2X4Rs. A series of mutants were made to understand the amino acid 
sequence differences that may account for difference in the localisation of human and rat 
P2X4Rs. A further examination was conducted to examine a role for P2X4Rs in 
autophagic flux. My results suggest a synergistic interaction between P2X4R and P2X7R 
which inhibits autophagic flux, similar to the effect of bafilomycin treatment. Therefore, the 
effect of P2X4/7R in autophagy may be mediated by the alkalinisation of lysosomes.  
Altogether the results of my project improve our understanding of how the P2X4R Ca2+ 
channel regulates lysosome function. 
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1. Introduction 
1.1. The discovery of ATP as a signaling molecule 
Adenosine 5’-triphosphate (ATP) is a universal energy carrier within cells (Fig. 1). ATP 
was first discovered in 1929 and isolated from liver and muscle tissues by Karl 
Lohmann (Lohmann, 1929). In 1937, Hans Krebs described a key cellular process, the 
citric acid cycle that generates ATP during aerobic respiration (Krebs, 1937). 
Subsequently, ATP was shown to function as the main energy source within cells by 
Fritz Lipmann (1936-1941) (Sacktor, 1955; Singleterry et al., 2014). The ability of ATP 
to store and release energy is mainly due to the presence of energy-rich phosphate 
bonds, such that hydrolysis of ATP to adenosine diphosphate (ADP) and adenosine 
monophosphate (AMP) generates energy for cellular functions such as muscle 
contraction (Jarvis and Khakh, 2009; Sacktor, 1955). These ideas were quickly 
accepted and later in 1953 both scientists, Hans Krebs and Fritz Lipmann, shared the 
Nobel Prize in Physiology or Medicine.  
 
The idea proposed by Geoffrey Burnstock that ATP also functions as a signalling 
molecule was not so readily accepted. The first evidence indicating extracellular 
 
Figure 1 The chemical structure of ATP (adenosine 5′-triphosphate). 
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adenine as a signalling molecule was shown in the cardiovascular system. Drury and 
Szent-Gyorgyi showed that the intravenous injection of adenine compounds induced 
bradycardia, disruptions in the conduction of cardiac excitation waves and the dilation 
of coronary arteries (Drury and Szent-Györgyi, 1929). Following this study, ATP was 
recognised to play a role at the neuromuscular junction where it was shown to 
potentiate the effects of acetylcholine (ACh) in producing skeletal muscle contraction 
(Buchthal and Folkow, 1948). Emmelin and Feldberg (1948) also demonstrated 
complex effects in response to the intravenous injection of ATP into cats, including 
circulatory, respiratory and muscle reflex responses. Furthermore, ATP was shown to 
be released from sensory nerves to produce vasodilation of rabbit ear arteries (Holton, 
1959).  
In 1962, Geoffrey Burnstock and colleagues showed effects of ATP in 
neurotransmission within the gastrointestinal tract and went on to describe its actions 
in mediating relaxation of the smooth muscle of the ileum (Burnstock et al., 1970). ATP 
was thus described as a neurotransmitter to mediate non-adrenergic and non-
cholinergic transmission within the autonomic nervous system. Burnstock suggested 
that ATP satisfied all the criteria for it to be classified as a neurotransmitter, as 
originally proposed by Henry Dale: It can be synthesised and stored in nerves, 
exogenous application binds and activates the post-synaptic receptors, and enzymatic 
inactivation or uptake of neurotransmitter takes place. Two year later, Geoffrey 
Burnstock proposed the Purinergic Hypothesis describing ATP as a neurotransmitter 
that binds to purinergic receptors (Burnstock, 1972).  
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1.1.1. Mechanism of ATP release 
In neuronal cells, ATP is stored in synaptic vesicles and released via exocytosis in 
response to depolarisation of the nerve terminal (Reichardt and Kelly, 1983).  Exocytic 
release of ATP also occurs in many other cells including pancreatic acinar cells, 
hepatocytes and glial cells (Fitz, 2007; Krause et al., 1996). Additionally, ATP can be 
released via channels in the membrane such as the pannexin-1 hemichannel (Bao et 
al., 2004).  Mechanical stress has been shown to activate the plasma membrane 
pannexin-1 receptor to enable ATP release to the extracellular environment (Bao et 
al., 2004). Under pathological conditions such as hypoxia, inflammation, and following 
mechanical injury it is also likely that uncontrolled ATP release occurs because of cell 
lysis. This is thought to contribute to a massive upregulation of purinergic signalling. 
1.1.2. Mechanism of ATP degradation 
Ecto-nucleotidases are enzymes that hydrolyse nucleotides in the extracellular 
environment (Robson et al., 2006). They are sub-classified into four classes including 
the ecto-nucleoside triphosphate diphosphohydrolases (ENTPDase), ecto-5’-
nucleotidase (eN), ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs), 
and alkaline phosphatases (APs) (Zimmermann et al., 2012). Rapid ATP breakdown 
by ecto-nucleotidases ensures the localised action of purinergic signalling and the 
availability of ADP and adenosine for cell signalling (Zimmermann et al., 2012).  
1.2. Purinergic receptors  
Purinergic receptors are classes as either P1, which are activated by adenosine, or 
P2, which are activated by ATP and ADP. P2 receptors are sub-categorised into two 
distinct families; ionotropic P2X receptors (P2XRs) and metabotropic P2Y receptors 
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(P2YRs). Early on, receptor classification was based upon differences in 
pharmacological and kinetic properties (Burnstock and Kennedy, 1985). P2T 
receptors were described which were selective for ADP and expressed in platelets, 
but these were later shown to be a subtype of P2Y receptors. Similarly, P2U, were 
described as activated by pyrimidines like UTP, but these were also shown later to be 
a subtype of P2Y receptor (Burnstock, 2006; Gordon, 1986). We now know that within 
the family of P2Y receptors are GPCRs gated by ATP, ADP, UTP, UDP and UDP-
glucose. It was not until the early 1990s, that the first P2Y purinergic receptor was 
cloned by Eric Bernard’s group, and later Alan North and Ann-Marie Surprenant’s 
group cloned the first P2X receptor (Valera et al., 1994; Webb et al., 1993).  
1.2.1. P1 receptors  
P1 receptors are also known as adenosine receptors (A receptors). Four subtypes 
have been identified: A1, A2A, A2B, and A3 receptors. Both A2A and A2B receptors are 
Gαs-coupled GPCRs and stimulate adenylyl cyclase activity, whereas A1 and A3 
receptors couple to Gαi and inhibit adenylyl cyclase activity. Adenosine receptors are 
mainly found in the respiratory, nervous, and cardiovascular systems (Burnstock, 
2006). They exert a cytoprotective role, including protection from ischemia, 
maintaining oxygen demands and triggering anti-inflammatory responses. Therefore, 
adenosine receptors are potential therapeutic targets for cardiovascular and 
inflammatory diseases (Jacobson and Gao, 2006).  
1.2.2. P2Y receptors 
There are 8 subtypes of P2YR which share the same general structure of seven 
transmembrane domains, an extracellular N-terminus and intracellular C-terminus. 
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P2Y1R, P2Y2R, P2Y4R, P2Y6R and P2Y11R are Gαq-coupled GPCRs that activate PLC, 
whereas P2Y12R, P2Y13R and P2Y14R are Gαi-coupled GPCRs that inhibit adenylyl 
cyclase. With regards to their activation, P2Y1R, P2Y12R and P2Y13R are activated by 
ADP with an EC50 of 100 nM, P2Y11R is activated by ATP, and P2Y2R and P2Y4R are 
nearly equipotently activated by UTP and ATP. However, P2Y4R is preferentially 
activated by uracil nucleotides (Abbracchio et al., 2006), P2Y6R and P2Y14R are 
activated by UDP, and lastly P2Y14R is activated by UDP-glucose (Jacobson et al., 
2015). P2YRs are widely distributed in many different cell types, including, platelets, 
osteoclasts, endothelial and immune cells to mediate a wide array of physiological 
functions.  
1.2.3. P2X receptors  
P2XRs have a trimeric structure with a central pore that allows sodium (Na+), 
potassium (K+) and calcium (Ca2+) ions to permeate following agonist activation (Saul 
et al., 2013). The subtypes share less than 50 % similarity in their amino acid 
sequences and their length varies from 379 to 595 amino acids, with P2X7R being the 
longest (Gever et al., 2006) and P2X4R fairly short at 384 amino acids (North, 2002). 
All receptors share a similar overall structure, with each subunit having a large 
extracellular domain, two transmembrane domains and cytoplasmic N- and C-termini 
(Fig. 2). The extracellular loop is the largest component of the receptor and contains 
10 cysteine residues, which form disulphide bonds and are conserved in all P2XR 
subtypes (North, 2002). The extracellular domain is the key component for the binding 
of agonists, antagonist, and allosteric ligands that modulate the activity of P2XRs. The 
N-terminal tail of P2XRs is relatively short, ranging between 20 to 30 amino acid 
residues. In contrast, the length of C-termini of P2XRs differs from approximately 30 
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amino acid residues in P2X6R to 236 residues in P2X7R (Kaczmarek-Hájek et al., 
2012).  
 
1.3 Heteromerisation of P2X receptors 
P2XRs are either homotrimers or heterotrimers, and subunit composition dictates 
receptor function. Only P2X6R is unable to form functional homotrimers (Torres et al., 
1999). Thus far, heterotrimers that have been characterised include P2X1/2R, 
P2X1/4R, P2X1/5R, P2X2/3R, P2X2/6R, and P2X2/6R (Coddou et al., 2011). Even 
though P2X7R does not appear to form heterotrimers (Torres et al., 1999), there is 
  
Figure 2 Schematic diagram of the basic P2XR structure spanning the bilayer 
plasma membrane. Orange depicts the extracellular loop; blue represents the 
transmembrane domains with black cytosolic N- and C- terminal tails; green circles 
represent the 10 conserved cysteine residues and black circles represent the 
location of rat P2X4R mutations. 
COOH
H2N
Extracellular 
Cytoplasm 
K67
C353
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evidence showing that P2X7R homotrimers interact with P2X4R homotrimers (Antonio 
et al., 2011; Boumechache et al., 2009; Guo et al., 2007). In addition to 
heterotrimerisation, there is evidence that P2XR can form higher order complexes 
including dimers of trimers and trimers of trimers (Nicke et al., 1998; Torres et al., 
1999). Receptor density has been shown to affect receptor gating properties, perhaps 
because of the formation of these stable higher order complexes (Fujiwara and Kubo, 
2004).  
1.4 Crystal structure of P2XR  
The crystal structure of zebra fish P2X4R (zfP2X4R) was the first to be described by 
Kawate et al. (2009) at 3.1 Å resolution (Fig. 3A). zfP2X4R was crystallised in an ATP-
free state with N- and C- termini truncated to aid crystallisation. The overall 
architecture of the zfP2X4R subunit was described as resembling the shape of a 
dolphin, with the large extracellular domain as the head region with both upper and 
lower bodies and transmembrane domain akin to the fluke (Fig. 3B). The large 
extracellular domain protrudes ~70 Å above the membrane plane and is enriched with 
disulphide bonds. The transmembrane α-helices span ~28 Å and are oriented in an 
anti-parallel manner which angles ~45° away from the membrane plane. The study 
proposed two ion access pathways, the first mediated through fenestrations located 
within the extracellular domain close to the transmembrane domains. The second was 
suggested as the central pore of the homotrimer, with activation of the receptor 
resulting in an enlargement of this opening to allow ion flux (Kawate et al., 2009). 
Kawate et al. (2009) speculated that the ATP binding site is located in a deep groove 
at the interface between each subunit and this was supported by evidence from 
mutagenesis studies which indicated an important role for eight amino acids that are 
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highly conserved throughout the P2XR family. Of these, Lys 70 (rat P2X4R is K67), 
Lys 72, Thr 189, Asn 296, Arg 298 and Lys 316 were shown to extend towards the 
proposed ATP binding groove, suggesting they could have a crucial role in ATP 
binding (Jiang et al., 2000; Kawate et al., 2009; Roberts et al., 2008). 
Later, the same group published the crystal structure of zfP2X4R in an open, ATP-
bound state (Hattori and Gouaux, 2012). This provided substantial information about 
the structural changes that occur upon agonist binding and the residues that line the 
open pore. This direct comparison of ATP-free and ATP-bound states demonstrated 
that the ATP-binding pocket is indeed located ~40 Å from the transmembrane domains. 
The adenine base of ATP is recognised by Thr 189, which forms hydrogen bonds 
located deep within the ATP binding pocket. Furthermore, the study showed that Lys 
70 forms a crucial interaction with the triphosphate group which resides at the centre 
of the ATP structure (Hattori and Gouaux, 2012). The upper body of the extracellular 
domain is comprised of β sheets that are expected to be rigid and resistant to 
conformational change (Kawate et al., 2009). A substantial difference observed in the 
ATP-bound state was that the lower body domain flexed outwards. This in turn 
expanded the transmembrane helices away from the central axis, thereby increasing 
the opening between the ion-conducting second transmembrane domains (TM2) 
(Hattori and Gouaux, 2012). Specifically, TM1 and TM2 rotate anti-clockwise away 
from the central axis of P2X4R, an iris-like movement, thereby expanding the 
conductive pore. The central conduction pore is highly acidic, which attracts cations 
and repels anions thus explaining the cation selective permeability of P2X4Rs (Hattori 
and Gouaux, 2012).  
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Figure 3 The crystal structure of zfP2X4R. (A) The crystal structure for zfP2X4R 
homotrimer resolved at 3.1 Å resolution. Each colour denotes a P2X4R subunit.  The 
large extracellular domain protrudes 70 Å above the membrane plane, whereas the 
transmembrane domains span 28 Å into the membrane bilayer.  (B) A single subunit 
of zfP2X4R which shows the sections that resemble the shape of a dolphin. (C) A 
schematic diagram which indicates the nature of the conformational change 
triggered by the binding of ATP. The black arrows represent the iris-like movement 
that expands the central conductive pore upon ATP binding. Images are adapted 
from Kawate et al. (2009) and Hattori et al. (2012).  
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C
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Recently, the crystal structures of P2X3R and P2X7R were also published. The human 
P2X3R (hP2X3R) was crystallised in several states, including apo/resting, an agonist-
bound/open-pore, an agonist-bound/closed-pore/desensitised, and two antagonist-
bound/closed states (Mansoor et al., 2016). This study provides a detailed insight into 
several aspects of the structure. Importantly the construct used for crystallisation 
included more of the cytoplasmic domain than the previously solved zfP2X4 structure. 
It is evident that the proximal cytoplasmic domains form a structure that plays a key 
role in the gating of the receptor. The open state of hP2X3R shows a feature whereby 
the cytoplasmic residues form into a domain called the ‘cytoplasmic cap’. This cap 
includes β-strands from both termini, which associate to form a structure at the 
cytoplasmic surface of the central pore. This cap is only visible in the ATP-bound open 
state and not in the apo or desensitised states of hP2X3R indicating a role in regulating 
the stability of the open state. They generated a chimeric construct that included N-
terminus of P2X2R substituted for the equivalent region of P2X3R, and, unlike wild 
type P2X3R, this chimera desensitised slowly. This mutant exhibited a rigid cap with 
several hydrophobic bonds that stabilised its cytoplasmic cap structure, indicating an 
association between the stability of this domain and the rate of desensitisation.  
In the same year, Karasawa and Kawate (2016) crystallised P2X7R from panda 
(Ailuropoda melanoleuca) (pdP2X7R). pdP2X7R was solved at ~3.5 Å and obtained 
in the apo state, co-crystals of ATP with the antagonist state, and the antagonist-only 
state. Overall, pdP2X7R shares the similar dolphin-like architecture of zfP2X4R and 
at the amino acid level it has 45 % similarity with zfP2X4R and 38 % similarity with 
hP2X3R. In analysing pdP2X7R, they identified an allosteric site where several known 
antagonists bind, which is proximal to the ATP binding pocket. There are 13 residues 
surrounding this allosteric site which protrudes from β-sheets (β4, β13 and β14) in the 
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upper body domain of the neighbouring subunits and is referred to as a ‘turret-like’ 
structure. The turret-like structure and inter-subunit cavity are much narrower in 
zfP2X4R and hP2X3R than in pdP2X7R. A series of cysteine mutations were 
introduced in the drug-binding cleft and at least four residues (F103C, K110C, T308C, 
and I310C) were identified where modification by a large cysteine-reactive agent was 
sufficient to hinder the ATP-mediated conformation change required for channel 
activation (Karasawa and Kawate, 2016). Narrowing of the turret-like structure upon 
ATP binding appears to be required for P2X7R activation. However, the presence of 
an antagonist locks the inter-subunit cavity and turret-like structure diameter, thus 
hindering the movement of the pore-lining helices for channel opening. Similarly, in 
the ATP-bound open state, this allosteric site becomes relatively inaccessible to 
antagonists suggesting that they might not be effective inhibitors at high ATP 
concentrations. 
1.5 The functional properties and tissue distribution of P2XRs 
1.5.1 P2X1R 
P2X1R has the highest affinity for ATP of all P2XRs, with an EC50 of ~1 µM (Coddou 
et al., 2011). After activation, P2X1R exhibits fast desensitisation with a slow recovery 
period. Following agonist stimulation, P2X1R permeates cations with relatively high 
Ca2+ permeability over Na+ (PCa/PNa = ~4.5). P2X1R is predominantly expressed in 
smooth muscle cells and platelets, such that P2X1R knockout mice demonstrate a 
reduction in thrombus formation and platelet aggregation, suggesting a key role for 
P2X1R in thrombosis (Hechler et al., 2003). In addition to platelet function, P2X1R 
also plays a crucial role in the contraction of the vas deferens, as demonstrated by 
male P2X1R knockout mice being infertile not due to lack of sperm production, but 
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rather an inability to get them to ejaculate (Mulryan et al., 2000). A role for P2X1R has 
also been demonstrated in the autoregulation of renal blood flow and the 
vasoconstriction of preglomerular arteries and afferent arterioles. Administration of the 
P2X1R antagonist, NF279 inhibited the effect of pressure-regulated afferent 
constriction in afferent arterioles (Guan et al., 2007). In addition, inhibition of P2X1R, 
using either the non-selective antagonist PPADS or the P2X1R specific antagonist 
IP5I, reduced the glomerular filtration rate, thus further implicating P2X1R in renal 
autoregulation (Osmond and Inscho, 2010; 2009).  
1.5.2 P2X2R 
P2X2R is activated by ATP with an EC50 < 10 µm and exhibits slow desensitising 
kinetics. Following activation, P2X2R permeates cations, but with a lower Ca2+ 
permeability than P2X1R, PCa/PNa = ~2.5. P2X2R is abundantly expressed in the 
central and peripheral nervous systems, but is also widely distributed in non-neuronal 
tissues, including smooth muscle, urothelium, the carotid bodies and the adrenal 
medulla. P2X2R is involved in various sensory functions including taste (Eddy et al., 
2009; Finger et al., 2005), hearing (Housley et al., 2002) and chemosensing (Rong et 
al., 2003). A key role for P2X2R in chemosensation is shown by P2X2R-deficient mice 
failing to increase their ventilatory response to hypoxia. P2X2R-null mice also 
exhibited impaired intestinal peristalsis (Ren et al., 2003), demonstrating a role of 
P2X2R in enteric neurotransmission.  
1.5.3 P2X3R 
P2X3R is activated by ATP with an EC50 of < 10 µm, and following agonist stimulation, 
P2X3R generates a fast inward current that rapidly desensitises. The activation of 
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P2X3R results in a cation influx with similar permeability towards both Ca2+ and Na+ 
(PCa/PNa = ~1.2). P2X3R is expressed in heart, spinal cord, dorsal root ganglia, 
intestine and urinary bladder (Elneil et al., 2001; Garcia-Guzman et al., 1997; Liu et 
al., 2009). Two independent knockout studies have demonstrated a role of P2X3R in 
nociception, both demonstrating that the lack of P2X3R attenuated the formalin-
induced pain response (Cockayne et al., 2000; Souslova et al., 2000).  Additionally, 
knockdown of P2X3R using short interfering RNAs (siRNAs) inhibited the development 
of hyperalgesia in neuropathic pain models (Barclay et al., 2002; Dorn et al., 2004). 
Given the expression of P2X3R in urothelium and suburothelium, P2X3R has been 
implicated in sensing urinary bladder distension. Mice lacking P2X3R exhibit 
decreased voiding frequency and an increased bladder capacity, thus indicating a role 
of P2X3R in physiological conditions (Cockayne et al., 2000, 2005). P2X3R has also 
been implicated in afferent cardiovascular signalling where it has been detected in 
aortic bodies in juvenile and adult rats (Ford et al., 2015). Lastly, P2X3R has also been 
shown to mediate a pivotal role in carotid body chemoreception where it forms 
heterotrimers with P2X2R (Ford et al., 2015). 
1.5.4 P2X4R 
P2X4R is activated by ATP with an EC50 ranging from 1-10 µM (Bernier et al., 2008; 
North, 2002; Surprenant et al., 1996). The binding of ATP opens the ion channel pore 
which has a very high Ca2+ permeability, PCa/PNa = 4.2 (Jarvis and Khakh, 2009; 
Samways et al., 2014). Following agonist stimulation, P2X4R desensitises at a rate 
that is intermediate between the rapidly desensitising subtypes, P2X1R and P2X3R 
(within few milliseconds), and the very slowly desensitising subtypes that include P2X2 
and P2X7R (> 20 seconds) (Khakh and North, 2012; Roberts et al., 2006). P2X4R is 
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very widely expressed, including the central and peripheral nervous systems, immune 
system, endothelial, epithelial, and skeletal, smooth and cardiac muscle (Bo et al., 
1995, 2003; Buell et al., 1996; Naemsch et al., 1999; Soto et al., 1996; Xiang and 
Burnstock, 2005). It has been implicated in neuropathic and inflammatory pain and in 
vascular remodelling, further details are described in section 1.9 to section 1.12. 
1.5.5 P2X5R 
P2X5R is predominantly expressed in the immune system and central nervous system 
(Lê et al., 1997). The human isoform of P2X5R (hP2X5R) lacks both exon 3 and 10, 
thus encoding a truncated non-functional receptor that is retained in the endoplasmic 
reticulum (Bo et al., 2003; Kotnis et al., 2010). Despite the lack of plasma membrane 
hP2X5R, rat P2X5R (rP2X5R) has been shown to be activated by ATP with an EC50 
< 10 µM to generate rapidly activation with slow desensitisation rate (Coddou et al., 
2011).  
1.5.6 P2X6R 
P2X6R is the only P2XR subtype that does not form a functional homotrimer. However, 
P2X6R does form functional heteromeric receptors with both P2X2R and P2X4R 
(Gever et al., 2006), and it is expressed with P2X2R and P2X4R in the central and 
peripheral nervous systems. However, due to the lack of P2X6R knockout mouse 
model, the function of the heteromeric receptors remains poorly understood. Although, 
one study has shown that P2X6R is expressed in myocardial tissues and is 
upregulated following chronic heart failure (Banfi et al., 2005). 
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1.5.7 P2X7R 
P2X7R is significantly less sensitive to ATP than the other subtypes, with an EC50 > 
100 µM (Roberts et al., 2006). However, 2’,3’-(benzoyl-4-benzoyl)-ATP (BzATP) is a 
more potent agonist at P2X7R than ATP (EC50 ~10 µM). Unlike other subtypes of 
P2XR, P2X7R-mediated currents do not desensitise after agonist application (Roger 
et al., 2008). Instead the prolonged application of a high concentration of agonist 
sensitises the receptor and facilitates the currents. There is also a change in the 
selectivity of the pore following sensitisation of the receptor which allows large organic 
cations (up to ~800 Da in size) to permeate. This change in permeability is associated 
with changes in the downstream signalling that contributes to cell blebbing, and 
ultimately can lead to cell death (Robinson et al., 2014). 
There are species differences in the functional properties of P2X7R. Rat P2X7R 
(rP2X7R) sensitises faster than human P2X7R (hP2X7R). The rP2X7R has a 
calmodulin-binding motif within its C-terminal tail and this is known to contribute to 
receptor sensitisation: activation of rP2X7R increases calmodulin binding, which 
increases current facilitation, resulting in sensitised P2X7R potentiating the Ca2+ influx 
and a larger conductance (Roger et al., 2008, 2010). hP2X7R has a slower 
sensitisation than the rat isoforms due to a calmodulin-independent process, the 
detailed molecular process of which remains unclear (Roger et al., 2010). In addition, 
presence of cholesterols on the plasma membrane negatively regulate the 
sensitisation process of human and rodent P2X7R (Robinson et al., 2014). Cholesterol 
acts to suppress the channel pore opening, particularly large pores, limiting pore 
dilation and excess activation. There are also distinct species-dependent agonist 
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sensitivities, such that hP2X7R is comparably less sensitive to ATP and BzATP than 
the rodent P2X7Rs (Donnelly-Roberts et al., 2009; Rassendren et al., 1997). 
Together with P2X4R, P2X7R is expressed in endothelium, microglial and epithelial 
cells, but P2X7R is also abundantly expressed in lymphocytes, monocytes, and 
macrophages (Surprenant and North, 2009). The role of P2X7R in the inflammatory 
response has been extensively studied and P2X7R is implicated in both chronic 
inflammatory and neuropathic pain. Mice in which P2X7R is knocked out show 
attenuated inflammatory and neuropathic pain phenotypes (Chessell et al., 2005; 
Honore et al., 2006, 2009). Furthermore, the activation of P2X7R induces the release 
of pro-inflammatory cytokines IL-1β from microglial cells (Di Virgilio, 2007; Ferrari et 
al., 1997). One inducers of IL-1β release is lipopolysaccharide (LPS), a pathogen-
associated molecular pattern (PAMP) molecule. When LPS binds to toll-like receptors 
(TLRs) on macrophages, the inactive pro-IL-1β accumulates in the cytoplasm, a 
process known as priming. Subsequently, ATP-dependent activation of P2X7R 
facilitates the conversion of pro-IL-1β into mature IL-1β and the release of the mature 
IL-1β into the extracellular space (Ferrari et al., 1997). This process involves P2X7R 
mediated K+ efflux which triggers the assembly and activation of the NOD-like receptor 
(NLR)P3 inflammasome which in turn activates caspase-1 (formerly known as IL-1β-
converting enzyme) (Franceschini et al., 2015; Mariathasan et al., 2006). P2X7R 
knockout mice lack the ability to process pro-IL-1β in response to ATP (Labasi et al., 
2002; Solle et al., 2001). IL-1β is thought to be packaged into either lysosomes or 
microvesicles, which are located at the vicinity of plasma membrane, and released via 
lysosomes exocytosis (Andrei et al., 2004; Dubyak, 2012) or microvesicle release 
(Bianco et al., 2005; MacKenzie et al., 2001). 
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1.6 P2X-like receptor in Dictostylium  
A homologue of P2XR is found in the amoeba Dictyostelium discoideum and is called 
P2XAR. P2XAR localises within contractile vacuoles (CVs), which share some 
similarities with lysosomes (Fountain et al., 2007; Ludlow et al., 2009). Properties of 
P2XAR in D. discoideum suggest that mammalian P2XRs may have evolved as a 
receptor in intracellular compartments rather than at the plasma membrane. 
Functional studies have demonstrated that P2XAR is an ATP-gated cation channel 
(EC50≈ 100 µM) that has a high Ca2+ permeability (PCa/PNa= ~2) (Fountain et al., 2007; 
Ludlow et al., 2009). The CV is a lysosome-like organelle with an acidic luminal pH 
and high Ca2+ concentrations, which regulates osmoregulation of D. discoideum 
(Fountain et al., 2007). P2XAR is involved in osmoregulation by facilitating vacuole 
fusion followed by CV discharge under hypo-osmotic conditions (Parkinson et al., 
2014). P2XAR facilitates the fusion between mature CVs and the plasma membrane 
of D. discoideum as demonstrated by P2XAR-null mutant causing an accumulation of 
tethered CVs to the plasma membrane without fusion (Parkinson et al., 2014). In 
response to ATP stimulation, P2XAR generates a localised Ca2+ signal in the 
immediate vicinity of the CV, which activates the Ca2+ sensitive Rab GAP to suppress 
the activity of Rab11a on the CV, thereby facilitating vacuole fusion with the plasma 
membrane. This is because the active Rab11a, Rab11s-GTP binds to drainin, thereby 
blocking drainin redistribution that is required for the fusion of vacuolar membrane to 
cellular surface (Parkinson et al., 2014). Interestingly, P2X4R is localised to lysosomes 
and thus, this model suggests that the lysosomal localisation of P2X4R in mammalian 
cells might represent a conserved mode of action to regulate the vesicle trafficking. 
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1.7 P2XR pharmacological properties 
The pharmacological properties of different P2XRs reveal important differences, not 
least in sensitivity to ATP as mentioned previously. These differences are summarised 
in Table1. P2X1R, P2X3R and P2X5R are activated by sub-micromolar concentrations 
of ATP whereas P2X2R and P2X4R are activated by low micromolar ATP 
concentrations. P2X7R however requires very high concentrations of ATP (EC50 > 100 
µM; Roberts et al., 2006). There are other agonists including BzATP, which is 
reasonably selective for P2X7R (EC50 of ~10 µM for rP2X7R and EC50 of ~100 µM for 
hP2X7R) (North, 2002; Rassendren et al., 1997) but also acts as a partial agonist at 
P2X1R, P2X2R, P2X3R and P2X4R. With regards to the potency of BzATP against 
P2X4R, one study suggested a low EC50 for BzATP (~10 µM) at rP2X4R (He et al., 
2003) but others have reported a much higher EC50 of > 100 µM (Abdelrahman et al., 
2017; Guo et al., 2007). However, others have used both a Ca2+ influx assay and patch 
clamp recordings, and found no response was observed following 100 µM BzATP 
administration to astrocytoma and HEK293 cells expressing rP2X4R, respectively 
(Abdelrahman et al., 2017; Guo et al., 2007). Unlike rP2X4R, mouse and human 
P2X4Rs are reported to have lower EC50s of ~3 µM and < 1 µM, respectively, for 
BzATP (Abdelrahman et al., 2017). Another non-selective agonist is 2-methylthio-ATP 
(2-MeSATP) which is only a partial agonist at P2X4R and P2X7R, but it is a full agonist 
for the rest of the P2XR subtypes.  
In terms of antagonists, suramin is a non-selective antagonist of all P2XRs and P2YRs 
(Jones et al., 2000; Soto et al., 1996), although, both P2X4R and P2X7R are relatively 
insensitive. PPADS is another commonly used P2XR antagonist that blocks P2X1R, 
P2X2R, P2X3R and P2X5R, but, it is a weak or ineffective antagonist of P2X4R and 
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P2X7R. PPADS antagonises P2X1, P2X2R, P2X3R and P2X5R with an IC50 of 1-3 
µM, whereas it antagonists P2X7R with an IC50 of ~50 µM. As for P2X4R, PPADS 
exhibits species specific potency, whereby PPADS inhibits mouse and human P2X4R 
with an IC50 of ~10 µM, rP2X4R is relatively insensitive (IC50 > 100 µM) (Jones et al., 
2000; Soto et al., 1996). Studies have proposed that a domain of approximately 100 
amino acids between 81 to 183 located in the extracellular domain of rP2X4R may be 
the cause of species differences in PPADS sensitivity (Garcia-Guzman et al., 1997). 
TNP-ATP is a non-selective antagonist that inhibits P2X1R, P2X3R, P2X2/P2X3R at 
nanomolar concentrations, P2X7R with an IC50 of > 30 µM, and also inhibits P2X4R 
at similar concentrations for human, rat, and mouse orthologues with an IC50 of ~5-15 
µM (Virginio et al., 1998). 
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Table 1. The pharmacological profile of rat P2XRs  
Agonists 
(EC50; µM) 
P2X1R P2X2R P2X3R P2X4R P2X5R P2X6R P2X7R 
ATP <1 ~1-10 ~1-10 10 <10 - 100 
BzATP ~0.7-
25 
~6-30 0.08 >100 >500 - ~10 
2-MeSATP <1 1 <1 ~10-
100 µM 
<1 - ~200 
Antagonists 
(IC50; µM) 
       
Suramin 1-2 10 3 >300 ~4 >100 >500 
PPADS 1 ~1-3 ~1 >100 <3 >100 50 
TNP-ATP 0.006 2 0.001 ~5-15 - - >30 
Notes: The table are adapted from Jarvis and Khakh, (2009), Coddou et al. (2011) 
and Khakh and North, (2012). 
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1.8 P2XR modulators 
In term of modulators, the anti-parasitic drug ivermectin is a potent positive allosteric 
modulator of P2X4R (Khakh et al., 1999). Ivermectin potentiates the agonist potency 
profile of ATP-induced current mediated by P2X4R (EC50 = ~0.25 µM) (Khakh and 
North, 2012; Priel and Silberberg, 2004). Binding of ivermectin to the transmembrane 
domains of P2X4R has been suggested to stabilise the open state of P2X4R, resulting 
in an increased current (Hattori and Gouaux, 2012; Priel and Silberberg, 2004). 
P2XRs can also be modulated by extracellular cations including protons and trace 
metals. For example, extracellular Mg2+ decreases the ATP-induced P2X7R activation 
(Miyoshi et al., 2010). The presence of extracellular Zn2+ acts as an allosteric 
modulator of all P2XRs, such that the P2X1R and P2X7R ATP-mediated currents are 
attenuated, but these currents are potentiated for the rest of P2XRs (Coddou et al., 
2011). In addition, extracellular Cu2+ is a potent modulator of P2X7R, inhibiting 
currents with an IC50 of 0.5-4 µM (Virginio et al., 1998). For P2X2R, Cu2+ exhibits a 
biphasic effect such that it potentiates P2X2R-mediated currents at concentrations 
between 10 and 100 µM, but exhibits an inhibitory effect at millimolar concentrations 
(Coddou et al., 2011). ATP-induced currents in P2X4R expressing cells are inhibited 
by Cu2+, but potentiated by Zn2+, although, Zn2+ exhibits a biphasic effect such that 
low concentrations increase ATP potency, but it decreases ATP efficacy at higher 
concentrations (30 μM – 1 mM) (Coddou et al., 2011). Cu2+ inhibits channel activity of 
P2X4R by reducing the Emax of P2X4R-mediated current (Coddou et al., 2011). There 
is evidence to suggest that Cu2+ binds to histidines, aspartic acid, glutamic acids and 
cysteine (Aitken, 1999), and H140 in the extracellular domain of P2X4R is crucial for 
the inhibitory effect of Cu2+ (Coddou et al., 2003).  
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Protons also act as an allosteric modulator of P2XRs, affecting ATP-mediated currents. 
Extracellular protons enhance the potency of agonists at P2X2R without affecting the 
maximal agonist responses, such that acidification strongly increases the P2X2R-
mediated current following ATP stimulation, but alkalinisation causes strong inhibition 
of the current (Clyne et al., 2002; Stoop et al., 1997). In contrast, an acidic extracellular 
environment reduces ATP potency for P2X1R, P2X3R and P2X4R without altering the 
maximum current amplitude. Despite the reduction in ATP potency, acidification only 
causes a modest reduction of ATP-mediated current for P2X1R and P2X3R and 
alkalinisation does not cause any effect in the current. This is different from P2X4R 
where acidification strongly attenuated ATP-mediated currents, whereas, 
alkalinisation increases the current, acidification shifted the ATP concentration-
response relationship towards higher concentrations of ATP (Stoop et al., 1997). A 
mutagenesis study has identified the key residue involved in proton modulation of 
P2X4R, histidine 286. Mutation of this residue to alanine removes the inhibition of 
P2X4R currents by increasing pH (Clarke et al., 2000). H286 is located away from 
ATP-binding pocket, suggesting the allosteric modulation by protons may affect the 
gating of the receptor rather than ATP binding (Coddou et al., 2011). Similarly, 
acidification reduces both the potency and efficacy of ATP in P2X5R activity, whilst it 
only reduces the peak current of P2X7R without altering the potency of agonist binding 
(Gever et al., 2006; Virginio et al., 1998). These modulators provide additional 
regulators for receptor functioning. 
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1.9 Structure function analysis of P2X4 receptors  
Several mutations within the TM2 domain have been identified of rP2X4R that play a 
dominant role in the gating of P2X4R. In particular, P2X4R-C353W renders the 
receptor non-functional and P2X4R-C353W acts in a dominant negative manner to 
inhibit wild type P2X4R activity suggesting that one subunit with this mutant within the 
trimeric assembly is sufficient to inhibit receptor function (Guo et al., 2007; Silberberg 
et al., 2005). P2X4R-K67A is non-functional and it has a mutation in the ATP binding 
pocket that prevents ATP binding (Silberberg et al., 2005; Stojilkovic et al., 2010). As 
shown in the crystal structure of ATP-bound zfP2X4R, the residue at Lys 70 of 
zfP2X4R, which is K67 in the rat isoform, is crucial in ATP binding due to ammonium 
residues at Lys 70 that are situated at the centre of the triphosphate of ATP where 
binding occurs in the ATP binding pocket (Hattori and Gouaux, 2012). Both of P2X4R-
C353W and P2X4R-K67A are used as controls in this thesis. 
1.10 Trafficking and targeting of P2X4R  
Plasma membrane P2X4Rs are either rapidly retrieved and targeted to lysosomes, or 
shuttled between the plasma membrane and lysosomes for recycling of the receptor 
(Royle et al., 2005). Within the C-terminal domain is a non-canonical tyrosine-based 
motif (YXXGL, X denotes any amino acid), whilst the N-terminal domain contains a 
dileucine-like motif, and both of these motifs are important in the endocytosis and 
targeting of P2X4R to lysosomes (Qureshi et al., 2007; Royle et al., 2002, 2005). 
Endocytosis of P2X4R involves the AP2 clathrin adaptor protein complex which is 
responsible for recognising the tyrosine-based motif and the dileucine-like motifs of 
P2X4R (Royle et al., 2002, 2005).  
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The trafficking of P2X4R is cell specific. For example, in active microglial cells, 
P2X4Rs rapidly shuttle between the plasma membrane, late endosomes, and 
lysosomes (Boumechache et al., 2009), whereas in other cells such as bone marrow 
derived macrophages (BMDMs), the receptors stably reside in lysosomes (Toulme et 
al., 2010). Within lysosomes, P2X4R is able to resist degradation due to N-linked 
glycans that decorate the luminal/extracellular domain of P2X4R (Qureshi et al., 2007). 
Rapid constitutive endocytosis of P2X4R is mediated via dynamin and clathrin-
dependent processes, and it is inhibited by dynasore, an inhibitor of dynamin that is 
required for clathrin-dependent coated vesicle formation during endocytosis (Royle et 
al., 2002; Boumechache et al., 2009).   
1.11 Physiological and pathological roles of P2X4R  
P2X4R is widely expressed in immune, epithelial and endothelial cells (North, 2002; 
Weinhold et al., 2010). It plays an important role in many different processes, including 
controlling blood pressure, neuropathic pain, and inflammation. Evidence for its role in 
neuropathic pain is growing. The first demonstration was the upregulation of plasma 
membrane P2X4R in microglial cells after peripheral nerve injury (PNI) (Tsuda et al., 
2003). The upregulation of P2X4R was associated with tactile allodynia and 
pharmacological inhibition of P2X4R reversed tactile allodynia (Tsuda et al., 2003; 
Ulmann et al., 2008). Furthermore, knockout and knockdown studies showed that 
P2X4R deficiency was sufficient to attenuate the development of tactile allodynia. 
Moreover, intrathecal delivery of P2X4R-activated microglial cells to naïve mice was 
sufficient to induce tactile allodynia, supporting the evidence for a role of P2X4R in 
neuropathic pain (Tsuda et al., 2003). In addition, the upregulation of P2X4R in 
microglial cells regulates the release of brain-derived neurotrophic factor (BDNF), 
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which is suggested to modulate hypersensitive pain in PNI mice (Trang et al., 2009; 
Ulmann et al., 2008). Specifically, enhanced expression of P2X4R in microglial cells 
results in an increase in Ca2+ influx which triggers downstream signalling including 
p38-MAPK to induce soluble N-ethylmaleimide-sensitive fusion protein attachment 
protein receptors (SNARE)-dependent exocytosis of BDNF (Trang et al., 2009). With 
regards to inflammatory pain, P2X4R-deficient mice exhibit reduced inflammatory pain 
behaviour following complete Freund's adjuvant (CFA)-induced inflammation (Ulmann 
et al., 2010). The study showed that the lack of inflammatory pain behaviour is due to 
the reduction of P2X4R-dependent prostaglandin E2 (PGE2) production in P2X4R-
deficient macrophages. In contrast, elevation of PGE2 production was observed 
following ATP-mediated P2X4R activation in wild type macrophages. These results 
suggest that the stimulation of P2X4R in macrophages is responsible for PGE2 
release, a central mediator of inflammation that is directly related to hypersensitivity in 
inflammatory pain (Ulmann et al., 2010). 
Apart from its role in pain, P2X4R in endothelial cells has been shown to mediate 
vascular remodelling such that shear stress in vascular endothelial cells stimulates 
P2X4R-mediated Ca2+ entry and production of the vasodilator nitric oxide (NO). 
Knockout of P2X4R in mice demonstrated raised blood pressure, a lack of vascular 
remodelling and decreased shear stress-induced release of NO, confirming the crucial 
role of P2X4R in the controlling vascular tone and vascular remodelling (Yamamoto et 
al., 1998). In addition to being a shear stress sensor, P2X4R in vascular endothelial 
cells has been suggested to exert a neuroprotective role via ischemic preconditioning 
(IPC). IPC is transient ischemia that recovers with subsequent reperfusion. There is 
evidence that shear stress stimulated P2X4R activation elevates the expression of the 
neuroprotective factor osteopontin (Ozaki et al., 2016). This P2X4R-dependent 
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osteopontin upregulation is required for IPC-mediated neuroprotection following 
middle artery occlusion in mice. However, inhibition of P2X4R, using 5-BDBD, blocked 
the upregulation of osteopontin, thereby inhibiting ischemic preconditioning-induced 
neuroprotection. Similarly, intracerebroventricular injection of osteopontin mimicked 
P2X4R-mediated neuroprotective effect of ischemic preconditioning in mice (Ozaki et 
al., 2016). 
There is good evidence to suggest that P2X4R plays a role in inflammation given its 
wide co-expression with P2X7R, which plays a key role in immune responses. A study 
by Vaccari et al. (2012) suggested an early inflammatory role of P2X4R in 
inflammatory signalling, such that impaired inflammasome signalling was observed in 
P2X4R knockout mice after spinal cord injury with lower level of caspase-1 activation 
and interleukin-1β (IL-1β) cleavage. This P2X4R-mediated inflammatory response is 
suggested to be an initial inflammatory signal that is amplified by P2X7R. Consistently, 
another study demonstrated a synergistic interaction between P2X4R and P2X7R in 
releasing IL-1β and IL-18 from bone-derived dendritic cells. The release of IL-1β is 
attenuated in P2X4R-knockout dendritic cells suggesting a synergistic interaction 
between P2X4R and P2X7R in inflammatory response, but the detail mechanism is 
yet to be elucidated (Sakaki et al., 2013).  
1.12 A role for lysosomal P2X4R in lung alveolar type II cells  
P2X4Rs are widely expressed in lung tissues, including the intracellularly localised 
P2X4R in lamellar bodies (LBs) of the lung alveolar type-II (ATII) epithelial cells 
(Miklavc et al., 2010). LBs are lysosome related organelles that store surfactants, the 
release of which facilitates maintenance of surface tension in lungs. Exocytosis of LBs 
and the efficient release of surfactants requires a localised surge of Ca2+ at the 
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proximal fusion site between LBs and the plasma membrane, which is called fusion-
activated Ca2+ entry (FACE) (Miklavc et al., 2010). The initial fusion between LBs and 
the plasma membrane opens a narrow fusion pore that allows influx of extracellular 
ATP and efflux of protons. The resultant activation of P2X4Rs mediates a localised 
Ca2+ signal, which triggers the widening of the fusion pore and surfactant release 
(Miklavc et al., 2010). In conjunction with the patch clamp technique, imaging studies 
confirmed that active P2X4Rs mediate the fusion of LBs and surfactant release, but 
fusion of LBs is attenuated upon removal of extracellular ATP (Miklavc et al., 2010). 
The over expression of the dominant negative mutant, P2X4R-C353W in ATII cells 
attenuated Ca2+ entry and caused a reduction in the number of LB fusions (Miklavc et 
al., 2010). The evidence suggests that P2X4R is essential in regulating the 
conventional fusion of LBs in ATII cells and shows a physiological role for P2X4Rs in 
lysosome-like compartments.  
1.13 Lysosome structure 
The lysosome is the primary degradative compartment of a cell that contains various 
acidic hydrolases as well as more than 25 different lysosomal transmembrane proteins 
(Xu and Ren, 2015; Zhong et al., 2016). The lysosome is a heterologous organelle 
that varies in size (0.1 µm - 1.0 µm in diameter in most mammalian cells), morphology, 
and distribution (Wartosch et al., 2015; Xu and Ren, 2015). The acidic nature of the 
lysosome is maintained by the vacuolar-type proton pump (V-ATPase), which 
maintains the pH at approximately pH 4.6 (section 1.16) (Mellman et al., 1986; Mindell, 
2012).  
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1.14 The function of lysosomes 
Lysosomes have been long regarded as a disposal organelle, but lysosomes are now 
recognised as organelles that modulate many cellular processes, including 
degradation of intro- and extracellular substrates and cell death.  
Lysosomes receive substrates for degradation from different routes: extracellular 
components are delivered to lysosomes via the endocytic pathway and digestion of 
intracellular macromolecules or recycling of intracellular organelles occurs via the 
autophagy pathway, which will be discussed in the next section (Luzio et al., 2007). 
The endocytic pathway is tightly pH regulated, whereby pH gradually decreases from 
early endosomes (pH 6.0) to late endosomes (pH 5.5), and finally lysosomes (pH 4.6). 
The sequential drop in pH suggests that pH may be important in vesicular maturation, 
delivery of substrates, fusion of endosomes with lysosomes, and finally lysosome 
clearance. Tight regulation of lysosome pH is important to maintain lysosome 
biogenesis because most lysosome hydrolases have optimal activity under acidic 
conditions (Hu et al., 2015; Xu and Ren, 2015).  
Due to the high content of hydrolytic enzymes, lysosomes can potentially be harmful 
and they have been shown to contribute to cell death. The release of lysosomal 
proteases is suggested to modulate apoptosis signalling. One example is via 
lysosomal membrane permeabilisation (LMP), a process where the membrane of 
lysosomes is permeabilised allowing the leakage of lysosome hydrolases, specifically 
cathepsins, into the cytoplasm to mediate apoptosis. Consistent with this, some 
cathepsins have been implicated to retain functional activity at neutral pH, such as 
cathepsin B, D and L (Boya and Kroemer, 2008). There is evidence showing that the 
microinjection of cathepsins into the cytoplasm is sufficient to trigger initiation and 
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progression of the apoptosis pathway (Appelqvist et al., 2013; Bivik et al., 2006; 
Schestkowa et al., 2007). Furthermore, upregulation of cathepsin levels in the 
extracellular space is implicated in many human cancers (Gyrd-Hansen et al., 2004; 
Palermo and Joyce, 2008) and this enhanced level of cathepsins promotes cancer 
progression, such that it degrades the extracellular matrix (ECM) and its basement 
membrane to facilitate cancer invagination (Tardy et al., 2006). Evidence also shows 
that the knockout of specific cathepsins reduces tumour growth and cell proliferation 
(Vasiljeva and Turk, 2008). Despite the evidence of LMP in cancer and cell death, the 
exact molecular mechanisms and induction of LMP remain unknown.  
1.14.1  Autophagy 
Autophagy is a catabolic process, also known as self-digestion, that is essential for 
the recycling of intracellular organelles and macromolecules in response to nutrient 
and energy starvation. There are three main modes of autophagy: chaperone-
mediated autophagy, microautophagy and macroautophagy (Zhang, 2013). 
Macroautophagy is suggested to be the main mode of autophagy, and hereafter will 
be referred as autophagy.  It mainly degrades and recycles a large portion of 
cytoplasmic contents and organelles.  
1.14.2 The molecular mechanisms of autophagy  
Autophagy is stimulated by diverse stimuli, such as nutrient starvation, hypoxia and 
pathogen invasion and the central mediator of autophagy is mammalian target of 
rapamycin complex 1 (mTORC1). Activity of mTORC1 is regulated by anabolic input, 
for example, cellular nutrient status. Active mTORC1 constitutively inhibits the protein 
kinase ULK complex (the molecular complex for the autophagy induction), by 
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phosphorylation to reduce the activity of ULK complex (Gallagher et al., 2016). During 
nutrient starvation, the activity of mTORC1 is suppressed, thus relieving the ULK 
complex inhibition to recruit autophagy-related (ATG) proteins for autophagy initiation 
(Jung et al., 2009).   
Following autophagy initiation, a double membrane bound vesicle, the 
autophagosome, is formed. The synthesis of autophagosomes is controlled by ATG 
proteins through vesicular nucleation, elongation, and maturation. Despite extensive 
study of autophagosome biosynthesis, the source of autophagosome membranes is 
only speculative, and although it may derive from the ER and/or mitochondria, it 
remains unclear (Tooze, 2010). Biosynthesis is followed by autophagosome 
elongation and maturation, before shaping and closure of the autophagosome, a 
process controlled by two ubiquitin-like conjugating systems (Wirawan et al., 2012; 
Zhou et al., 2013). Firstly, ATG7, the E1-like enzyme, activates ATG12. Then, the 
active ATG12 translocates to ATG10, an E2-like enzyme, to conjugate ATG12 with 
ATG5 into a complex (Van Limbergen et al., 2009). This ATG12-ATG5 complex is then 
formed into a multimeric structure with ATG16L1, which acts as an E3-ligase for the 
second ubiquitin-like mechanism to complete the autophagosome maturation (Ohsumi, 
2014). The next steps involve the microtubule-associated protein light chain 3 (LC3). 
Under nutrient rich conditions, a low level of LC3 protein is cleaved into soluble LC3-I 
protein by ATG4, a cysteine protease (Hanada et al., 2007). In response to the 
initiation of autophagy, a combination activation of ATG7 (E1-like enzyme), which 
mediates formation of ATG12-ATG5-ATG16L1 complex (E3 ligase), is transferred to 
ATG3 (E2-like enzyme) to facilitate the conjugation of the soluble LC3-I protein and 
phosphotidylethanolamine (PE) to produce LC3-II protein. In conjunction with the 
activity of ATG3, the ATG12-ATG5-ATG16 multimeric complex facilitates the efficient 
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lipidation of LC3-I protein into LC3-II protein, which decorates both inner and outer 
membranes of autophagosomes (Hanada et al., 2007). In addition, the presence of 
LC3-II protein on autophagosomes has been suggested to facilitate the elongation and 
closure of autophagosomes (Nakatogawa et al., 2007; Shen and Mizushima, 2014). 
Taking advantage of the solubility of LC3 proteins from the soluble LC3-I protein into 
the lipidated form of LC3 protein (LC3-II), LC3 proteins act as a major marker in the 
investigation of autophagy process.  
After the formation and maturation of autophagosomes, they are delivered to fuse with 
lysosomes. The fusion between autophagosomes and lysosomes forms 
autophagolysosomes (sometimes known as autolysosomes) where degradation 
occurs. The localised elevation of Ca2+ signals and the pH of lysosomes are important 
factors for the fusion between autophagosomes and lysosomes (Kawai et al., 2007). 
The fusion is suggested to be similar to the homotypic fusion of vacuoles in which the 
fusion is facilitated by the SNAREs Vam3 and Vti1 (syntaxin7 and VTI1B are the 
mammalian homologues). In addition, Rab7 has been shown to play an important role 
in this fusion; Rab7-depleted cells inhibit the fusion between autophagosomes and 
lysosomes, resulting an accumulation of LC3-II proteins (Ganley et al., 2011). 
Moreover, the knockdown of LAMP1 and LAMP2 proteins have also been shown to 
inhibit this fusion, suggesting a role for LAMP1 and LAMP2 in this fusion machinery, 
although the detailed mechanism underlying this fusion remains elusive (González-
Polo et al., 2005; Luzio et al., 2007). Once both autophagosome and lysosome are 
fully integrated, content mixing enable the activation of hydrolases to undergo the 
lysosomal degradation and subsequently release resulting metabolites into cytoplasm. 
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1.14.3 Autophagy in disease 
Autophagy is a cellular adaptation to starvation and acts as a sensor of cellular energy 
and nutrient status (Boya et al., 2013). Autophagy initiation in response to nutrient 
starvation allows degradation of intracellular organelles and metabolites to supply 
energy and/or nutrients to maintain cellular viability (Rubinsztein et al., 2012). One 
example of autophagy is during starvation which evokes the digestion of lipid droplets 
in the liver to generate free fatty acids from triglycerides as an energy supply (Singh 
et al., 2009). Studies suggest that autophagy acts as a double-edged sword; its tumour 
suppressor property inhibits the initial growth of cancerous cells but, conversely some 
studies have demonstrated a role of autophagy in the pro-survival pathway of cancer 
cells under unfavourable conditions. For example, autophagy sustains viability of 
cancerous cells by providing a consistent nutrient supply via aerobic glycolysis to 
sustain rapid proliferation and survival of cancer cells in a low nutrient 
microenvironment and hypoxic conditions (Choi et al., 2013). Additionally, autophagy 
has been suggested to prevent cancerous cells from programmed cell death upon 
metastasis (Wirawan et al., 2012).  
It is tempting to associate autophagy with neurodegenerative diseases, for example 
Parkinson’s disease, because of the pathological phenotype of mass aggregates 
observed in several neurodegenerative diseases that could be associated with 
impaired autophagic degradation. Despite the lack of direct evidence for impaired 
autophagy in neurodegenerative disease, studies have shown raised expression of α-
synuclein in rat PC12 cells (a cell line derived from pheochromocytoma of adrenal 
medulla), which is a hallmark of Parkinson’s disease, could disrupt the 
autophagosome biogenesis and lysosome acidification, thus resulting in the disruption 
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in autophagic clearance (McBrayer and Nixon, 2013; Winslow et al., 2010). 
Pathological manipulation to increase the autophagy process reduces α-synuclein in 
aggregates, indicating a potential therapeutic target in treating neurodegenerative 
disease via autophagy induction (Rubinsztein et al., 2012).  
1.15 Lysosome dysfunction and disease 
As lysosomes contribute to many different cellular processes, disruption of lysosomes 
has been implicated in several diseases. One example is Niemann-Pick type C (NPC) 
disease, an autosomal recessive disease. NPC disease arises from the loss of NPC1 
and NPC2 proteins that are lysosomal-limiting membrane proteins and soluble 
lysosomal proteins, respectively (Garver et al., 2010). NPC2 transports cholesterols 
to lysosomes; however, the role of NPC1 remains elusive (Lloyd-Evans and Platt, 
2010). NPC1 has been suggested to bind cholesterols in lysosomes given its sterol-
sensing domain. This suggests both NPC1 and NPC2 proteins are important in 
regulating cholesterol level in cells (Lloyd-Evans and Platt, 2011). Given the 
importance of Ca2+ as an ubiquitous intracellular messenger and Ca2+ is concentrated 
in lysosomes, NPC1-mutant cells exhibit a reduction in lysosomal Ca2+ release, which 
may be one of the underlying factors contributing to the disruption in cholesterol 
trafficking and recycling (Lloyd-Evans et al., 2008). A study by Cao et al. (2015b) 
showed the increase of lysosome Ca2+ signals is sufficient to ablate the accumulation 
of cholesterols in lysosomes, a hallmark of NPC-mutant fibroblasts, and restored 
lysosomal membrane trafficking. This showed that the over expression of the 
lysosomal Ca2+-activated big-conductance K+ channel (BK) formed a macromolecular 
complex with lysosomal Ca2+ release channel, transient receptor potential mucuolipin 
(TRPML1). The complex enables BK channels to mediate counter cation influx that 
34 
 
facilitates the Ca2+ release from lysosomes via TRPML1, thereby reversing lysosomal 
storage defects in NPC cells.  
In addition, mutations in the Mcoln1 gene, encoding TRPML1, have been implicated 
in mucolipidosis type IV (MLIV) disease (Bach, 2005). MLIV has the clinical features 
of disrupted endolysosomal membrane trafficking, reduced lysosomal Ca2+ release 
and excessive accumulation of undigested substrates (Cheng et al., 2010). The 
mutation in TRPML1 causes enlargement of late endosomes and lysosomes, probably 
due to disruption in lysosomal Ca2+ signalling, which in turn impacts the balance of 
lysosome fusion and/or fission (Cheng et al., 2010). Together, these pathological 
situations indicate the importance of lysosomal Ca2+ homeostasis in cellular function 
and suggest that the modulation of lysosomal Ca2+ channels such as TRPML1 and 
P2X4R could be potential therapeutic targets for treating lysosomal diseases. 
1.16 Regulation of lysosome acidification 
Lysosome pH is maintained at pH ~4.6 mainly by V-ATPase, a protein complex that 
utilises ATP to pump H+ into the lumen of lysosomes (Colacurcio and Nixon, 2016; 
Forgac, 2007; Nishi and Forgac, 2002). The V-ATPase protein complex is comprised 
of at least 14 different protein subunits that hydrolyse ATP and drive H+ uptake against 
the concentration gradient from the cytoplasm (Cotter et al., 2015). For each ATP 
molecule being hydrolysed by V-ATPase, two to four H+ are transported across the 
lysosomal membrane (Colacurcio and Nixon, 2016; Cotter et al., 2015; Kettner et al., 
2003). However, the accumulation of H+ in the lumen of lysosomes generates a 
positive transmembrane potential that curbs V-ATPase activity, but a counter-ion flux, 
mediating cation efflux and/or anion influx, helps circumvent this, thereby sustaining 
active transport of H+ into lysosomes (Steinberg et al., 2010). In cooperation with the 
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V-ATPase, the presence of the Cl−/H+ antiporter ClC-7 on the lysosome membrane 
has been shown to regulate the counterbalance of ion transportation such that the 
influx of two Cl− influx and efflux of one H+ into cytoplasm across the lysosome 
membrane also contributes to lysosome acidification. Knockdown of ClC-7 and 
disruption in the trafficking of ClC-7 to lysosomes result in reduced lysosome acidity 
(Di et al., 2006; Graves et al., 2008; Majumdar et al., 2011).   
Disruption in lysosome pH has been implicated in pathological conditions. One 
example is the increase in lysosomes pH in fibroblasts with an Alzheimer-associated 
presenilin1 (PS1) mutation (Coffey et al., 2014). The study demonstrated that the PS1-
mutation cells have an elevated lysosomal pH, reduced cathepsin D activity, and 
accumulation of autophagic substrates. An increase in intracellular cAMP restored the 
impaired lysosome function suggesting it has a pivotal role of lysosome pH. Inhibition 
of lysosome acidification may suggest that lysosome pH may be one of the 
contributing factors that causes a lysosome proteolysis defect, thereby exacerbates 
the progression of Alzheimer’s disease. 
1.17 The mechanisms of lysosome fusion  
Lysosomes can fuse with several different cellular compartments, including late 
endosomes, phagosomes, autophagosomes, and the plasma membrane (Luzio et al., 
2007, 2010). Fusion of lysosomes is essential for vesicular transport and for delivery 
of metabolites to cells. With regards to vesicular transport, several theories have been 
proposed as to the mechanisms of lysosome fusion including kiss-and-run, direct 
fusion, tubulation and fusion & fission (Bright et al., 2005; Fig. 4). 
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 Lysosome fusion is composed of three consecutive steps, including tethering, 
formation of the trans-SNARE complex, and fusion. Tethering between late 
endosomes and lysosomes is facilitated by Rab7, which recruits vacuolar protein 
sorting (Vps) 18 and Vps 39, which are components of the homotypic fusion and 
vacuole fusion protein sorting (HOPs) complex. These proteins help the aggregation 
of late endosomes and lysosomes prior to fusion (Caplan et al., 2001; Poupon et al., 
2003). Following tethering, both Q- and R- SNAREs that localise to late endosome 
and lysosome membranes, respectively are formed into a trans-SNARE complex 
between 2 organelles. In heterotypic fusion between late endosomes and lysosomes, 
the vesicle associated membrane protein-7 (VAMP7) forms a bundle with Qa-, Qb- and 
Qc- SNAREs (syntaxin7, VTI1B and syntaxin8), to facilitate the fusion between late 
endosomes and lysosomes (Antonin et al., 2000; Luzio et al., 2007; Pryor et al., 2004). 
Complete formation of the trans-SNARE complex induces Ca2+ and calmodulin-
dependent lysosome fusion (Luzio et al., 2007; Pryor et al., 2000).  
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Lysosome exocytosis is an important process for cellular mechanisms such as plasma 
membrane repair, secretion of hydrolytic enzymes, and upregulation of receptors 
(Samie et al., 2013). It is now known that both secretory and non-secretory lysosomes 
undergo exocytosis (Jaiswal et al., 2002; Xu and Ren, 2015). Similar to the secretory 
lysosomes, studies have suggested that the motility of non-secretory lysosomes is 
also mediated by microtubule-based proteins, including kinesin, which regulates the 
anterograde movement of lysosomes towards the plus-end of microtubules, and 
dynein that modulates the retrograde movement towards the minus end of 
microtubules at the perinuclear region (Li et al., 2016; Reddy et al., 2001). The 
anterograde movement of lysosomes towards the cell periphery and their 
accumulation at the plasma membrane facilitates their tethering to the plasma 
membrane (Medina et al., 2011; Samie et al., 2013; Xu and Ren, 2015). Similar to the 
 
Figure 4 Mechanisms of lysosome fusion. A schematic diagram demonstrating three 
different modes of lysosome fusion including kiss-and-run (where lysosomes transiently 
fuse (kiss) to exchange their contents (left)), direct fusion (where lysosomes completely 
fuse to mix their contents (middle)), and tubulation (where a lysosome extends a short 
tubule that connects with another lysosome to enable exchange of contents). These modes 
of fusion can occur between two lysosomes or between a lysosome and a late endosome.  
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fusion between late endosomes and lysosomes, the fusion between lysosomes and 
the plasma membrane is facilitated by the formation of a trans-SNARE complex, which 
is comprised of the Q-SNAREs syntaxin-4 and synaptosome associated protein of 23 
kDa (SNAP23). Upon formation of the trans-SNARE complex between the plasma 
membrane and lysosomes, the Ca2+ sensor synaptotagmin-VII is essential for 
complete fusion to occur and the release of lysosomal contents to the extracellular 
space (Luzio et al., 2007; Rao et al., 2004). There is evidence demonstrating that 
peripherally localised lysosomes have a more alkaline luminal content than 
juxtanuclear lysosomes due to a decrease in V-ATPase activity and increased H+ leak 
(Johnson et al., 2016). This would favour recruitment of P2X4R activity to trigger Ca2+-
dependent exocytosis.  
1.18 Lysosomes contain ATP 
In addition to their central role in degradation, lysosomes act as a reservoir for ATP 
and the concentration of ATP is thought to be in the millimolar range (Zhang et al., 
2007). Glycyl-L-phenylalanine-betanaphthylamide (GPN) is a cathepsin C substrate 
that is thought to selectively permeabilise the lysosome membrane, which results in 
the release of ATP from lysosomes, but not from mitochondria (Zhang et al., 2007). 
Another study has used quinacrine, a fluorescent dye that localises to intracellular ATP 
stores, to show that compartments containing the lysosomal associated membrane 
protein1 (LAMP1) have high levels of ATP (Huang et al., 2014).  
1.19 Lysosomes as intracellular Ca2+ stores  
Lysosomes contain a high concentration of Ca2+ comparable to that of the principal 
cellular Ca2+ store, the ER (~0.5 mM; Patel and Cai, 2015). The lysosomal Ca2+ 
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concentration is ~5000 fold higher than in the cytoplasm, which contains 
approximately 100 nM (Patel and Cai, 2015). Such a steep Ca2+ gradient between the 
lumen of lysosomes and cytoplasm requires either a Ca2+ exchanger mechanism or a 
Ca2+-ATPase. The nature of this Ca2+ transport mechanism in mammalian cells 
remains unknown. However, in yeast a Ca2+ /H+ exchanger (CAX) is important in 
maintaining the high luminal Ca2+ concentration, but there is no evidence for the 
expression of CAX in the majority of mammalian cells, with genomic encoding for CAX 
only being detected in two mammals, Ornithorhynchus anatinus and Sarcophilus 
harrisii (Melchionda et al., 2016). It was shown that over expression of CAX causes a 
modest decrease in Ca2+ release from the ER in response to carbachol (a cholinergic 
agonist that stimulates Ca2+ release from the ER) in SHSY5Y cells, a human-derived 
bone marrow neuroblast cell line (Luciani et al., 2009). This suggests that CAX 
sequesters Ca2+ into lysosomes, leading to a modest drop in the ER Ca2+ 
concentration and thus making less available for release upon stimulation (Melchionda 
et al., 2016). 
Lysosomes express various Ca2+ release channels, for example the TRPML1 and the 
two-pore channel-2 (TPC2), in addition to P2X4R. TRPML1 localises to both 
endolysosomes and lysosomes, and has 6 transmembrane domains with intracellular 
N- and C- termini (Zhong et al., 2016). TRPML1 channels are activated by 
phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), and are cation permeable, showing 
preferential Ca2+ permeability (Dong et al., 2010; Patel and Cai, 2015; Yamaguchi et 
al., 2011). Evidence suggests nicotinic acid adenine dinucleotide phosphate (NAADP) 
activates TRPML1 to mediate lysosome Ca2+ release, however this has been a subject 
of controversy (Zhang and Li, 2007). TRPML1 has been shown to regulate lysosomal 
pH such that the knockdown of TRMPL1 results in more acidic lysosomes compared 
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to wild type (Soyombo et al., 2006). Moreover, TRPML1 mediates lysosome 
membrane trafficking via fusion and/or fission: cells lacking TRPML1 have enlarged 
lysosomes, whereas over expression of TRPML1 reverses this phenotype suggesting 
a key role for TRPML1 in fission (Dong et al., 2010). This has been implicated in the 
human disease, MLIV, an autosomal recessive lysosomal storage disease (LSD). This 
disease is associated with disrupted lysosome biogenesis further emphasising the 
importance of TRPML1 in regulating Ca2+ signalling in lysosome function (Zhong et al., 
2016).  
TPC2 channel is a cation-selective channel that has been implicated in the regulation 
of lysosome function, including trafficking along the endocytic pathway and the 
regulation of lysosome fusion and fission (Grimm et al., 2014; Ruas et al., 2010). TPC2 
channels exist as dimers and each subunit is comprised of two repeats of 6 
transmembrane domains in tandem (Patel and Cai, 2015; Penny et al., 2016; Pitt et 
al., 2010). There are several studies demonstrating that TPC2 channels are activated 
by both NAADP and PI(3,5)P2 and are permeable to Ca2+ following stimulation (Jha et 
al., 2014; Patel and Cai, 2015). A role for TPC2 in the regulation of membrane 
trafficking has previously demonstrated that the knockout of TPC2 causes a disruption 
in the internalisation of growth factor receptors and accumulation of low-density 
lipoprotein (LDL) (Grimm et al., 2014; Patel and Cai, 2015). Furthermore, there is 
evidence showing a role of TPC2 in autophagy, such that the over expression of TPC2 
in HeLa and embryonic stem cells inhibits the fusion between autophagosomes and 
lysosomes (Lu et al., 2013). Blockade of this fusion resulted in an accumulation of 
autophagosomes, thereby disrupting the progression of autophagy. The knockdown 
of TPC2 and pharmacological blockade of NAADP antagonist, NED-19 reversed this 
effect. Furthermore, the study showed that the activation of TPC2 alkalinises the 
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lysosome via Ca2+ release, thereby inhibiting the fusion between lysosomes and 
autophagosomes. Together with TRPML1, these results suggest the importance of 
lysosomal Ca2+ release channels in lysosome function.  
The elevation of cytosolic Ca2+ in the immediate vicinity of lysosomes is necessary for 
efficient fusion of lysosomes with other organelles (Rodríguez et al., 1997). Growing 
evidence indicates that the source of the Ca2+ signal for lysosome fusion is derived 
from lysosomes themselves. Indeed, the first evidence suggesting the importance of 
lysosomal Ca2+ efflux in lysosome fusion was shown in a cell-free experiment in yeast 
using two Ca2+ chelating reagents. The study showed that the membrane 
impermeable 1,2-bis-(o-aminophenoxy)ethane-N,N,N’,N’-tetra-acetic acid (BAPTA) 
inhibited homotypic vacuole fusion, whereas a second membrane impermeable Ca2+ 
chelator EGTA has no effect (Peters and Mayer, 1998). This was due to the rapid 
chelating effect of BAPTA, which is 100 times faster than EGTA. BAPTA induced a 
dispersedly low Ca2+ gradient across the cytoplasm, including the immediate vicinity 
of lysosome, that is fast enough to suppress any biological response. In addition, the 
presence of ionomycin, a Ca2+ ionophore that mobilises intracellular Ca2+ stores, 
depletes luminal vacuole Ca2+ and abolished all fusion even without pre-treatment with 
BAPTA. However, vacuoles become fusion-competent once the luminal Ca2+ in 
vacuoles was restored, indicating the luminal Ca2+ is required for vacuole fusion. This 
agrees with another study in a cell-free vesicle fusion assay using mammalian cells. 
This showed inhibition in the fusion between late endosomes and lysosomes using a 
membrane permeable ester Ca2+ chelator, EGTA-AM, emphasising the importance of 
luminal Ca2+ release from lysosome is essential for the fusion of lysosomes (Pryor et 
al., 2000). 
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1.20 P2X4Rs function as a Ca2+ release channel 
A previous collaboration between the Murrell-Lagnado group and Xianping Dong’s 
group at the University of Dalhousie investigated the role of rP2X4R in lysosome 
function. They utilised lysosomal patch clamp electrophysiology to investigate the 
activity of rP2X4R expressed in Cos-1 cells. P2X4R is oriented in lysosomes such that 
the extracellular ATP binding site faces the lumen (Fig. 5). Under conditions where 
the lysosome lumen was dialysed with an acidic solution (pH 4.6) containing ATP (0.1 
mM), there was no P2X4R-mediated current observed. However, when the pH was 
increased to 7.4, a P2X4R-mediated current was recorded (Huang et al., 2014). This 
demonstrated the importance of pH in regulating the ability of ATP to activate P2X4R. 
Further experiments demonstrated that lysosomal P2X4Rs exhibit a similar 
pharmacological profile to plasma membrane P2X4R and are potentiated by 
ivermectin, but insensitive to suramin (Huang et al., 2014).  
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A further study demonstrated that enlargement of lysosomes (hereafter referred to as 
vacuolated lysosomes) occurred following expression of rP2X4R in Cos-1 cells, but 
not in cells expressing rP2X4R-S341W, which is a non-functional P2X4R mutant with 
a mutation in TM2 (Silberberg et al., 2005). The number of vacuolated lysosomes in 
cells expressing rP2X4R was further potentiated following lysosome alkalinisation, 
using methylamine (MA), NH4Cl or bafilomycin-A1 (Baf-A1) (Cao et al., 2015), 
suggesting that the activation of lysosomal P2X4R following lysosomal alkalinisation 
was able to mediate homotypic lysosome fusion (Cao et al., 2015). The P2X4R-
mediated lysosome fusion was shown to be dependent upon calmodulin (CaM) which 
forms a physical complex with P2X4R (Cao et al., 2015). Despite the evidence for 
P2X4R-dependent lysosome fusion following lysosome alkalinisation, the study does 
not show under what physiological conditions P2X4R is activated.  
 
 
Figure 5 A schematic diagram of P2X4R in the lysosomes is oriented such that its 
extracellular domain, which is decorated by N-linked glycans, faces the lysosomal 
lumen, whereas both N- and C-termini face the cytoplasm.  
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1.21 Cytosolic Ca2+ signaling and the ER  
1.21.1 Ion channels in the ER  
A major source of Ca2+ that mediates the cytosolic Ca2+ signal is the ER. The two main 
Ca2+ release channels in the ER membrane are inositol 1,4,5 triphosphate receptors 
(IP3Rs) and ryanodine receptors (RyRs), receptors activated by IP3 and cyclic ADP-
ribose (cADPR), respectively (Patel and Cai, 2015). IP3 is released by phospholipase 
C mediated hydrolysis of phosphatidylinositol 4,5 biphosphate (PI(4,5)P2), a pathway 
triggered downstream of  GPCRs that couple to Gq proteins (Raffaello et al., 2016). 
The localised elevation of Ca2+ released via IP3Rs triggers the clustering of IP3Rs and 
this ultimately results in the potentiation and propagation of Ca2+ signals along the ER, 
and a rise in the global Ca2+ concentration within cells (Rahman, 2012; Wilson et al., 
1998). It has been suggested that IP3R activity is tightly regulated by the cytosolic 
[Ca2+]; specifically, a low concentration of Ca2+ triggers IP3R activation, whereas a high 
concentration of Ca2+ impedes IP3R activation and reduces Ca2+ release. This biphasic 
Ca2+ sensitivity of IP3R is however dependent on the IP3 concentration (Adkins and 
Taylor, 1999). Beside Ca2+ release channels, the ER is also able to uptake Ca2+ by 
the sarcoplasmic reticulum Ca2+ ATPase (SERCA). SERCA is a P-type ATPase that 
utilises one ATP molecule to transport two Ca2+ ions from the cytoplasm against the 
concentration gradient into the ER (Krebs et al., 2015).    
1.21.2 Ca2+ signaling between the ER and lysosomes 
Most lysosomes are localised to the perinuclear region in close proximity to the ER. 
Electron microscopy studies have shown that ER and lysosomes are ~20 nm apart 
(Kilpatrick et al., 2013; Lam and Galione, 2013). Additionally, TIRF microscopy studies 
in Cos-7 cells show lysosomes to be highly associated with the ER whereby some 
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mobile lysosomes migrate along with the ER tubules (López-Sanjurjo et al., 2013). 
Tight positioning between these two organelles suggests that they are intimately 
associated and that interactions between them might be important in the regulation of 
organelle Ca2+ signalling. 
Indeed, it has been shown that stimulation of lysosomal Ca2+ release can facilitate the 
mobilisation of Ca2+ release from the ER and vice versa, whereby the release of ER 
Ca2+ via IP3R triggers Ca2+ release from acidic vesicles (Kilpatrick et al., 2013; Morgan 
et al., 2013). One example of the functional crosstalk between lysosomes and the ER 
was shown by the potent Ca2+ mobilising messenger, NAADP which targets acidic 
lysosomal-related organelles. In smooth muscle cells, NAADP triggers localised Ca2+ 
signals from lysosome-like organelles and this is subsequently amplified by Ca2+ 
release from the SR to generate cytoplasmic Ca2+ signals (Kinnear et al., 2004). 
Similarly, Baf-A1, a V-ATPase inhibitor that triggers lysosome alkalinisation, was 
shown to trigger a cytoplasmic Ca2+ signal, but blocked the NAADP-mediated Ca2+ 
signal. Baf-A1 is thought to discharge Ca2+ from lysosomal-related organelles, thereby 
preventing NAADP-dependent Ca2+ release from lysosomes. Furthermore, this 
subsequent response of global Ca2+ signal evoked by NAADP was abolished upon SR 
Ca2+ depletion by thapsigargin (a SERCA inhibitor) or inhibition of SR Ca2+ release 
channels (Kinnear et al., 2004). This finding suggests that the mobilisation of 
lysosome-related Ca2+ store is sufficient to trigger the activation of SR/ER Ca2+ release 
channels (IP3Rs and RyRs) and further amplify global Ca2+ response.  
In addition to smooth muscle cells, another study demonstrated that lysosomal Ca2+ 
release is sufficient to evoke ER-mediated Ca2+ signals in human fibroblasts (Kilpatrick 
et al., 2013). Akin to the mechanism mediated by NAADP, the lyso-osmotic agent GPN, 
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which perforates lysosome membrane, generated a prominent Ca2+ signal followed by 
global oscillatory Ca2+ responses, which are mediated by IP3Rs on the ER. The 
inhibition of Ca2+ release from the ER, either by ER Ca2+ depletion (using thapsigargin) 
or by inhibition of IP3Rs (via the non-selective IP3R antagonist 2-aminoethoxydiphenyl 
borate, 2-APB) attenuated this GPN-evoked Ca2+ signal and abolished the global Ca2+ 
oscillations. These confirmed that the GPN-induced lysosomal Ca2+ signal is sufficient 
to stimulate ER Ca2+ release, but is prevented in the absence of the ER Ca2+ release 
(Kilpatrick et al., 2013). Another study confirmed these findings using a computational 
model, which simulated the microdomains between lysosomes and the ER (Penny et 
al., 2014). Using the model, it was consistently demonstrated that GPN and NAADP 
can drive the global Ca2+ oscillation through the ER Ca2+ release. It was also found 
that only a low [Ca2+] from lysosomes is needed for the stimulation of the ER Ca2+ 
release, which aligns with ER-lysosome proximity and the high affinity of IP3Rs for 
Ca2+. Collectively, these findings strongly suggest that mobilisation of lysosomal Ca2+ 
is sufficient to stimulate the ER-mediated Ca2+ release.  
Apart from the lysosomal Ca2+ release pathway, there is growing evidence to establish 
the mechanism of lysosome Ca2+ reuptake and the source of lysosomal Ca2+. There 
is evidence that describes lysosome Ca2+ refilling occurs from the ER and that 
perturbation of lysosome activities is sufficient to disrupt this mechanism. The study 
showed that disruption of lysosomal refilling is sufficient to cause aggregation of Ca2+ 
in the ER, resulting an increased ER Ca2+ release (López-Sanjurjo et al., 2013). This 
was shown by both Baf-A1 and GPN, which dissipates the lysosome H+ gradient and 
perforates the lysosome membrane respectively, enhancing the ER Ca2+ release in 
response to carbachol. Furthermore, the enlargement of lysosome size using 
vacuolins, molecules that induce enlargement of endosomes and lysosomes (Cerny 
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et al., 2004), also enhanced the carbachol-evoked Ca2+ response. In addition, 
carbachol was observed to trigger lysosome alkalinisation, suggesting that lysosome 
pH is likely to modulate lysosomal Ca2+ refilling (López-Sanjurjo et al., 2013). This 
suggests that several lysosome attributes, including pH, size, and membrane integrity, 
are essential in maintaining lysosome Ca2+ refilling from the ER. Nonetheless, the 
study does not rule of the possibility of the potential reciprocal relationship where Ca2+ 
release from lysosomes can stimulate the ER Ca2+ release, thereby potentiating global 
Ca2+ signals, and vice versa (López-Sanjurjo et al., 2013).  
Results have also been reported to explain a mechanism of lysosome Ca2+ refilling 
that is tightly associated with ER Ca2+ signalling. The study monitored the lysosome 
Ca2+ signal, but not global Ca2+ signal, using GCaMP3-ML1, a Ca2+ reporter, that is 
conjugated to the lysosome Ca2+ channel TRPML1 (Garrity et al., 2016). 
Administration of the TRPML1 agonist, ML-SA1 induced a prominent Ca2+ signal, 
which was suggested to be a measure of Ca2+ release from lysosomes. The study 
further suggested that the lysosomal Ca2+ store is refilled from the ER via IP3Rs, a 
process independent of lysosome pH. Given a sufficient time interval (~5 mins), 
repeated application of ML-SA1 evoked a reproducible, transient Ca2+ signal, 
suggestive of lysosome refilling occurring between applications. However, lysosome 
Ca2+ is depleted by rapid repeated applications of ML-SA1 as demonstrated by a 
decrease in Ca2+ signal, indicating that lysosomes are continuously refilled with a 
certain time interval. Similarly, lysosome refilling was observed using GPN. Consistent 
with Kilpatrick et al. (2013), both studies demonstrated lysosomal Ca2+ uptake from 
the ER via IP3Rs. For example, the inhibition of IP3Rs using Xestospongin-C (a 
selective IP3R antagonist) or 2-APB (a non-selective IP3R antagonist) decreased the 
ML-SA1-induced lysosome Ca2+ release. Furthermore, the ER Ca2+ content that was 
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chelated by TPEN (N,N,N',N'-Tetrakis (2-pyridylmethyl) ethylenediamine; a membrane 
permeable metal chelator with low binding affinity to Ca2+) reduced the lysosomal Ca2+ 
release (Garrity et al., 2016). However, this study suggested that lysosomal Ca2+ 
refilling is only dependent on the ER Ca2+ release mediated by IP3Rs, independent of 
lysosome pH, which was demonstrated by Baf-A1, such that the amplitude of ML-SA1-
mediated Ca2+ signal remains unaltered in the presence of Baf-A1. The study 
reasoned that if pH of lysosomes is required for lysosome refilling, Baf-A1 should 
decrease the TRML1-mediated Ca2+ signal given the disruption in lysosome Ca2+ 
refilling from the ER, but this was not observed in the study (Garrity et al., 2016). This 
contradicts the proposed mechanism by López-Sanjurjo et al. (2013). However, the 
role of lysosome pH in lysosome refilling cannot be ruled out for the following reasons. 
First, the Ca2+ signals reported by GCaMP3-ML1 might be saturated by TRPML1-
evoked lysosomal Ca2+ signals, and modest decrease in lysosomal Ca2+ release 
following Baf-A1 treatment will not be resolved by GCaMP3-ML1. Secondly, there is a 
possibility that lysosome refilling only allows a limited concentration of Ca2+ from the 
ER given the size and number of lysosomes in relative to the ER. Lastly, if lysosomes 
sequester Ca2+ from the ER, presumably perturbation of lysosome refilling will impact 
on both lysosomes and the ER; decrease lysosomal Ca2+ content and increase the 
Ca2+ content in the ER, as shown by Lopez-Sanjurjo et al. (2013) and Melchionda et 
al. (2016). The study by Garrity et al. (2016) only showed that Baf-A1 did not change 
the Ca2+ release from lysosomes, but not monitoring the Ca2+ content from the ER.  
Although disparities exist, all studies of lysosome Ca2+ release and refilling measured 
Ca2+ release from lysosomes and the ER, and all findings consistently agree that the 
stimulation of lysosomal Ca2+ release is sufficient to potentiate ER Ca2+ release, and 
vice versa (Kilpatrick et al., 2013, Penny et al., 2014, López-Sanjurjo et al., 2013, and 
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Garrity et al., 2016). Together, the evidence suggests a functional interaction between 
the ER and lysosomes, such that Ca2+ shuttles between these organelles to regulate 
the intracellular Ca2+ signalling. Further studies are required to unravel the exact 
molecular mechanism in the ER-lysosome Ca2+ signalling.  
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2. Thesis aims 
Intracellular P2X4Rs can act as receptor reserves that traffic to and from the cell 
surface in response to stimuli. In cells with specialised secretory lysosomes, the type 
II alveolar cells, they have also been shown to be activated upon fusion of the 
lysosome with the cell surface, thereby promoting full collapse of the lysosome. Recent 
evidence suggests that the activity of P2X4Rs in intact lysosomes can also be 
triggered following lysosome alkalinisation. Indeed, one study has shown that 
pharmacological agents that increase the pH of lysosomes are sufficient to activate 
P2X4R and promote homotypic lysosome fusion. However, the physiological and 
pathological regulators of the intracellular P2X4R are yet to be identified. The aim of 
this study was to identify regulators of lysosomal P2X4R and to determine what role 
P2X4Rs play in lysosome function. Specifically, I investigated the following: 
1. The role of P2X7R as a regulator of lysosome P2X4R. This was based upon 
previous observations that activation of P2X7R triggers the alkalinisation of 
lysosomes and that P2X7R is commonly co-expressed with P2X4 in immune, 
epithelial and endothelial cells. 
2. The role of G protein-coupled receptors that trigger release of Ca2+ from the ER 
in activating P2X4R.  This was based on previous observations that Ca2+ entry 
into lysosomes can trigger alkalinisation and the main source of Ca2+ for 
entering lysosomes is that released from the ER. 
3. The role of P2X4R in regulation of autophagy. Autophagic flux is highly 
dependent upon lysosome fusion with the autophagosome and lysosome pH 
which determines the activity of the lysosomal proteases.  
4. A comparison of the subcellular distribution of human P2X4R and rat P2X4R.  
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3. Material & Methods  
3.1  Cell culture 
3.1.1 Cell lines 
Four different cell lines were used in this study: Human cervical cell line (HeLa), 
normal rat kidney (NRK), human embryonic kidney (HEK293) and mRFP-LC3 HeLa 
cells. The first two cell lines were primarily used for Ca2+ imaging and confocal 
imaging studies because their large cell size and typically flat footprint facilitates 
imaging of individual lysosomes in cells. HEK293 cells were used in surface 
biotinylation assays of P2X4Rs. 
3.1.2 Cell maintenance 
HeLa, NRK and HEK293 cells were maintained in growth medium containing: 
Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich, catalogue number: 
D6046) with 10 % fetal bovine serum (FBS; Sigma-Aldrich), and 100 U/ml penicillin 
and streptomycin (P/S), at 37 °C in humidified air with 5 % CO2. Cells were grown in 
75 cm2 flasks (T75) and passaged every 3 days as follows: DMEM was removed, 
cells were washed with 5 ml phosphate buffered saline (PBS) and then incubated 
with 2 ml of 0.05 % trypsin-EDTA solution, which detached cells from the culture 
flask. Subsequently, 8 ml of DMEM was added to neutralise trypsin-EDTA. Cells 
were collected into a 50 ml tube, counted using a haemocytometer and 
approximately 2.5 million cells were added to a new T75 flask with 15 ml of growth 
medium.  For experiments, following trypsinisation, cells were seeded on to 1 % 
poly-L-lysine coated coverslips in 6-well plates, with 250000 cells per well. 
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For protein expression experiments, approximately 3 million cells were seeded into a 
T75 flask and 100000 cells onto 1 % poly-L-lysine 25 mm coated coverslips in a 12-
well plate for immunocytochemistry experiments.  
3.1.3 Isolation and culture of bone marrow derived macrophages (BMDM) 
WT and P2X4-/- mice were a kind gift from Dr Fred Tam (Imperial College, London). 
Hind legs of wild type (WT) and P2X4-/- mice were dissected from the pelvic region 
and sterilised using 70 % ethanol and rinsed using PBS. Fur, skin and muscle were 
removed to isolate femurs, which were cut to expose bone marrow that was 
collected using a 24G needle syringe filled with Roswell Park Memorial Institute 
medium (RPMI, Sigma) containing 10 % FBS and 100 U/ml of P/S. Bone marrow 
was filtered through a 70 μm cell strainer and centrifuged at 1000 g for 5 minutes. 
The BMDM cell pellets were re-suspended with RPMI media containing 30 % of the 
RPMI media that was used to grow mouse connective tissues, L929 cells culture (a 
kind gift from Dr Xing Jian Xu). The growth medium of L929 cell culture contained 
growth factors that support the growth of BMDM cells. Cells were plated onto 1 % 
poly-L-lysine coated 25 mm coverslips with 1.5 million cells per well of a 6-well plate.  
RPMI media was changed every 2-3 days and BMDM cells were assayed after 8-9 
days in culture. 
3.1.4  Transfection  
Poly-ethyl enimine (PEI)  
Cells were seeded 24 h prior to transfection so that they were 80 % confluent at the 
time of transfection.  In each well of a 6-well plate, a total of 2 µg of plasmid DNA 
was mixed with 4 µl of 1 mg/ml PEI (Polysciences, Inc) in 140 µl of serum-free 
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DMEM. The transfection mixture was incubated for 10 minutes at room temperature 
before being administered to cells with 2 ml of fresh grown medium at 37 °C. Cells 
were imaged 24-48 h post-transfection. This transfection method was used for most 
experimental assays in both HeLa and NRK cells. 
Lipofectamine 3000 
This method was used for transfection of LAMP-GECO in NRK and HeLa cells, to 
obtain high expression in cells, for Ca2+ imaging. Cells were grown to 80 % 
confluency and transfected using Lipofectamine 3000 (Thermo Scientific) according 
to the manufacturer’s protocol. In brief, for each well of a 6-well plate, 4 µl of 
Lipofectamine 3000 reagent was diluted in 125 µl of Opti-MEM (Gibco). 2 µg of 
plasmid DNA was added and 5 µl of the P3000 reagent (2.5 µg/µl). This mixture was 
incubated for 10 minutes at room temperature before being administered to cells with 
2 ml of fresh grown media. Cells were incubated for 48 h at 37 °C and then used for 
experiments.  
3.2  Cell based assays  
3.2.1 Single cell Ca2+ imaging  
Fluo4-AM  
For measurement of cytosolic Ca2+, [Ca2+]c, in a single cell measurement, HeLa cells 
were seeded onto 1 % poly-L-lysine coated 25 mm coverslips in a well of a 6-well 
plate the day before experiment. Confluent cells were loaded with Fluo4-AM (2 µM, 
Life Technologies) with 20 % pluoronic acid in normal extracellular solution (NES, 
which contained: NaCl (140 mM), KCl (5 mM), CaCl2.H2O (2 mM), MgCl2.6H2O (1 
mM), D-Glucose (10 mM), HEPES (10 mM) in 1 litre dH2O, adjusted to pH 7.3 using 
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NaOH, for 45 minutes at room temperature. Cells were washed twice with NES and 
de-esterified in NES for a further 30 minutes at room temperature. De-esterification 
of the dye was essential to reduce leakage of Fluo4-AM dye out of the loaded cells. 
For experiments using histamine (50 µM; Sigma), cells were imaged in nominal Ca2+ 
free NES solution at room temperature using a Leica SP5 confocal microscope: 
fluorescence (excitation 490 nm, emission 520 nm, detailed in section 3.5 below), 
0.650 sec per frame for 600 frames for a total of 7 minutes. Histamine (50 µM) was 
administered after 1 minute of recording and after 3 further minutes ionomycin (5 µM, 
Apollo Scientific) with 5 mM Ca2+ containing NES was administered to obtain the 
Fmax, which defined as high and saturating Ca2+ concentration when most 
fluorophore, Fluo4-AM in the cell are bound.  
GECO and LAMP-GECO 
 [Ca2+]c signals in NRK and HeLa cells were obtained using the Ca2+ reporter 
plasmids LAMP-GECO and G1.2-GECO, which were kind gifts from Professor Colin 
Taylor (Department of Pharmacology, University of Cambridge). 400000 cells were 
seeded onto 1 % poly-L-lysine coated 25 mm glass coverslips and after 24 h, cells 
were transfected with either LAMP-GECO or G1.2-GECO using Lipofectamine 3000 
and PEI, respectively as explained above. 24-48 h post-transfection, cells were used 
for single-cell Ca2+ imaging experiments. Both LAMP-GECO and G1.2-GECO were 
excited at 488 nm and fluorescence was measured at 519 ± 20 nm using a SP5 
Leica microscope detailed in section 3.5. Fmax was obtained using ionomycin (5 µM) 
loaded in 5 mM Ca2+-containing NES at the end of each experiment.   
For the lysosome Ca2+ store depletion assay, cells were seeded at 400000 cells on 1 
% poly-L-lysine coated 25 mm glass coverslips. After 24 h, cells were transfected 
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with G1.2-GECO, with and without P2X4R, using PEI. 24 h post-transfection, cells 
were used for experiments. GPN (100 µM, Santa Cruz) was administered after 1 
minute of recording in nominal Ca2+ free NES, whereby NES was made up without 
CaCl2.H2O (2 mM) as indicated above, from 2 minutes post GPN treatment, 
histamine (50 µM) was administered followed by 3 further minutes before ionomycin 
(5 µM) was added to obtain the Fmax. 
3.2.2 Analysis of Ca2+ signals in cell population 
Fluorescence was measured at room temperature using a Leica SP5 confocal 
microscope. F is the measured fluorescence of Ca2+ indicators, F0 determines the 
mean fluorescence 30 seconds before addition of agonist and Fmax indicates the 
peak fluorescence value after ionomycin treatment. F0 and Fmax were calibrated to 
normalise the difference in dye loading or leaking and difference in expression of 
plasmid Ca2+ indicators.  
3.2.3 Pulse Chase Analysis  
Confluent NRK or HeLa cells were seeded on to 1 % poly-L-lysine coated 25 mm 
glass coverslips and transfected with P2X4R and/or P2X7R using PEI. 48 h post-
transfection, cells were incubated with 0.5 mg/ml of the pH insensitive dye, Texas 
Red Dextran-10kDa (DR; Thermo Scientific) for 5 h at 37 °C and 5 % CO2 in DMEM. 
During this period, DR was endocytosed and localised in lysosomes, which was thus 
utilised to mark lysosomes. DR was removed and cells were washed for 3 times with 
PBS. Cells were further incubated for 2 h without DR dye in complete growth 
medium before being subjected to drug treatment, either 2'(3')-O-(4-Benzoylbenzoyl) 
adenosine-5'-triphosphate (BzATP; Sigma) or histamine. Cells were washed twice 
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with PBS and used for imaging with a Leica SP5 confocal microscope. Images were 
captured and analysed as detailed in section 3.5 and 3.6, respectively. 
3.2.4 Lysosome position analysis 
The boundary of the cells was determined using bright field images. The lysosome 
position analysis was adapted from Li et al. (2016). The nucleus was determined by 
DAPI, a nuclear and chromosome counterstain dye, and the perinuclear region was 
selected by expanding 5 µm outward of the nucleus. The total cell intensity (Itotal) = 
Intensity of cell – nucleus intensity. Perinuclear intensity (Inuc) = Intensity of 5 µm 
outward of nucleus – nucleus intensity. Peripheral intensity (Iperipheral) = Intensity of 
cell – Intensity of 5 µm outward of nucleus. Intensity of perinuclear region (I<5 µm) = 
(Inuc /Itotal)-100; I>5 = (Iperipheral /Itotal)-100; and Perinuclear index= Iperinuclear -Iperipheral  
3.2.5 Lysosome size analysis 
Lysosome size was analysed using ImageJ in which the threshold of fluorescence 
intensity of DR was set at 100-255 A.U. to analyse particles in outlined cells. 
Particles which were considered as lysosomes had a circularity range of 0.7-1.0 µm 
with diameter ranging between 0.2-5.0 µm. 
3.3  Biochemistry  
3.3.1 Analysis of protein expression  
HEK293 cells were grown to 80 % confluence in T75 flasks for 24 h. Cells were 
washed with ice cold PBS before being re-suspended using cell extraction buffer, 
which contained: NaCl (138 mM), KCl (5 mM), Na2HPO4 (1 mM), glucose (7.5 mM), 
HEPES (21 mM), EDTA (2 mM), pH adjusted to 7.4 using NaOH. Cells in extraction 
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buffer were centrifuged at 1000 g for 5 minutes at 4 oC. Pelleted cells were re-
constituted in solubilisation buffer, which contained Tris-HCl (25 mM), NaCl (150 
mM), EDTA (10 mM), Triton X-100 (1 %), phenylmethylsulfonyl fluoride (PMSF, 16 
mM; Sigma), and protease inhibitor cocktail (1 mg/ml; Sigma), for 1 h at 4 oC. The 
sample was next centrifuged at 50000 g for 30 minutes at 4 oC before supernatant 
collection for protein concentration measurement using the PierceTM BCA Protein 
assay kit (Life Technologies). Protein samples were diluted in 2X laemmlli buffer 
(Sigma) in 1:1 ratio. This protein sample mixture was subjected to protein analysis 
assay by SDS-PAGE followed by immunoblotting. 
3.3.2 Western blot 
Protein samples were assessed using 10 % sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE), wherein 20 µl protein samples 
were loaded in each lane of a SDS-PAGE gel along with 7.5 µl of ladder in lane 1 
(Spectra broad range, Thermo Scientific), which was made up to a total of 20 µl with 
2X laemmli buffer. In the subsequent step, proteins from the acrylamide gel were 
transferred onto a polyvinylidine difluoride nitrocellulose membrane (Thermo 
Scientific). Running buffers for gel electrophoresis contained Tris-base (250 mM), 
glycine (2 M), SDS (10 %) in 1 litre of dH2O and pH adjusted to 8.4 using 
concentrated HCl; semi-dry transfer buffer contained Tris-base (250 mM), glycine (2 
M), SDS (10 %), methanol (2 %) in 1 litre of dH2O, pH adjusted to 8.4 using HCl 
solution. The membrane was washed and blocked with 5 % milk dissolved in TBS-
Tween for 1 h at room temperature. Proteins that were on nitrocellulose membranes 
were incubated with appropriate primary antibodies (1:600 dilutions), in 2.5 % milk in 
TBS-Tween overnight at 4 oC. Membranes were washed with TBS-Tween to remove 
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unbound antibodies. Membranes incubated for 2 h with the appropriate secondary 
antibodies (conjugated to horseradish peroxidase, HRP) that was made up in 2.5 % 
milk in TBS-Tween. Prior to immunoblot imaging, the membranes were washed with 
TBS buffer to remove excessive antibodies. Developing the blot was performed 
using SuperSignal West Pico Chemiluminescent substrate or Femto assay kits 
(Thermo Scientific). Pictures were taken at different exposure times using 
VisionWorksLS Image Acquisition and Analysis Software. 
3.3.3 Surface biotinylation proteins 
HEK293 cells were grown to 80 % confluency in T75 flasks and transfected using 
PEI. 24 h post-transfection, the growth medium was removed and replaced with 8 ml 
of ice-cold PBS containing biotin-sulfo-NHS (0.2 mg/ml, Thermo Scientific). After 1 h 
on ice at 4 oC, cells were washed 3 times with 10 ml Tris-buffered saline (Tris-HCl 
(25 mM), NaCl (150 mM), EDTA (10 mM) in 500 ml dH2O and pH adjusted to 7.4 
using concentrated HCl solution) to inhibit the biotinylation reaction. Cells were 
collected in Tris-buffered saline and centrifuged at 1000 g for 5 minutes at 4 oC. 
Pelleted cells were collected and solubilised in solubilisation buffer (250 µl, 1 h, 4 
oC). Cells in solubilisation buffer were centrifuged at 50000 g for 1 h and the 
supernatant was then incubated with 30 µl of monomeric avidin-coated agarose 
beads (Thermo Scientific) at 4 oC for 2 h. The conjugated protein complex was 
further centrifuged at 1000 g for 5 minutes to collect the entire bound protein 
complex. This was then washed 3 times in solubilisation buffer and mixed with 50 µl 
of 2X laemmli buffer for immunoblotting. To analyse biotinylated proteins that were 
precipitated by avidin, 4 % of the total sample was loaded as an input and 20 % of 
laemmli buffer sample was loaded as surface biotinylated proteins.  
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3.3.4 Immunocytochemistry 
Confluent NRK and HeLa cells were grown on 1 % poly-L-lysine coated coverslips 
and subjected to drug treatment, as detailed in Figure legends. Following drug 
exposure, cells were washed with PBS and fixed in 3 % paraformaldehyde (PFA) for 
20 minutes at room temperature. The cells were fixed in blocking solution, which 
contained NaCl (137 mM), KCl (2.7 mM), Na2HPO4 (10 mM), KH2PO4 (2 mM), goat 
serum (5 %), bovine serum albumin (BSA; 3 %) and saponin (0.5 mg/ml, 1 h; 
Sigma), to permeabilise membrane of cells. After 1 h, cells were incubated with 
primary antibodies, which were diluted at 1:250 in blocking solution as indicated in 
Figure legends, for 1.5 h. Cells were washed with PBS to remove unbound 
antibodies and incubated with the appropriate secondary antibody (1:250), for 1.5 h 
in dark at room temperature. Before mounting onto microscope slides (VWR) with 
Vector shield (Vector Laboratories, CA), cells were air-dried for 15 minutes in the 
dark. Images were captured using an oil-immersion 63X objective on a confocal 
microscope Leica SP5 as detailed in section 3.5 below. Colocalisation analysis was 
performed by measuring Pearson’s coefficient using ImageJ with JACoP plugin. 
Details of antibodies are listed in the Table A below.  
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Table A: List of antibodies used in immunoblot and immunocytochemistry 
Antibodies Concentration Company 
P2X4 (1:250) Alomone labs 
Actin (1:600) Sigma  
Anti-mouse HRP (1:1000) Thermo Scientific 
Anti-rabbit HRP (1:1000) BioRAD 
3.4  Molecular Biology 
A summary of point mutations in P2X4R with fluorescence-tagged constructs that 
were generated is given in Table B. 
Table B: List of P2X4R mutants  
Construct Species Antibiotic resistance 
P2X4-K67A-EGFP Mouse Kanamycin 
P2X4-M31A-EGFP Human Ampicillin 
P2X4-A6S-A7S-EGFP Human Ampicillin 
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3.4.1 Point mutation of P2X4  
Primers for point mutations of P2X4Rs are detailed in Table C using an in-house 
point mutation method where sequence indicated in red indicates mutation being 
made. The PCR mixtures contained 5 μl of 10X Cloned Pfu Reaction Buffer 
(Stratagene), 0.5 μg of plasmid template, 0.5 μl of each primer, and 1 μl of 250 nM 
deoxyribonucleotide triphosphates (dNTPs) and 41.5 μl of milli-Q water to give a final 
volume of 49 μl. PCR was started with a “hot start” at 95 oC for 1 minute before 
addition of 1 μl of PfuTurbo DNA polymerase (Stratagene). This was followed by 15 
repeats of: denaturing of DNA at 95 oC for 30 seconds, primer annealing at 55 oC for 
1 minute and extension at 68 oC for 6 minutes. Once the PCR reaction was 
completed, the PCR mixtures were left to cool down at 4 oC for 2 minutes. 1 μl of 
DnpI enzyme, which selectively cleaves methylated DNA, thus removing template 
DNA, was incubated with the PCR mixture for 1 h at 37 oC followed by 
transformation of Escherichia coli, section 3.4.2. 
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Table C: Primers for P2X4R mutants 
Construct Forward Primer Reverse Primer 
P2X4-
K67A-
EGFP 
AGCTCGGTGACAACCGCAGCC
AAAGGTGTGGCT 
AGCCACACCTTTGGCTGCGGT
TGTCACCGAGCT 
P2X4-
M31A-
EGFP 
CGCAGCCGCAAAGTGGGGCTC
GCGAACCGCGCCGTGCAACTG 
CAGTTGCACGGCGCGGTTCGC
GAGCCCCACTTTGCGGCTGCG 
P2X4-A6S 
A7S-
EGFP 
ATGGCGGGCTGCTGCTCCGTG
CTGGCGGCCTTCCTGTTC 
GAACAGGAAGGCCGCCAGCAC
GGAGCAGCAGCCCGCCAT 
 
3.4.2 Bacteria transformation  
1 µl of PCR mixture was added to 75 μl XL-10-Gold ultracompetent cells (Agilent 
Technologies). The mixture was kept on ice for 30 minutes and then heat shocked 
for 45 seconds at 42 oC, followed by 2 minutes on ice. 900 μl of LB broth (Fisher 
Scientific) was added and the tube placed in shaking incubator at 37 oC for 1 h. A 
200 μl of mixture was spread onto agar plate with either kanamycin (50 µg/ml) or 
ampicillin (100 µg/ml) antibiotics and incubated at 37 °C overnight. Colonies were 
picked, placed in 5 ml LB with appropriate antibiotic, and placed in the shaking 
incubator at 37 oC at the speed of 2 g for overnight. 
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3.4.3 Miniprep of DNA 
The plasmid DNA was isolated from E. coli using a Gene JETTM Plasmid Miniprep 
Kit (Fermentas) according to the manufacturer’s protocol. 
3.4.4 Sequencing of P2X4 mutants 
Mutant plasmid DNAs were verified by a Sanger sequencing service (Source 
BioScience LifeSciences). 
3.4.5 Gibson assembly of ligation of human P2X4R  
To construct hP2X4R-EGFP, untagged plasmid human P2X4R (hP2X4R) was 
inserted into a pEGFP vector using the Gibson assembly kit according to the 
manufacturer’s protocol. In brief, hP2X4 was amplified via PCR as an insert 
fragment. A double digest using two enzymes, NheI and SacII, were used to 
linearise vector pEGFP for 1 h at 37 oC. The assembly mix composed of 3 μl of 
digested pEGFP, 5 μl of hP2X4, 10 μl of Gibson assembly mix and 2 μl of dH2O to 
give a final volume of 20 μl. The mixture was incubated for 15 minutes at 50 oC. The 
ligated product was then left to cool and 5 μl used for transformation, as indicated in 
section 3.4.2. To verify the PCR product, plasmid DNA was extracted via mini-prep 
(detailed in section 3.4.3) followed by restriction digest and Sanger sequencing to 
confirm the sequence.  
3.5  Confocal Microscopy 
Fluorescence from fluorescence probes in live cells was visualised using a Leica 
SP5 microscope. Prior to imaging, cells were washed twice using NES, to remove 
excessive fluorescence probes. Coverslips were placed into a chamber with NES 
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and imaged with a 63X oil-immersion objective. The laser settings (488 nm argon 
laser set at 19 % and 543 nm helium neon laser set at 30 %) and pinhole of the 
camera (150 μm) were set at constant throughout experiments. Pictures were taken 
in the format of 1024 x 1024 pixels using an imaging speed at 100 Hz. Table D gives 
the laser settings that were used to visualise the fluorescent probes/fluorophores.  
Table D: Lists of fluorescence probes and lasers setting  
Fluorescence Probes Lasers Excitation (nm) 
EGFP/FITC Argon 488 
Alexa-Fluor 488 Argon 488 
Fluorescein 
isothiocyanate- 
10kD dextran 
Argon 488 (Maximal excitation 
for this probe is 490) 
Lysotracker DND 99 Red Helium/Neon 543 (Maximal excitation 
for this probe is 577) 
Magic Red CathepsinTM B Helium/Neon 543 (Maximal excitation 
for this probe is 590) 
mCherry Helium/Neon 543 
Oregon Green 488-10 kDa 
Dextran 
Argon 488 
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Texas Red Dextran-10kDa  Helium/Neon 543 (Maximal excitation 
for this probe is 595) 
Fluo4-AM/LAMP-
GECO/G1.2-GECO 
Argon 488 
3.6  Data analysis 
Most results are presented with mean ± SEM from N, independent experiments, or n, 
number of cells, as indicated in the Figure legends. Statistical analysis was assessed 
using GraphPad Prism, with unpaired Student t tests or one-way ANOVA followed by 
Tukey tests for post-hoc analysis being used as indicated in the Figure legends.  
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4. Investigating the role of P2X4R in lysosome function  
4.1. Introduction 
Previous studies have shown that native mouse and rat P2X4Rs are predominantly 
located within lysosomes in microglia, macrophages, and endothelial cells (Qureshi 
et al., 2007). In microglial cells grown in culture, the receptors dynamically traffic 
between lysosomes and the plasma membrane, but in macrophages they reside 
within the lysosomes and show much slower trafficking to the surface. 
Heterologously expressed P2X4Rs in NRK cells are also targeted to lysosomes 
(Qureshi et al., 2007). 
Lysosomal P2X4Rs have been studied by patch clamping the enlarged lysosomes 
and dialysing the lumen of the lysosome to measure P2X4R mediated current. The 
P2X4R channels mediated an inward current in the presence of ATP, but only when 
the lumen was alkalinised (Huang et al., 2014). It was shown that various 
alkalinisation reagents were sufficient to activate P2X4R, including NH4Cl, 
methylamine and Bafilomycin-A1, an inhibitor of the H+ ATPase. Following activation, 
P2X4Rs mediated lysosomal Ca2+ efflux, which triggered homotypic lysosome fusion 
(Cao et al., 2015). The main aim of this study was to identify physiological regulators 
of lysosomal P2X4Rs and to examine their role in lysosome Ca2+ signalling and 
fusion.  
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4.2. Results 
4.2.1. Characterisation of the subcellular distribution of wild type and mutant 
P2X4R in NRK and HeLa cells 
There are several markers available to label lysosomes based on their acidity 
(Lysotracker), enzyme activity (Cathepsin B), presence of known lysosomal-
associated membrane protein-1 (LAMP1) and trackable endocytosed materials for 
example Texas Red 10-kDa Dextran (DR). To investigate the sub-cellular distribution 
of P2X4R, I first used DR as a lysosome marker and compared its distribution with 
an EGFP tagged form of LAMP1 (LAMP1-GFP).  NRK and HeLa cells were used in 
the study because they are large flat cells well suited to imaging by confocal 
fluorescence microscopy. Cells were plated onto glass coverslips, transfected with 
LAMP1-GFP and 24 h later, cells were incubated with DR for 5 h followed by a 2 h 
chase without the dye. Images were taken of live cells and extensive co-localisation 
of compartments labelled with LAMP1-GFP and DR was observed at the perinuclear 
region in both NRK and HeLa cells (Fig. 4.1A-B). The co-localisation of these two 
dyes was quantified by calculating the Pearson’s coefficient, and the values obtained 
for NRK and HeLa cells were 0.7363 ± 0.012 A.U. and 0.6663 ± 0.032 A.U., 
respectively (Fig. 4.1C).  This suggests that DR-positive compartments are mostly 
LAMP1 positive and thus DR does label late endosome (LE)/lysosomes.  
Having confirmed that DR is a useful LE/lysosome marker, I next investigated its 
distribution with respect to that of P2X4R. I have conducted most of my study using 
rat P2X4R (rP2X4R), unless stated otherwise. rP2X4R-EGFP was expressed in both 
NRK and HeLa cells to compare trafficking in two different cell types. rP2X4R-EGFP 
was distributed in puncta in the perinuclear region and these puncta co-localised with 
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DR (Fig. 4.2A-B). A similar experiment was carried out using LAMP1-mCherry as a 
lysosome marker and this was also shown to co-localise with rP2X4R-EGFP within 
the perinuclear compartments. Thus, these results confirm those previously obtained 
and show that rP2X4R is targeted to lysosomes in these two cell lines (Fig. 4.2C-D).  
To further characterise the compartments containing rP2X4R, NRK cells expressing 
rP2X4R-EGFP were incubated with lysotracker for 1 h, which is a marker of acidic 
compartments. rP2X4R-EGFP containing compartments within the perinuclear 
region co-localised with lysotracker indicating that rP2X4R is targeted to acidic 
LE/lysosomes (Fig. 4.3A). Finally, I compared the distribution of rP2X4R-EGFP with 
that of a marker of the activity of the lysosomal enzyme cathepsin B. The reagent, 
Magic Red, fluoresces upon cleavage by cathepsin B and compartments with 
greatest fluorescence also contained rP2X4R-EGFP. The larger vacuoles show 
expression of rP2X4R-EGFP at the limiting membrane of lysosomes (Fig. 4.3B).  
Overall these results indicate that rP2X4R is targeted to compartments that have 
many of the key features of lysosomes; they are perinuclear, acidic, contain the 
active form of cathepsin B and contain LAMP1. There are other compartments 
containing rP2X4R-EGFP that do not share all of these properties and which might 
reflect different types of LE/lysosomes, or endosomes earlier on in the endocytic 
pathway.  
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Figure 4.1 Co-localisation of lysosome markers in NRK and HeLa cells.  
(A&B) Lysosomes were labelled by both LAMP1-GFP and Texas Red 10-kDa 
Dextran (DR), which was incubated for 5 h followed by a 2 h chase, in NRK (A) 
and HeLa cells (B), white lines depict the plasma membrane of the cell. Scale 
bars, 10 µm. (Ai & Bi) Confocal images showing high-magnification images of 
intracellular structures of both lysosome markers in NRK (Ai) and HeLa (Bi) cells. 
Scale bars, 5 µm. (C) The co-localisation of two lysosome markers, LAMP1-GFP 
and DR, measured using Pearson’s coefficient. Results are mean ± s.e.m. from 
total number of cells, n, as indicated.  
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Figure 4.2 rP2X4Rs are localised to lysosomes in NRK and HeLa cells. 
Lysosomes were labelled using DR (A-B) and LAMP1-mCherry (C-D) in NRK and 
HeLa cells expressing rP2X4R-EGFP. White lines depict the plasma membrane of 
the cell. All scale bars, 10 µm. 
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Figure 4.3 rP2X4Rs are localised to lysosomes in NRK cells. Lysosomes were 
marked by lysotracker (A) and cathepsin B (B) in NRK cells expressing rP2X4R-
EGFP. White lines represent the plasma membrane of the cell. (A&B) Scale bars, 
10 µm. (Ai & Bi) High-magnification images of intracellular lysosomes co-labelled 
by rP2X4R-EGFP and lysosome markers; lysotracker (Ai) and cathepsin B (Bi) in 
NRK cells. Scale bars, 5 µm. 
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I next compared the distribution of wild type (WT) rP2X4R with two non-functional 
mutants that I intended to use as negative controls in future experiments. The two 
mutants are the dominant negative mutant rP2X4R-C353W, which contains a 
mutation in the pore-lining, second transmembrane domain (Silberberg et al., 2005), 
and rP2X4R-K67A which contains a mutation in the ATP binding pocket that 
prevents ATP from binding (Stojilkovic et al., 2010). Using DR as a lysosome marker, 
both WT and mutants of rP2X4R were shown to co-localise with DR to a similar 
extent. Thus, the lack of functionality of the mutant receptors did not appear to alter 
their localisation to lysosomes (Fig. 4.4A-C). LAMP1-mCherry was also co-
expressed with the different rP2X4R-EGFP in NRK cells and again a similar extent of 
co-localisation of rP2X4R-EGFP with LAMP1-mCherry at the perinuclear region was 
observed (Fig. 4.4D-E). 
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Figure 4.4 Both WT and mutant rP2X4R are targeted to lysosomes in NRK cells.  
Confocal images show NRK cells transiently transfected with EGFP-tagged 
rP2X4R-WT (A), rP2X4R-K67A (B) or rP2X4R-C353W (C). Lysosomes were 
marked by DR. (D-E) NRK cells expressing either rP2X4R-WT (D) or rP2X4R-
C353W (E). Lysosomes were marked by LAMP1-mCherry. White lines represent 
the plasma membrane of the cell. All scale bar, 10 µm.  
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4.2.2 Role of P2X4R in the endocytosis pathway 
Previously, Huang et al. (2014) showed by patch clamping lysosomes, that 
lysosomal alkalinisation triggered a P2X4R-mediated current suggesting a potential 
role of P2X4R in lysosome function. Given that P2X4R is targeted to lysosomes, the 
terminal destination of the endocytosis pathway, I investigated if expression of 
functional rP2X4R affects the rate of endocytosis. DR uptake in NRK cells 
expressing rP2X4R-EGFP was compared with DR uptake in cells expressing the 
mutant rP2X4R-C353W.  Confocal images show a similar fluorescence intensity of 
DR in both rP2X4R-WT and rP2X4R-C353W expressing cells after either 2 h or 5 h 
of DR loading (Fig. 4.5A-E). This demonstrates that rP2X4R is unlikely to modulate 
the rate of endocytosis. The degree of co-localisation between WT and mutant 
rP2X4R and DR, were very similar after both 2 h and 5 h of DR incubation (Fig. 
4.5F). This suggests that short incubation of DR (2 h) is sufficient for DR to be 
endocytosed and localised to lysosomes, independent of functional rP2X4R.  
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Figure 4.5 Over expression of functional rP2X4R did not regulate the 
endocytosis pathway in NRK cells. Representative confocal images of NRK cells 
transiently transfected with rP2X4R-EGFP or rP2X4R-C353W. Lysosomes 
labelled by DR were incubated for either 2 h (A-B) or 5 h (C-D) in cells 
expressing either rP2X4R-WT or rP2X4R-C353W. All scale bars, 10 µm. (E-F) 
The co-localisation level of rP2X4R-EGFP with DR measured by the 
fluorescence intensity of DR (E) and Pearson’s coefficient (F) in rP2X4R-WT and 
rP2X4R-C353W expressing cells. Results are mean ± s.e.m. from 2 independent 
experiments with total number of cells between 39 and 45. 
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4.2.3 Pharmacological alkalinisation of lysosomes induces lysosome fusion 
Activation of P2X4R in lysosomes by the pharmacological manipulation of pH has 
been shown to promote homotypic lysosome fusion in Cos-1 cells, resulting in the 
formation of enlarged vacuole-like lysosomes (Cao et al., 2015). To see if I could 
reproduce this result in NRK cells I conducted a similar experiment. Cells expressing 
rP2X4R-EGFP were incubated with DR to label lysosomes and their size was 
measured with and without alkalinisation of the lysosome. I compared the actions of 
the weak base methylamine (MA; 10 mM, 0.5 h) and an inhibitor of the vacuolar-type 
H+ ATPase, Bafilomycin-A1 (Baf-A1; 200 nM, 1 h) applied to cells in normal 
extracellular solution (NES) at 37 °C. Images of DR-positive lysosomes under control 
conditions and following MA and Baf-A1 treatments are shown in Fig. 4.6A for cells 
expressing rP2X4R-EGFP. The distribution of lysosome size was categorised into 
small (< 1.0 µm), medium (1.0-1.5 µm) and large (> 1.5 µm) and cells expressing 
rP2X4R showed a reduction in small lysosomes from 90.58 % to 53.92 % in 
response to MA treatment (Fig. 4.6B). Moreover, the percentage of medium and 
large size lysosomes increased from 8.74 % and 0.66 %, respectively, to 38.52 % 
and 7.55 %, respectively. Similar results were obtained using Baf-A1 although the 
effects were not as dramatic; there was a decrease in the percentage of small size 
lysosomes and the percentage of medium and large size lysosomes increased (Fig. 
4.6B). A box plot was generated showing the median, 10th and 90th percentile of total 
lysosome size pooled from at least 20 cells for each condition (Fig. 4.6C). Cells 
expressing WT rP2X4R showed a modest increase in lysosome size following either 
MA or Baf-A1 treatment: the median size increased from 0.84 µm to 1.00 µm (p < 
0.001, n = 20) upon MA treatment whilst Baf-A1 treatment induced an increment of 
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lysosome size from 0.84 µm to 0.94 µm (p < 0.001, n = 20). These results support 
the previous findings obtained using Cos-1 cells.   
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Figure 4.6 rP2X4R mediates lysosome fusion following lysosome alkalinisation. 
Representative images of NRK cells expressing EGFP-tagged of rP2X4R WT 
under control conditions or treated with either MA (10 mM, 0.5 h) or Baf-A1 (200 
nM, 1 h). All scale bars, 5 µm. (B) The distribution of lysosome size in NRK cells 
expressing WT rP2X4R-EGFP under conditions indicated. MA experiments show 
mean results of total number of 20 cells. Results obtained from Baf-A1 experiments 
show mean ± s.e.m. from 2 independent experiments with total number of 40 cells. 
(C) Box plot demonstrates the median, with 10th and 90th percentile of lysosome 
size in rP2X4-EGFP expressing NRK cells treated with either MA or Baf-A1. 
Results are mean ± s.e.m. from experiments with total number of cells at least n = 
20. ***P < 0.001, one-way ANOVA followed by Tukey’s analysis. 
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4.2.4 A comparison of homotypic lysosome fusion in macrophages from WT 
and P2X4-/- mice  
Bone marrow derived macrophages (BMDMs) from P2X4R-/- and WT mice were 
provided for a single experiment in which the effects of MA treatment on lysosome 
size was compared over a series of time points.  Fluorescein isothiocynate (FITC)-
10-kDa dextran was loaded for 5 h in BMDMs to enable lysosome size 
measurements and although the fluorescence of FITC-dextran is quenched under 
acidic conditions, alkalinisation of lysosomes using MA relieved this quenching. 
Without MA pre-treatment, there was no difference in lysosome size between WT 
and P2X4R-/-  BMDMs. Following exposure to MA (10 mM), an increase in lysosome 
size was apparent for both groups of BMDMs (Fig. 4.7A-B). This was quantified by 
counting the number of cells with at least one lysosome greater than 2 µm in 
diameter. After 15 and 30 minutes of MA treatment, 30 % and 73 % respectively of 
WT cells had at least one enlarged lysosome whereas for the P2X4-/- cells the 
values were 13 % and 22 %, respectively (Fig. 4.7C). However, unfortunately I did 
not have access to more BMDMs from P2X4R KO mice and thus unable to confirm 
this preliminary finding. These results are consistent with the results obtained by Cao 
et al. (2015) that the recombinant P2X4R expressed in Cos-1 cells, and suggest that 
alkalinisation of the lysosome is sufficient to activate P2X4R and promote lysosome 
homotypic fusion.  
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Figure 4.7 Efficient lysosome fusion is mediated by endogenous P2X4R in BMDMs 
following lysosome alkalinisation. Representative images of WT (A) and knockout 
of P2X4R (B) in BMDMs with lysosomes labelled by FITC 10-kDa dextran following 
MA (10 mM) treatment for 0 h (control), 15 minutes, 0.5 h and 1 h. All scale bars, 5 
µm. (C) Graph showing the percentage of cells with enlarged lysosomes (at least 
one lysosome size ≥ 2 µm) under conditions indicated. Results are mean of total 
number of 23-60 cells. 
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4.2.5 The role of P2X7R in promoting P2X4R-dependent lysosome fusion 
P2X7R is frequently co-expressed with P2X4R in immune, epithelial and endothelial 
cells (Guo et al., 2007) and several studies have shown that the activation of plasma 
membrane P2X7R can induce lysosome alkalinisation (Takenouchi et al., 2009 and 
Guha et al., 2013). 
To investigate any functional interaction between P2X4R and P2X7R in lysosome 
fusion, I co-transfected NRK cells with rP2X4R-EGFP and rat P2X7R (rP2X7). 
Lysosomes were labelled with DR, and the agonist BzATP was applied at a 
concentration (30 µM), sufficient to activate rP2X7R (EC50 of ~10 µM for rP2X7R and 
EC50 of ~100 µM for hP2X7R; Rassendren et al., 1997). Following application of 
BzATP for 0.5 h, confocal images revealed enlarged vacuole like lysosomes that 
were marked by both rP2X4R-EGFP and DR (Fig. 4.8B). The enlarged lysosomes 
were observed towards the cell periphery as well as within the perinuclear region 
(Fig. 4.8B). I defined enlarged lysosomes in NRK cells as lysosomes greater than or 
equal to 1.8 µm, which was obtained from the mean plus twice the standard 
deviation of lysosome size from the total number of lysosomes measured under 
control conditions (n = 50 cells). To quantify lysosome fusion, the percentage of cells 
with 2 or more lysosomes greater than or equal to 1.8 µm was counted and there 
was a 2.6-fold increase in the percentage of cells with enlarged lysosomes in 
response to BzATP (66.4 ± 3.6 % vs 26.2 ± 4.0 %, p < 0.05) (Fig. 4.8C). This result 
suggests that the activation of rP2X7R can promote lysosome fusion. There was 
however a tendency for cells post-BzATP treatment to have formed blebs and be 
rounded up and a typical example is shown in Fig. 4.9.  This indicates the toxic 
effect of prolonged activation of rP2X7R using BzATP. Also in several of the cells 
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there was a clear increase in rP2X4R-EGFP at the cell surface suggesting that 
considerable exocytosis of lysosomes had taken place.  
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Figure 4.8 Stimulation of rP2X7R triggers P2X4R-dependent lysosome fusion. (A) 
Confocal images of NRK cells expressing rP2X4R-EGFP and rP2X7R with 
lysosomes labelled by DR. (B) BzATP treatment (30 µM, 0.5 h) induced 
enlargement of lysosomes in cells co-expressing rP2X4R-EGFP and rP2X7R. (A-
B) White lines represent the plasma membrane of the cell. All scale bars, 10 µm. 
(C) The percentage of cells with 2 or more enlarged lysosomes (≥ 1.8 µm) 
following BzATP treatment (30 µM, 0.5 h) is significantly increased by stimulation 
with BzATP. Results are mean ± s.e.m. from 3 independent experiments. **P < 
0.01, unpaired student’s t test. 
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Figure 4.9 Representative confocal images of cell blebbing pre (A) and post (B) 
BzATP treatment (30 µM, 0.5 h) in some NRK cells co-expressing rP2X4R-EGFP 
and rP2X7R with lysosomes labelled by DR. (A-B) All scale bars, 10 µm.   
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The toxic effects of stimulation of rP2X7R have been reported previously and it 
occurs because the rat receptor rapidly undergoes pore dilation in response to 
BzATP (Robinson et al., 2014). Activation of human P2X7R (hP2X7R) is generally 
much less toxic to cells and it exhibits slower pore dilation and sensitisation 
(Humphreys et al., 1998; Rassendren et al., 1997; Robinson et al., 2014). I therefore 
switched to using hP2X7R and compared the size of lysosomes with and without 
treatment with 100 µM BzATP for 0.5 h. A higher concentration of BzATP was 
administered because this is a less potent agonist at hP2X7R compared to rP2X7R, 
as detailed in section 1.7 of introduction. Cells co-expressing hP2X7R and rP2X4R-
EGFP showed enlarged vacuole-like lysosomes following the incubation with BzATP 
(Fig. 4.10A) and the percentage of cells with enlarged lysosomes was significantly 
increased from 15.6 ± 2.0 % to 61.7 ± 5.3 % (p < 0.001) (Fig. 4.10B); no cell 
blebbing and rounding up was observed.   
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Figure 4.10 Stimulation of hP2X7R induces rP2X4R-dependent lysosome fusion. 
(A) Confocal images of NRK cells co-transfected with rP2X4R-EGFP and hP2X7R 
with lysosomes labelled by DR following BzATP treatment (100 µM, 0.5 h). (B) The 
percentage of cells with 2 or more enlarged lysosomes (≥ 1.8 µm) in response to 
control and BzATP treatments, as indicated. (A-B) Results are mean ± s.e.m. from 
3 independent experiments. ***P < 0.001, unpaired student’s t test. All scale bars, 
10 µm. 
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Further experiments were carried out to compare lysosomes in cells expressing 
rP2X4R and hP2X7R individually, rP2X4R and hP2X7R together, and hP2X7R with 
the non-functional rP2X4R mutants (rP2X4R-C353W and rP2X4R-K67A).  The 
results are shown in Fig. 4.11. Only in cells co-expressing both functional rP2X4R 
and hP2X7R were there an increase in the frequency of cells with enlarged 
lysosomes following incubation with BzATP (100 µM, 0.5 h) (Fig. 4.11A). In cells 
expressing rP2X4R alone, I also tested the effects of 100 µM MgATP, a 
concentration sufficient to fully activate any P2X4Rs at the plasma membrane, but 
this did not produce an increase in the number of cells with enlarged lysosomes (Fig. 
4.11B). Therefore, ruling out any contribution of the plasma membrane rP2X4R. A 
comparison was made of the distribution of lysosome size for the different conditions 
by plotting frequency histograms, as shown in Fig. 4.12. For cells expressing P2X4R 
and P2X7R alone, there was no shift in frequency for any of the four size categories 
after incubation with BzATP, whereas for cells co-expressing the rP2X4R and 
hP2X7R there was a significant shift in the distribution towards larger lysosomes (> 1 
µm) (Fig. 4.12A-C). This shift in lysosome size distribution was not seen for either of 
the non-functional mutant rP2X4Rs when co-expressed with hP2X7R, which 
indicates that the enhancement in the size of lysosomes triggered by BzATP is 
dependent upon the expression of a functional rP2X4R and on the expression of 
hP2X7R. Altogether these results suggest a synergistic effect of P2X4R and P2X7R 
in lysosome fusion and that P2X7R is a likely physiological regulator of lysosomal 
P2X4Rs. 
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Figure 4.11 Synergistic interaction occurs between P2X4R and P2X7R in lysosome 
fusion. (A) Representative images of NRK cells co-expressing wild type rP2X4R-
EGFP, the dominant mutant rP2X4R-EGFP (C353W) or the non-functional mutant 
rP2X4R-EGFP (K67A) with hP2X7R, or cells expressing rP2X4R or hP2X7R alone. 
Cells were treated with and without BzATP (100 µM, 0.5 h). Lysosomes were 
labelled using DR. (B) Histogram of cells with 2 or more enlarged lysosomes (≥ 1.8 
µm) following control, BzATP (100 µM, 0.5 h) and MgATP (100 µM, 0.5 h) 
treatments, and in the conditions indicated. (A-B) All results are mean ± s.e.m. 
from 3 independent experiments. *P < 0.05 and **P < 0.01, one-way ANOVA 
followed by Tukey’s analysis. All scale bars, 10 µm. 
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Figure 4.12 Activation of P2X4R and P2X7R shifts lysosome distribution to larger 
lysosome sizes following BzATP treatment. (A-D) The relative frequency 
distribution of lysosome size in cells expressing rP2X4-EGFP alone (A), hP2X7R 
alone (B), cells co-expressing rP2X4R-EGFP and hP2X7R (C) or rP2X4R mutants 
(C353W and K67A) with hP2X7R (D). Conditions are control, BzATP (100 µM, 0.5 
h) or MgATP (100 µM, 0.5 h), as indicated. All results are mean ± s.e.m. from 3 
independent experiments. (C) *P < 0.05, **P < 0.01 and ***P < 0.001, unpaired 
student’s t test.  
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4.2.6 The effect of P2X4R and P2X7R on the subcellular distribution of 
lysosomes  
For cells co-expressing P2X4R and P2X7R, the distribution of DR-labelled 
lysosomes post-BzATP treatment looked different; more evenly distribution over the 
cell rather than clustered within the perinuclear region. This suggests that activation 
of P2X7R not only promotes P2X4R-dependent homotypic lysosome fusion, but also 
promotes the anterograde movements of lysosomes toward the periphery of the cell 
where they can undergo lysosome exocytosis. To investigate this further I analysed 
the distribution of rP2X4R-EGFP positive compartments before and after a 30 minute 
treatment with BzATP (100 µM) and dynasore (80 µM) (an inhibitor of dynamin 
dependent endocytosis). I quantified this by measuring the distance between 
lysosomes marked by rP2X4R-EGFP and the nucleus and obtained a value for the 
perinuclear index (Li et al., 2016), where a high value corresponds to greater 
clustering of lysosomes in the vicinity of the nucleus. Perinuclear index is a 
measurement of the fluorescence intensity of lysosome populations that are less 
than 5 µm away from the nucleus minus the fluorescence intensity of lysosome 
populations that are more than 5 µm away from nucleus (detailed in chapter 3.2.4).  
A comparison was made between cells expressing rP2X4R alone, together with 
hP2X7R and for the non-functional K67A mutant receptor with hP2X7R. Only in cells 
co-expressing both functional receptors were there a significant decrease in 
perinuclear index after treatment with agonist BzATP and dynasore (1.8 ± 0.12 A.U. 
to 0.87 ± 0.08 A.U.; p < 0.001) (Fig. 4.13A-B). As a positive control, ionomycin (5 µM; 
10 minutes), a Ca2+ ionophore that has previously shown to potentiate the rate of 
lysosome exocytosis (Qureshi et al., 2007), was administered to NRK cells. A 
reduced perinuclear index, was observed for all three groups of cells following 
91 
 
ionomycin treatment (Fig. 4.13B). It is not necessarily that the decrease in 
perinuclear index is an absolute indicator of lysosome exocytosis, but the peripheral 
localisation of lysosomes induced by ionomycin could be an early indicator of 
lysosome docking that facilitates exocytosis. 
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Fig. 4.13 Synergistic effect of P2X4R and P2X7R in the redistribution of lysosomes 
towards the cell periphery. (A) Representative images showing NRK cells 
expressing rP2X4R-EGFP alone, or co-expressing either WT or mutant K67A of 
rP2X4R-EGFP with hP2X7R. Cells were treated with BzATP (100 µM, 0.5 h) and 
dynasore (80 µM, 0.5 h). Nucleus was determined by DAPI staining. White lines 
represent the plasma membrane of the cell. (B) Histogram showing the distribution 
of lysosomes as measured by perinuclear index, a measurement of the distance of 
lysosome populations from nucleus, detailed in section 3.2.4. Cells co-expressing 
rP2X4R and hP2X7R show a lower perinuclear index following BzATP and 
dynasore treatment, indicating redistribution of lysosomes away from nucleus. (A-
B) All results are mean ± s.e.m. from 3 independent experiments. ***P < 0.001, 
one-way ANOVA followed by Tukey’s analysis. All scale bars, 10 µm.  
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4.2.7 The synergistic role of P2X4R and P2X7R in lysosome fusion is Ca2+ 
dependent 
Having shown that P2X4R and P2X7R act synergistically to increase the size of 
lysosomes, I investigated if this effect is dependent upon extracellular Ca2+. I 
hypothesised that a rise in cytoplasmic [Ca2+] via plasma membrane P2X7R was 
required for lysosome alkalinisation. BzATP was applied to NRK cells co-expressing 
rP2X4R and hP2X7R, in either 2 mM extracellular Ca2+ or nominally Ca2+ free NES. 
In 2 mM Ca2+ NES, there was a significant increase in the proportion of cells with 
enlarged lysosomes following BzATP treatment (14.0 ± 2.2 % to 46.8 ± 2.8 %; p 
<0.05), but this was abolished in Ca2+ free NES (Fig. 4.14). This result suggests that 
Ca2+ entry via P2X7R is required to trigger lysosome fusion. It is possible that the 
P2X7R-mediated Ca2+ signal might trigger lysosome alkalinisation, thereby activating 
P2X4R to mediate lysosome fusion. 
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Figure 4.14 Activation of P2X7R induces P2X4R-mediated lysosome fusion and 
this is dependent on Ca2+ influx. Summary results show the percentage of cells co-
expressing rP2X4R-EGFP and hP2X7R with 2 or more enlarged lysosomes (≥ 1.8 
µm) under conditions indicated: with (2 mM Ca2+) and without extracellular Ca2+ (0 
mM Ca2+) in normal extracellular solution (NES). All results are mean ± s.e.m. from 
3 independent experiments. *P < 0.05, one-way ANOVA followed by Tukey’s 
analysis.  
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4.2.8 P2X7R stimulation induces lysosomal alkalinisation that is dependent 
on extracellular Ca2+ 
To investigate this further, I monitored how lysosome pH is modulated by BzATP in 
cells co-expressing rP2X4R and hP2X7R in the presence and absence of 
extracellular Ca2+. Lysosome pH was assessed using two different dextran 
conjugates: pH-dependent Oregon Green 488 10-kDa Dextran (OG) and pH-
insensitive DR.  Cells were incubated in the presence of both dyes for 5 h followed 
by a 2 h chase and as expected, the two dyes co-localised within the same 
compartments (Fig. 4.15). The intensity of OG fluorescence in resting cells was low 
because it is quenched by the acidic lysosomal environment.  In the presence of 
extracellular Ca2+ (2 mM), there was an increase in fluorescence intensity of OG 
after BzATP (100 µM) application, indicative of lysosomal alkalinisation (Fig. 4.16A), 
whereas there was no increase in OG fluorescence intensity when the experiment 
was carried out in nominally Ca2+-free NES (Fig. 4.16B). The fluorescence intensity 
of DR remained at a similar level throughout all the experiment. The fluorescence 
ratio of OG:DR was calculated at two time points post BzATP application and 
compared to the ratio immediately prior to agonist (Fig. 4.16C). There was a 
significant increase in the ratio at both 120 s and 300 s (1.6 ± 0.09 A.U. and 2.1 ± 
0.15 A.U. respectively) but only in the presence of extracellular Ca2+ (Fig. 4.16C).  
These results lead me to conclude that Ca2+ entry through P2X7R results in 
alkalinisation of lysosomes.  
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Figure 4.15 Lysosomes were co-labelled by Oregon Green 488 10-kDa Dextran 
(OG; pH sensitive dye) and Texas Red 10-kDa Dextran (DR; pH insensitive dye) 
for lysosome pH measurement in NRK cells. Representative images of lysosomes 
marked by both lysosome markers: OG and DR in rP2X4R and hP2X7R co-
expressing NRK cells. All scale bars, 10 µm.  
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Figure 4.16 P2X7R stimulation induces lysosomal alkalinisation and this is 
dependent on extracellular Ca2+. Graphs showing the changes in fluorescence of 
each dye (OG and DR) over time following BzATP (100 µM) treatment in either 2 
mM Ca2+ (A) or 0 mM Ca2+ (B) containing NES. Cells were co-expressed with 
rP2X4R and hP2X7R. The increase in fluorescence of OG indicates a rise in 
lysosome pH following BzATP treatment in 2 mM Ca2+ NES. (C) Summary of data 
showing the fluorescence ratio of OG: DR measured at different times after BzATP 
(100 µM) treatment in either 2 mM Ca2+ or 0 mM Ca2+, as indicated. All results are 
mean ± s.e.m. from 3 independent experiments. ***P < 0.001, one-way ANOVA 
followed by Tukey’s analysis. 
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4.2.9 Cytoplasmic Ca2+ signals generated by P2X4R and P2X7R 
It has previously been shown that lysosome fusion is triggered by Ca2+ release from 
lysosomes and an increase in the level of cytoplasmic Ca2+ in the vicinity of 
lysosomes (Cao et al., 2015). To investigate how P2X4R and P2X7R contribute to 
the cytoplasmic Ca2+ response following BzATP application I first used a cytoplasmic 
Ca2+ indicator, G1.2-GECO (G-GECO) to measure cytoplasmic changes in [Ca2+]. 
NRK cells were co-transfected with G-GECO, and either rP2X7R alone or rP2X7R 
with rP2X4R or the K67A mutant. rP2X7R was used in the rest of Ca2+ imaging 
experiments due to the short BzATP treatment that is unlikely to induce cell blebbing. 
Experiments were carried out in NES containing 1 mM Ca2+ and following application 
of BzATP there was a rapid increase in G-GECO fluorescence intensity (Fig. 4.17A). 
The increase in [Ca2+] was similar in cells expressing rP2X7R alone or rP2X7R with 
either the WT or mutant rP2X4R. It presumably reflects the Ca2+ entry via plasma 
membrane rP2X7R. (Fig. 4.17B). Thus, the cytoplasmic Ca2+ response is dominated 
by rP2X7R mediated Ca2+ entry under these conditions.   
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Figure 4.17 P2X7R stimulation induces an elevation in the cytosolic [Ca2+] as 
measured by cytosolic G-GECO. (A) The Ca2+ signal recorded by G-GECO in NRK 
cells expressing either rP2X7R alone or co-expressing either WT or mutant K67A 
rP2X4R with rP2X7R following BzATP (30 µM) treatment in 1 mM Ca2+ NES. (B) 
Summary of data showing the magnitude change of G-GECO after BzATP (30 µM) 
treatment, as indicated. All results are mean ± s.e.m. from 3 independent 
experiments.  
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To measure cytoplasmic Ca2+ changes in the vicinity of the lysosome, a different 
Ca2+ reporter construct was used, namely LAMP1-GECO. This was a gift from 
Professor Taylor’s lab and was generated by Peace Atakpa who tagged G1.2-GECO 
to the cytoplasmic tail of LAMP1 (Ca2+ binding affinity of 1.2 µM; Zhao et al., 2011). 
First, I wanted to demonstrate the lysosomal localisation of LAMP1-GECO and so I 
transfected it into NRK cells and co-labelled lysosomes using DR. Confocal images 
show that LAMP1-GECO largely co-localised with DR in compartments at the 
perinuclear region indicating the lysosome targeting of LAMP1-GECO (Fig. 4.18A). 
There was some LAMP1-GECO labelling that did not co-localise with DR and one 
possibility is that LAMP1-GECO also labeled quiescent population of lysosomes that 
was not receiving recently endocytosed materials. Next, NRK cells were co-
transfected with LAMP1-GECO, rP2X4R and rP2X7R and the fluorescent response 
to BzATP was compared to cells transfected with either LAMP1-GECO and rP2X7R 
alone, LAMP1-GECO with rP2X7R and rP2X4R-K67A, or LAMP1-GECO with 
rP2X4R alone. The fluorescence intensity of LAMP1-GECO (F) was normalised to 
the maximal fluorescence (Fmax) produced by ionomycin (as detailed in section 3.2.2). 
In response to the application of BzATP (30 µM) in Ca2+-containing NES, a 
significant increase in F/Fmax was observed in cells expressing rP2X7R, however 
there was no change in F/Fmax in cells expressing rP2X4R alone (Fig. 4.18B-C). In 
cells co-expressing rP2X4R and rP2X7R, the fluorescent response to BzATP was 
significantly larger than in cells expressing rP2X7R alone. This suggests that 
rP2X7R-mediated Ca2+ influx induced lysosome alkalinisation, thereby activating 
lysosomal rP2X4R to mediate lysosome Ca2+ efflux, which contributed to the 
cytoplasmic [Ca2+] signal in the immediate vicinity of the lysosome (Fig. 4.18B-C). 
This lysosome Ca2+ signal was also larger in cells co-expressing rP2X4R and 
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rP2X7R than in cells co-expressing rP2X4R-K67A and rP2X7R (Fig. 4.18C). 
Together, these results suggest that lysosomal P2X4R can potentiate Ca2+ signals in 
the vicinity of lysosomes in response to the activation of plasma membrane P2X7R.  
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Figure 4.18 P2X7R stimulation induces lysosomal Ca2+ efflux via P2X4R, 
measured using LAMP1-GECO. (A) Representative confocal images of NRK cells 
co-expressing LAMP-GECO with rP2X4R and rP2X7R. Lysosomes were marked 
by DR. (B) Ca2+ signals recorded by LAMP1-GECO in NRK cells expressing either 
rP2X7R or rP2X4R alone or co-expressing either WT or mutant K67A of rP2X4R 
with rP2X7R. Cells were treated with BzATP (30 µM) in NES (1 mM Ca2+). (C) 
Histogram showing the magnitude change of Ca2+ response to BzATP recorded by 
LAMP-GECO under conditions indicated.  (A-C) All results are mean ± s.e.m. from 
3 independent experiments. *P < 0.05 and ***P < 0.001, one-way ANOVA followed 
by Tukey’s analysis. All scale bars, 10 µm.  
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4.3 Investigating role of H1R in P2X4R regulation  
4.3.1 Effect of H1R activation in lysosome fusion  
Another important source of Ca2+ for producing a rise in cytoplasmic Ca2+ is the ER. 
Receptors that couple to the phospholipase C (PLC) pathway and thus lead to the 
hydrolysis of phosphatidylinositol (4,5,) bisphosphate to produce IP3, lead to Ca2+ 
release from the ER via the IP3 receptor. It has previously been shown that this 
pathway can trigger lysosome alkalinisation (López-Sanjurjo et al., 2013). To test this 
further and see if P2X4R could be recruited downstream of Gq-coupled GPCR 
activation, I examined whether stimulation of the endogenous H1 histamine receptor 
in HeLa cells could act synergistically with P2X4R to enhance the cytoplasmic Ca2+ 
signal and trigger lysosome fusion. The H1R is an example of a Gq-coupled GPCR 
which triggers IP3 generation (Leurs et al., 1995).    
Lysosomes were marked by DR, and histamine was applied at 50 µM for 0.5 h and 1 
h in cells expressing either rP2X4R-EGFP or LAMP1-GFP in nominally Ca2+ free 
NES. rP2X4R expressing cells showed a significant enlargement of lysosome size at 
both 0.5 h (16.31 ± 4.95 %) and 1 h (24.75 ± 2.78 %, p < 0.05) (Fig. 4.19A and C). 
The enlarged lysosomes observed in cells expressing rP2X4R were at the periphery 
as well as at the perinuclear region (Fig. 4.19A). LAMP1-GFP transfected cells, 
however, did not have enlarged lysosomes following histamine treatment, nor was 
there any redistribution observed (Fig. 4.19C). These results suggest that activation 
of H1R recruits the activity of intracellular P2X4R to mediate lysosome fusion and 
H1R is thus likely to be a physiological modulator of P2X4R.  
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Figure 4.19 Histamine treatment triggers P2X4R-dependent lysosome fusion. (A-B) 
Representative images of HeLa cells expressing rP2X4R-EGFP (A) or LAMP1-
GFP (B) with lysosomes labelled by DR. Cells were incubated with histamine (50 
µM) for 0 h (control), 0.5 h and 1 h in nominal Ca2+ free (0 mM Ca2+) NES. White 
lines represent the plasma membrane of the cell. All scale bars, 10 µm. (C) 
Histogram showing the percentage of cells with 2 or more enlarged lysosomes (≥ 
1.8 µm) following histamine treatments (control, 0.5 h and 1 h). All results are 
mean ± s.e.m. from 3 independent experiments. *P < 0.05, one-way ANOVA 
followed by Tukey’s analysis.  
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4.3.2 H1R activation alkalinises lysosome pH  
I next assessed whether the synergistic effect of H1R and P2X4R is mediated via 
lysosome alkalinisation. To examine how the pH of lysosomes is modulated by H1R 
stimulation, I measured changes in lysosome pH following the administration of 
histamine in nominally Ca2+ free NES, and compared mock-transfected with rP2X4R 
transfected HeLa cells. Lysosome pH was assessed as before using DR and OG. 
Histamine (100 µM) in nominally Ca2+ free NES evoked an increase in OG 
fluorescence, indicating lysosome alkalinisation, in both mock transfected and cells 
expressing rP2X4R (Fig. 4.20A-B). To quantify the changes in lysosome pH, the 
fluorescence ratio of OG:DR was measured at 300 s post histamine administration 
and compared to the ratio of OG:DR under basal conditions, prior to histamine 
addition. There was a significant increase in the fluorescence ratio of OG:DR in both 
mock transfected cells (1.0 ± 0.09 A.U. increased to 1.9 ± 0.14 A.U.; p < 0.05) and 
rP2X4R transfected cell (0.9 ± 0.01 A.U. increased to 2.4 ± 0.46 A.U.; p < 0.05) (Fig. 
4.20C). These results suggest that H1R activation increases lysosome pH 
independently of rP2X4R expression. No decrease was observed in DR 
fluorescence in mock transfected cells (Fig. 4.20A), but a modest decrease in DR 
fluorescence in rP2X4R expressing cells (Fig. 4.20B) following histamine treatment 
suggesting that histamine might promote lysosome exocytosis in cells expressing 
rP2X4R. Together, these data suggest that H1R stimulation induced lysosome 
alkalinisation, independent of P2X4R expression.  
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Figure 4.20 Activation of H1Rs induces lysosome alkalinisation independent of 
P2X4R expression. (A-B) Changes of fluorescence of OG and DR in mock 
transfected (control) (A) and rP2X4R transfected (B) HeLa cells. Cells were treated 
with histamine (100 µM) in 0 mM Ca2+ NES. The increase in OG fluorescence 
indicates the rise in lysosome pH following histamine treatment. (C) A summary of 
data showing the fluorescence ratio of OG:DR measured before (basal) and after 
300 s of histamine treatment (100 µM). All results are mean ± s.e.m. from 3 
independent experiments. *P < 0.05, one-way ANOVA followed by Tukey’s 
analysis.  
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4.3.3 A synergistic interaction between H1R and P2X4R contributes to 
cytoplasmic Ca2+ signaling 
LAMP1-GECO and G-GECO were used as before to investigate both global 
cytoplasmic Ca2+ signals and signals in the immediate vicinity of the lysosomes. I 
wanted to test whether or not P2X4R contributes to the Ca2+ signals generated 
downstream of H1R activation. HeLa cells were transfected with LAMP1-GECO 
alone or together with rP2X4R and 50 µM histamine was applied in a nominally Ca2+ 
free NES, followed by ionomycin in 5 mM Ca2+ to establish the maximum 
fluorescence response (Fmax). Histamine evoked a transient cytoplasmic Ca2+ 
response in both groups of cells, presumably representing Ca2+ release from the ER, 
but the amplitude was significantly enhanced in cells expressing rP2X4R as can be 
seen when fluorescence (F) is normalized to Fmax (Fig. 4.21). Thus the presence of 
rP2X4R contributes to an enhanced cytoplasmic response to histamine in the vicinity 
of the lysosomes, suggesting that the lysosomal P2X4Rs become activated 
downstream of H1R activation.  
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Figure 4.21 Histamine-evoked Ca2+ response is potentiated by P2X4R. (A) Ca2+ 
signals recorded by LAMP1-GECO in HeLa cells expressing either control or 
rP2X4R following histamine (50 µM) treatment in 0 mM Ca2+ NES. (B) Histogram 
showing the magnitude change of Ca2+ response to histamine (50 µM) treatment. 
All results are mean ± s.e.m. from 3 independent experiments. ***P < 0.001, 
unpaired student’s t test.  
 
 
109 
 
Similar experiments were carried out using G-GECO to assess the change in global 
cytoplasmic [Ca2+] in response to histamine (50 µM). Again, rP2X4R significantly 
enhanced the fluorescence increase in response to histamine administration 
indicating a greater global Ca2+ response to H1R activation (Fig. 4.22A). In these 
experiments, there was an additional control group which was cells expressing G-
GECO and the non-functional rP2X4R-K67A mutant receptor. This non-functional 
mutant had no effect on the fluorescence response to histamine indicating the 
importance of P2X4R activation in contributing to the Ca2+ signal. The fluorescence 
signal to histamine in cells expressing rP2X4R was not only of larger amplitude, but 
it was also prolonged (Fig. 4.22A).  
Finally, a similar experiment was carried out but this time using the fluorescent Ca2+ 
indicator Fluo4 instead of G-GECO. The results were very similar; the response to 
100 µM histamine was increased in the presence of rP2X4R compared to mock 
transfected cells (Fig. 4.23A-B). Together, my results suggest that the activation of 
H1R evokes ER Ca2+ release, which is sufficient to recruit lysosomal P2X4Rs to 
mediate lysosome Ca2+ efflux, thus increasing local and global cytoplasmic Ca2+ 
signals.  
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Figure 4.22 P2X4R augments histamine-evoked Ca2+ signals. (A) Ca2+ signals 
recorded by cytosolic G-GECO in HeLa cells expressing control, rP2X4R or 
rP2X4R-K67A following histamine (50 µM) treatment in nominal Ca2+ free NES. (B) 
Histogram showing the magnitude change of Ca2+ response to histamine (50 µM) 
treatment, as conditions indicated. All results are mean ± s.e.m. from 3 
independent experiments. ***P < 0.001, one-way ANOVA followed by Tukey’s 
analysis.  
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Figure 4.23 The histamine-evoked Ca2+ signals are potentiated by functional 
P2X4R. (A) Ca2+ signals recorded from populations of Fluo4 (2 µM) loaded HeLa 
cells transiently transfected with either rP2X4R or mock transfected (control). Cells 
were stimulated with histamine (100 µM) in 0 mM Ca2+ NES. (B) Summary results 
showing the magnitude change in Ca2+ signal evoked by histamine (100 µM) 
treatment. All results are mean ± s.e.m. from 3 independent experiments. **P < 
0.01, unpaired student’s t test.  
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4.3.4 Effects of enhanced expression of P2X4R on ER Ca2+ content 
My results are consistent with functional cross-talk between lysosomes and ER that 
is mediated by lysosome alkalinisation downstream of Ca2+ release from the ER. 
However, to rule out the possibility that the over expression of rP2X4R elevates the 
Ca2+ content of the ER and thereby enhances the response to histamine, I measured 
levels of Ca2+ within the ER. This was achieved by using ionomycin, a Ca2+ 
ionophore that preferentially punctures the ER membrane, in HeLa cells expressing 
G-GECO alone or G-GECO plus rP2X4R. Following addition of ionomycin, in Ca2+ 
free NES containing 0.4 mM EGTA, there was a rapid rise in fluorescence, which 
reflects the ER Ca2+ content (Fig. 4.24A) and this was very similar with and without 
P2X4R. This suggests that the over expression of P2X4R in HeLa cells does not 
alter the ER [Ca2+].  
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Figure 4.24 Over expression of P2X4R did not alter the intracellular Ca2+ level in 
the ER. (A) Ca2+ signals recorded by G-GECO in mock transfected or rP2X4R 
transfected HeLa cells. Cells were stimulated with ionomycin (5 µM) in Ca2+ free 
NES with 0.4 mM EGTA. (B) A summary of results showing the magnitude change 
of Ca2+ response to ionomycin, which indicates the Ca2+ content of intracellular 
stores. Results are mean ± s.e.m. from 3 independent experiments.  
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4.3.5 Investigating effect of P2YR and P2X4R in Ca2+ regulation  
Another GPCR that couples to Gq and is endogenously expressed in HeLa cells is 
P2Y2R (Okuda et al., 2003). P2Y4 and P2Y6 were also shown to be present, but 
unlike P2Y2R they are not activated by ATP (von Kügelgen and Hoffmann, 2016). I 
tested whether lysosomal P2X4Rs contribute to the Ca2+ signal downstream of 
P2Y2R stimulation using a similar approach as described above. The fluorescence 
response to 10 µM NaATP was compared in cells expressing G-GECO alone or G-
GECO plus rP2X4R in nominally Ca2+ free NES. A rapid increase in fluorescence 
was observed in control cells (0.10 ± 0.01 A.U.) and this was amplified by rP2X4R 
(0.26 ± 0.03 A.U.; p < 0.001) (Fig. 4.25A-B). In addition, a prolongation of the Ca2+ 
response to NaATP treatment was observed in cells expressing rP2X4R, as had 
been observed following histamine addition in cells expressing P2X4R (Fig. 4.22).  
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Figure 4.25 P2Y2R-mediated Ca2+ signals are potentiated by rP2X4R in HeLa 
cells. (A) Ca2+ signals recorded by G-GECO in either rP2X4R transfected or mock 
transfected (control) HeLa cells. Cells were stimulated with NaATP (10 µM) in 0 
mM Ca2+ NES. (B) Histogram showing the magnitude change of Ca2+ response to 
NaATP treatment in HeLa cells. All results are mean ± s.e.m. from 3 independent 
experiments. ***P < 0.001, unpaired student’s t test.  
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The experiment was repeated, but this time in the presence of 0.4 mM of EGTA to 
chelate any residual Ca2+ in the Ca2+ free NES (EGTA-NES). The response to 
NaATP administration was again potentiated by expression of rP2X4R (0.23 ± 0.02 
A.U.) compared to the mock transfected cells (0.08 ± 0.01 A.U.; p < 0.001) and 
under these conditions any contribution of plasma membrane P2X4Rs in allowing 
Ca2+ entry can be ruled out (Fig. 4.26A-B). However, the presence of EGTA 
abolished the prolongation of Ca2+ response to NaATP in rP2X4R expressing cells 
such that the decay kinetics were similar to control cells.  
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Figure 4.26 P2X4R potentiates Ca2+ signal and slows the decay of the Ca2+ 
transient, which is sensitive to EGTA. (A) Ca2+ signals recorded from G-GECO 
expressing HeLa cells that were co-transfected with either rP2X4R, or mock 
(control). Cells were incubated with EGTA (0.4 mM) followed by NaATP (10 µM) 
treatment in 0 mM Ca2+ NES. (B) Summary results for the changes of Ca2+ signals 
after NaATP treatment in HeLa cells. All results are mean ± s.e.m. from 3 
independent experiments. ***P < 0.001, unpaired student’s t test. 
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Further experiments were carried out to investigate what might contribute to the 
prolonged response to histamine and ATP observed in cells expressing rP2X4R. I 
was interested in whether the prolongation of the Ca2+ response was a result of 
P2X4R mediated lysosome exocytosis causing ATP release, which then acts back 
upon plasma membrane P2X4R or P2Y2R. I returned to using histamine as the 
stimulus, but cells were bathed in apyrase (4 IU/µl), an enzyme that hydrolyses ATP, 
prior to addition of histamine so that any ATP released during the experiment would 
be rapidly hydrolysed. I compared the response in cells expressing G-GECO alone, 
together with rP2X4R or with the non-functional K67A mutant. In the presence of 
P2X4R the fluorescence response was still significantly larger, but this time was not 
prolonged (Fig. 4.27). In cells expressing just G-GECO or the K67A mutant, addition 
of apyrase had no effect on the fluorescence response.  
I further evaluated this data by comparing the area under the F/Fmax curves for all 
groups of cells with (Fig. 4.27A) and without (Fig. 4.22A) apyrase treatment. 
Consistently, apyrase treatment in cells expressing rP2X4R significantly decreased 
the AUC in response to histamine addition, but had no effects on either of the other 
two groups of cells (Fig. 4.28). Altogether, these results suggest that in cells 
expressing rP2X4R, following addition of histamine there is extracellular release of 
ATP. Presumably this reflects P2X4R mediated lysosome exocytosis and this ATP 
feeds back to activate either plasma membrane P2Y2R or P2X4R thereby 
prolonging the Ca2+ response.  
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Figure 4.27 P2X4R-dependent prolongation of the histamine-induced Ca2+ 
response is sensitive to apyrase. (A) Ca2+ signals recorded by G-GECO in HeLa 
cells expressing control, rP2X4R or rP2X4R-K67A. Cells were stimulated with 
histamine (50 µM) in the presence of apyrase (4 IU/µl), enzyme that hydrolyses 
ATP, in 0 mM Ca2+ NES. (B) A summary of data showing the magnitude change in 
histamine-evoked Ca2+ response in the presence of apyrase (4 IU/µl). All results 
are mean ± s.e.m. from 3 independent experiments. *P < 0.05 and ***P < 0.001, 
one-way ANOVA followed by Tukey’s analysis.  
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Figure 4.28 Histogram showing the summarised data of area under the curve 
analysis obtained from graphs Fig. 4.22 and Fig. 4.27, in the presence and 
absence of apyrase (4 IU/µl) in control, rP2X4R-WT or rP2X4R-K67A expressing 
cells. All results are mean ± s.e.m from 3 independent experiments. *P < 0.05, **P 
< 0.01 and ***P < 0.001, one-way ANOVA followed by Tukey’s analysis.  
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4.3.6 Effect of lysosome Ca2+ content depletion in P2X4R expressing cells 
My results suggest that the stimulation of Gq-coupled GPCRs, for example H1R and 
P2Y2R, activates lysosomal P2X4R to mediate lysosomal Ca2+ efflux that 
contributes to histamine- and NaATP-evoked Ca2+ signals. To further validate that 
the enhanced cytoplasmic Ca2+ signal is contributed by Ca2+ release from the 
lysosome, I tested whether or not disrupting the lysosome membrane prior to 
addition of histamine would prevent the potentiation by P2X4R. For this I used glycyl-
L-phenylalanine 2-naphthylamide (GPN), a substrate of cathepsin C that transiently 
permeabilises lysosome membranes. G-GECO expressing HeLa cells were treated 
with GPN (100 µM) and the fluorescence response in nominally Ca2+ free NES was 
measured for cells with and without rP2X4R expression. GPN treatment produced a 
small sustained Ca2+ signal that was comparable between the mock-transfected 
group and rP2X4R transfected cells, indicative of Ca2+ release from the lysosomes 
(Fig. 4.29A-B). Post GPN, both mock and rP2X4R expressing cells showed a 
transient Ca2+ response to histamine administration (Fig. 4.29A), but this time there 
was no significant difference between the two groups of cells (Fig. 4.29B). The 
responses to histamine however were very small after GPN treatment suggesting 
that GPN might not act simply on the lysosome membrane, but might also disrupt the 
ER membrane. Despite the limitations of this experiment, I can at least conclude that 
under conditions where the lysosome is not contributing to the cytoplasmic Ca2+ 
signal, the presence of P2X4R does not enhance the histamine-evoked Ca2+ 
response.  
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Figure 4.29 Lysosome membrane permeabilisation abolished P2X4R-mediated 
augmentation of histamine-evoked Ca2+ signals. (A) Changes in Ca2+ signals 
recorded by G-GECO in HeLa cells expressing with either control or rP2X4R. Cells 
were stimulated by GPN (100 µM) and histamine (50 µM) treatment in 0 mM Ca2+ 
NES. All results are mean from 3 independent experiments. (B) Histogram showing 
the magnitude change in Ca2+ signals stimulated by GPN (100 µM) and histamine 
(50 µM) treatment, as conditions indicated. All results are mean ± s.e.m. from 3 
independent experiments.  
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4.4 Discussion 
My results identify two physiological regulators of P2X4R, namely P2X7R and Gq-
coupled GPCRs. Both regulators recruit the activity of P2X4R via lysosome 
alkalinisation such that a localised elevation of cytoplasmic [Ca2+] at the vicinity of 
lysosomes increases the pH of lysosomes, which relieves P2X4R from inhibition 
enabling it to be activated by lysosomal ATP (Fig. 4.16 and Fig 4.20). This has a 
consequence for the homotypic fusion mediated by P2X4R and it also has a 
consequence for the lysosome Ca2+ efflux.  
My results demonstrate that P2X4R mediates enlargement of lysosomes following 
pharmacological manipulations of lysosome pH using Baf-A1 and MA, which agrees 
with the published data (Fig 4.6; Cao et al., 2015; Huang et al., 2014). However, 
lysosome fusion induced by Baf-A1 was less compared to MA. One explanation is 
that MA rapidly alkalinises lysosome pH whereas Baf-A1 is an inhibitor of the 
lysosome V-ATPase, which mediates lysosome acidification, and subsequently leads 
to increase in the pH of lysosomes.  
Next, I demonstrate the functional interaction of P2X4R and P2X7R in lysosome 
fusion. The confocal studies evidently show that the P2X7R agonist, BzATP is 
sufficient to promote lysosome fusion, only when P2X4R is co-expressed (Fig. 
4.11A). Also, both P2X4R mutants, K67A and C353W when co-expressed with 
P2X7R did not promote lysosome enlargement (Fig. 4.11). These provide evidence 
for a clear role of P2X4R in lysosome fusion.  
I have demonstrated that plasma membrane P2X7R recruits the activity of P2X4R 
via lysosome alkalinisation (Fig. 4.16). The activation of P2X7R reduces the acidity 
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of lysosomes but only in the presence of the extracellular Ca2+, which is consistent 
with the previous finding (Takenouchi et al., 2009). However, the detailed 
mechanism of this response remains unknown. One possibility is that the sustained 
elevation of cytoplasmic Ca2+ disrupts the cation counter flux in lysosomes, which 
tightly regulates the luminal content of Ca2+ and H+ concentration that is required to 
maintain lysosome pH (Steinberg et al., 2010).  
In addition to lysosome fusion, the activation of P2X4R and P2X7R also induced a 
change in lysosome distribution towards the cell periphery. This was observed from 
the confocal images and decrease in perinuclear index that most lysosomes 
migrated towards the cell periphery following BzATP and dynasore treatment (Fig. 
4.13). This was dependent on the co-expression of P2X7R and P2X4R, and was not 
observed in the mutant P2X4R-K67A suggesting a clear role of P2X4R and P2X7R 
in anterograde lysosome movements. Perhaps, the peripheral distribution of 
lysosome populations is a pre-requisite step for lysosome exocytosis. It was 
previously shown that peripheral lysosomes facilitate Ca2+-induced lysosome 
exocytosis such that the proximity of lysosomes to the plasma membrane facilitates 
vesicles docking and the elevation of cytoplasmic Ca2+ subsequently triggers the 
onset of lysosome exocytosis (Jaiswal et al., 2002; Luzio et al., 2007).  
My results provide evidence that P2X4R serves as a lysosomal Ca2+ release channel 
using LAMP1-GECO, which reported the cytoplasmic Ca2+ signal at the lysosome 
vicinity (Fig. 4.18). Published data have demonstrated that increase in lysosome pH 
also lowered the Ca2+ concentration in lysosomes (Christensen et al., 2002), 
complementing with my results that lysosome alkalinisation could lower lysosomal 
Ca2+ content via P2X4R. Cytoplasmic G-GECO did not identify this P2X4R-mediated 
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lysosome Ca2+ efflux, possibly due to the over expression of P2X7R in NRK cells, an 
ion channel that is sensitive to prolonged stimulation and mediates pore dilation 
(Robinson et al., 2014). The over expression of active P2X7R presumably facilitates 
extracellular Ca2+ influx and that dominates and/or saturates Ca2+ signal recorded by 
G-GECO, thus hinders resolving any Ca2+ signal derived from lysosomes.   
Secondly, I also assessed whether the sole increment of cytoplasmic Ca2+ via Gq-
coupled GPCR stimulation could induce lysosomal P2X4R activation. My results 
demonstrate that the activation of H1R triggered Ca2+ release from the ER. This 
activates P2X4R to enable lysosome Ca2+ efflux, potentiating the cytoplasmic Ca2+ 
response. This conclusion was drawn from experiments using three different Ca2+ 
indicators showing potentiation of histamine-induced Ca2+ signals only when P2X4R 
is present (Fig. 4.21 – Fig. 4.23). This augmented Ca2+ signal is likely to be the main 
stimulus for P2X4R-dependent lysosome fusion. Indeed, confocal images 
demonstrate that the treatment with histamine induced lysosome enlargement in a 
P2X4R dependent manner (Fig. 4.19). Similarly, activation of plasma membrane 
P2Y2R also increases in cytosolic Ca2+ signals and this were potentiated by P2X4R 
(Fig. 4.25). This observation confirms that P2Y2R also recruits the activity of 
lysosomal P2X4R in the same manner as H1R does, via the release of ER Ca2+. 
Histamine-induced lysosome alkalinisation is independent of P2X4R expression (Fig. 
4.20). This suggests that histamine causes an elevation of cytoplasmic [Ca2+] at the 
lysosome vicinity, which then triggers lysosome alkalinisation by an unknown 
mechanism, possibly via the same mechanism as P2X7R. In addition, lysosome 
alkalinisation has been shown to reduce lysosomal Ca2+ level in BMDMs and that is 
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in consistent with my result that P2X4R is activated in response to alkalinised 
conditions leading to lysosomal Ca2+ efflux (Christensen et al., 2002).  
My data demonstrates a prolonged phase of elevated Ca2+ in response to Gq-
coupled GPCR activation. This effect is only observed in the presence of P2X4R 
suggesting a downstream lysosome exocytosis mediated by P2X4R. It is possible 
that lysosome exocytosis increases the extracellular ATP that feeds back onto the 
activation of plasma membrane P2Y2R or P2X4R, thereby prolonging the overall 
Ca2+ signal (Sivaramakrishnan et al., 2012; Toyomitsu et al., 2012). Evidently in the 
Ca2+ imaging assay, EGTA and apyrase abolished this prolonged Ca2+ signal without 
affecting the potentiated Ca2+ signals. Together with the confocal images 
demonstrating lysosomes distributed to the cell periphery (Fig. 4.13), these results 
suggest that the activation of lysosomal P2X4R potentiates the cytoplasmic Ca2+ 
responses and triggers downstream signalling, lysosome exocytosis.  
Using GPN treatment to deplete lysosome Ca2+ content, I have confirmed that 
P2X4R potentiates H1R-induced Ca2+ signals via lysosome Ca2+ efflux. However, 
GPN pre-treatment also decreased the histamine-evoked Ca2+ response. It is 
possible that GPN, a substrate of cathepsin C, induces osmotic swelling and 
subsequently membrane permeabilisation, also targets the ER. Perhaps the ER 
contains a low concentration of cathepsin C, resulting in permeabilisation and 
reduction of the ER Ca2+ content, however the detailed mechanism of GPN activity in 
the ER remains unclear (Ronco et al., 2015). Overall, the increase in cytoplasmic 
[Ca2+] released from the ER triggers P2X4R-dependent lysosomal Ca2+ efflux, 
suggesting a functional interaction between ER and lysosomes, an idea that has 
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been proposed by several studies (Kilpatrick et al., 2013; López-Sanjurjo et al., 2013; 
Phillips and Voeltz, 2016).  
Overall, my results provide evidence that both P2X7R and Gq-coupled GPCRs serve 
as physiological regulators to recruit activity of P2X4R via lysosome alkalinisation. In 
response to lysosome alkalinisation, P2X4Rs can be activated to mediate lysosomal 
Ca2+ signals, thereby facilitating lysosome functions such as lysosome fusion and 
exocytosis. Evidence herein also suggests the effect of P2X4R in the lysosome Ca2+ 
release pathway. The stimulation of Gq-coupled GPCRs triggers IP3R-mediated Ca2+ 
signals from the ER, which recruits lysosomal P2X4R activity to mediate lysosome 
Ca2+ efflux that potentiates the overall Ca2+ response. This is similar to the proposed 
mechanism, that stimulation of lysosomal Ca2+ release can potentiate the Ca2+ 
signals from the ER and vice versa. For example, activation of TPC2 using NAADP 
triggers lysosomal Ca2+ release and this is sufficient to generate a prominent 
cytoplasmic Ca2+ signal, which is suggested to mediate by IP3Rs on the ER 
(Kilpatrick et al., 2013; Morgan et al., 2013). Collectively, my data suggest that 
stimulation of P2X4R via lysosome alkalinisation, as for NAADP-sensitive TPC2, is 
likely to mediate lysosomal Ca2+ efflux, and thus contribute to the ER-lysosome Ca2+ 
signalling.  
Alongside P2X4R, two other lysosomal release Ca2+ channels, TRPML1 and TPC2, 
have been implicated in Ca2+-dependent lysosome membrane trafficking. TRPML1 is 
activated by PI(3,5)P2 inducing fission and fragmentation of late endosomes and 
lysosomes (LE/L) (Cheng et al., 2010). In addition, fibroblasts with a mutation in 
TRPML1 that causes MLIV disease have an accumulation of enlarged LE/L, which 
could be rescued by over expression of TRPML1. Furthermore, lysosome depletion 
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of PI(3,5)P2 caused vacuole enlargement, supporting the role for TRPML1 in fission 
(Dong et al., 2010). However, unlike P2X4R activity, which required lysosome 
alkalinisation, the activity of TRPML1 was shown to be facilitated by acidification 
(Cheng et al., 2010; Dong et al., 2008).  Therefore, TRPML1 and P2X4R are likely to 
mediate separate roles in lysosome function despite both receptors mediating 
lysosomal Ca2+ signals. 
Despite the less well characterised TPC family, gathering evidence suggests a role 
of TPC2 in lysosome function. TPC2 localises to lysosomes and it is activated by 
NAADP and PI(3,5)P2 (Calcraft et al., 2009; Marchant and Patel, 2015). TPC2 
mediates lysosome Ca2+ release for lysosome fusion, such that the depletion of 
TPC2 accumulated cholesterols in hepatocytes due to the defects in lysosome fusion 
and subsequently degradation of cholesterols. This accumulation is reversed upon 
over expression of TPC2 in murine embryonic fibroblasts (Grimm et al., 2014; Ruas 
et al., 2010). Consistently, over expression of TPC2 causes lysosome enlargement, 
enhances endolysosome Ca2+ release that then alters endolysosome trafficking (Lin-
Moshier et al., 2014). These results demonstrate the effect of TPC2 in lysosome 
Ca2+ efflux and lysosome fusion, and these functions may be regulated alongside 
with P2X4R and other lysosome channels to control membrane trafficking.  
Considering the presence of three different lysosome Ca2+-permeable channels, it is 
of interest to understand how these receptors differentiate in mediating lysosome 
function. First, the pH of lysosomes is sufficient to distinct the activity of lysosomal 
channels: alkaline conditions inhibit TRPML1 activity (Dong et al., 2008), but 
lysosome alkalinisation potentiates P2X4R activity. In addition, different Ca2+ 
mobilising messengers may be recruited upon Ca2+ efflux via different lysosome 
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channels, thereby differentiating the mode of action between receptors. For example, 
P2X4R mediates lysosome fusion via the formation of protein complex with 
calmodulin (Cao et al., 2015). However, the possibility of the interaction between 
lysosomal Ca2+ release channels to meet the diverse downstream Ca2+-dependent 
responses cannot be ruled out.  
The role of intracellular P2X4R has been shown to contribute lysosome exocytosis in 
alveolar type II cells. P2X4R is localised in lysosome-related organelles, lamellar 
bodies (LBs), where it mediates localised Ca2+ signals following ATP treatment, 
thereby expanding the fusion pore to release surfactants (Miklavc et al., 2010). 
Although this study focussed on the role of P2X4R in completing exocytosis of pre-
docked LBs with the plasma membrane, without demonstrating any contribution of 
P2X4R prior to the docking of LBs, my results complement this study where I 
demonstrate that P2X4R-mediates lysosome Ca2+ efflux and lysosome fusion 
followed by anterograde movements of lysosomes to the plasma membrane. This 
suggests that P2X4R-mediated lysosomal Ca2+ signal may act as an initial signalling 
cue, contributing to lysosome exocytosis.  
Disruption in lysosome function, particularly elevated lysosome pH, has been 
detected in several neurodegenerative diseases. Raised lysosome pH is an 
emerging factor in the progression of neurodegenerative disease due to the 
ineffective lysosome enzyme activity for degradation, for example in Alzheimer’s 
disease (AD) with mutations in presenilin-1 (PS1). PS1 is a catalytic component of 
the Ɣ-secretase complex, which cleaves amyloid precursor protein to produce 
amyloid β (Aβ). Recently, PS1 also been shown to also act as a chaperone in the ER 
facilitating the maturation of the V0a1 subunit for the formation of V-ATPase (Lee et 
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al., 2015). Human fibroblasts with PS1 mutations demonstrated impaired 
glycosylation of V-ATPase and retention of V-ATPase in the ER, preventing 
lysosome acidification due to the diminished level of V-ATPase in lysosomes (Lee et 
al., 2015). Failure of lysosome acidification favours the activation of P2X4R and that 
may contribute to the progression of PS1-linked AD by exacerbating pathological 
features such as enlargement of lysosomes and impairment of lysosome biogenesis 
that is closely tied to cell death mechanism (Lee et al., 2015). Studies have 
demonstrated that mutations in PS1 caused ER Ca2+ dysregulation in PC12 cells, as 
well as human fibroblasts derived from AD patients, such that the IP3-evoked Ca2+ 
signal is exacerbated following ER stimulation (Chan et al., 2000; Guo et al., 1996; 
Ito et al., 1994). Furthermore, there is evidence to suggest that abnormal lysosomal 
Ca2+ homeostasis contributes to the pathological abnormalities in PS1-associated 
AD (Lee et al., 2015). The study demonstrated that stimulation of TRPML1 in PS1 
knockout fibroblasts exaggerated Ca2+ release in response to TRPML1 agonist, ML-
SA1, implicating the dysregulation of lysosomal Ca2+ signalling following lysosome 
alkalinisation. Defects in lysosome acidification could also activate other pH-sensitive 
lysosomal Ca2+ release channels like P2X4R, thereby contributing lysosome Ca2+ 
efflux and potentiating ER-mediated Ca2+ signals. Previous data has suggested that 
TRPML1 mediates lysosome fission rather than fusion. My results demonstrate 
P2X4R-mediated lysosome fusion and enlargement, which is consistent with the 
pathological phenotype of enlarged vacuoles aggregation in AD, suggesting a 
potential role for P2X4R in AD. Study from Lee et al. (2015) also suggested that 
disrupted intra-organelle Ca2+ homeostasis is a direct consequence of the pH 
change in lysosomes. Restoring lysosome pH was sufficient to rescue defects in 
lysosome Ca2+ signals, however reversing abnormality in lysosome Ca2+ efflux did 
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not restore lysosome acidic pH. This confirmed lysosome Ca2+ dysregulation is a 
secondary consequence of lysosome alkalinisation and impacted on the regulation of 
lysosome Ca2+ release channels. Therefore, it is important to fully understand the 
role P2X4R in lysosomes, alongside with other pH-sensitive lysosomal receptors, in 
the understanding of neurodegenerative diseases where lysosome pH is altered 
(McBrayer and Nixon, 2013).  
Indeed, there is one study demonstrated an implication of P2X4R in AD (Varma et al., 
2009). The study showed in an in vitro model that P2X4R was elevated in response 
to the exposure of Aβ in hippocampal neurons. Given the putative caspase 3 
cleavage site in the C-terminal tail of P2X4R and Aβ-induced caspase activity, the 
study showed that caspase 3 enhanced P2X4R activity, contributing to Aβ-mediated 
neuronal cell death (Varma et al., 2009). Consistently, over expression of P2X4R in 
rat hippocampal neurite elevated neurotoxicity of Aβ, but P2X4R knockdown 
attenuate this effect. This study suggested a role for P2X4 in the progression of AD 
may be mediated by enhanced cytoplasmic Ca2+ signal, however, the exact 
underlying mechanism remains to be determined.  
Intracellular Ca2+ signalling is tightly regulated through an intricate interaction of 
intra-organelles and the Ca2+ channels they express. The function of the ER as the 
major intracellular Ca2+ store is well-established, but increasing findings indicate 
lysosomes also contribute to intracellular Ca2+ signalling. Thus far, I have 
demonstrated the role of P2X4R in lysosome fusion that is dependent on a P2X4R-
mediated lysosome Ca2+ signal. This P2X4R-evoked Ca2+ signal potentiated ER-
mediated Ca2+ signals, suggesting that P2X4R contributes to the intracellular Ca2+ 
signalling. The presence of several Ca2+ channels in lysosomes is likely to spatially 
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organise Ca2+ signalling for diverse cellular processes. Therefore, further 
investigation is required to elucidate the detailed mechanisms between lysosomes 
and ER.  
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5. Investigating a role for P2X4R in autophagy  
5.1 Introduction  
The results presented in the previous chapter suggest that upon P2X7R activation 
there is a change in the pH of lysosomes, which recruits the activity of P2X4R in the 
lysosome. This mediates lysosomal Ca2+ efflux and facilitate homotypic lysosomes 
fusion. Following on from these findings I was interested to investigate whether or 
not there was also a role for P2X4R and P2X7R to act synergistically in the 
regulation of autophagy. Autophagy is an evolutionary conserved adaptive 
mechanism that is required for cellular homeostasis to maintain cell viability under 
metabolic stress and is initiated upon cellular stress such as nutrient deprivation. 
Once autophagy is initiated, isolation of a double layer membrane, called the 
autophagosome is formed, which sequesters parts of the cytoplasm. The 
autophagosomes recruit cytoplasmic LC3-I proteins that are conjugated with 
phosphotidylethanolamine (PE) to produce LC3-II. Autophagic flux requires the 
fusion of lysosomes with the autophagosomes to form autophagolysosomes and it is 
here where degradation occur as a consequence of delivery of the degradative 
enzymes from the lysosome. Autophagy is a dynamic process in which initiation, 
fusion and degradation are normally studied together and termed as autophagic flux 
(Klionsky et al., 2012). 
5.1.1 P2X7R and autophagic flux 
A role for P2X7R in the regulation of autophagic flux has previously been reported. In 
microglial cells, activation of P2X7R for 0.5 h to 1 h, using either ATP or BzATP, 
triggered LC3-II protein accumulation in normal growth medium, with little effect in 
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serum-free conditions (nutrient starvation) (Takenouchi et al., 2009). The 
accumulation of LC3 protein is associated with an increase in the number of 
autophagosomes and autophagolysosomes, suggesting the disruption of autophagic 
flux in response to P2X7R stimulation. In this study, they concluded that an increase 
in the pH of lysosomes triggered by P2X7R activation was likely to disrupt the activity 
of the lysosomal proteases, resulting in an accumulation of LC3 proteins in 
autophagosomes and autophagolysosomes. In a separate study, a role for P2X7R in 
reducing autophagic flux in retinal-pigmented epithelium was reported (Guha et al., 
2013). Activation of P2X7R inhibited the degradation of phagocytosed photoreceptor 
outer segments and LC3 proteins. In neither study was it suggested that there is a 
role for P2X4R in this process nor did they investigate a role for P2X4R.  
5.1.2 Assays and interpretations of autophagy  
Changes in the expression and distribution of the LC3 protein are hallmarks of 
autophagy. LC3 can be studied by fusion with either green fluorescence protein 
(GFP) or monomeric red fluorescence protein (mRFP).  During the initiation of 
autophagy, the C-terminus of the LC3-I protein is conjugated to PE to form LC3-II, 
and this associates with the membrane of the autophagosomes. As 
autophagosomes fuse with lysosomes, the membrane bound LC3-II proteins are 
degraded and delipidated, returning LC3 to the cytoplasm (Kabeya et al., 2004). This 
is seen as a reduction in the fluorescence intensity of LC3 puncta. The absence of 
puncta can therefore reflect either the lack of initiation of autophagy or efficient 
autophagic flux. Changes in the distribution and expression of LC3-II can be studied 
by confocal microscopy. Also, western blot analysis enables a comparison of the 
amount of LC3-I to LC3-II because they can be separated on a gel by virtue of their 
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different molecular mass and hydrophobicity (~14 kDa for LC3-I and ~16 kDa for 
LC3-II) (Mizushima, 2007).  
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5.2 Material & Methods  
5.2.1 Cell lines 
The cell line used in this study was HeLa cells stably expressing mRFP-LC3 (kind 
gift from Dr Aviva Tolkovsky, University of Cambridge). This cell line enables the 
study of the autophagy process by enabling the assessment of the changes in 
fluorescence intensity of mRFP-LC3, which is one of the markers for autophagy 
process as detailed section 5.1.2, using confocal imaging.  
5.2.2 Cell maintenance 
Cells were maintained in normal growth medium: Dulbecco’s modified Eagle’s 
medium (DMEM) with 10 % fetal bovine serum (FBS), and 100 U/ml penicillin and 
streptomycin (P/S) at 37 °C in humidified air with 5 % CO2 but in the presence of 
geneticin (1 mg/ml; Sigma) to select cells that were expressing mRFP-LC3 proteins. 
The maintenance and plating of these cells was performed as described in section 
3.1.2. 
5.2.3 Cell sorting 
To obtain consistent cellular expression of mRFP-LC3, HeLa cells were sorted by 
Nigel Miller in the Department of Pathology (University of Cambridge) using a MoFlo 
MLS high-speed cell sorter (BeckmanCoulter). Cells were allowed to grow up to 90 % 
confluency in a T75 flask, growth medium was removed and cells were rinsed with 
PBS. Cells were then trypsinised using 2 ml of 0.05 % trypsin-EDTA solution and 8 
ml of growth medium was added to inhibit further trypsin reaction. Cells were re-
suspended in 8 ml of growth medium and collected in a 15 ml tube. Cells were 
centrifuged at 100 g for 5 mins at room temperature and pellets were re-suspended 
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in PBS to remove residual phenol-red that was in growth media. The cell pellets 
were re-suspended in PBS and subjected to cell sorting facility, according to their 
fluorescence intensity. Sorted cells were then cultured and passaged accordingly.  
5.2.4 Autophagy assay 
Changes in the fluorescence intensity of mRFP-LC3 in HeLa cells were assessed in 
living cells using a Leica SP5 confocal microscope. To initiate autophagy, mRFP-
LC3 HeLa cells were starved by incubation in Earle’s Balance Salt Solution (EBSS) 
with 100 U/ml P/S at 37 °C and 5 % CO2 for 3 h. Cells were stimulated with the 
P2X7R agonist NaATP (300 µM) for 30 minutes immediately prior to imaging the live 
cells.  All settings on the confocal microscope were kept the same when taking 
images from HeLa cells that had been treated in different ways and the images were 
analysed using ImageJ. Typically, I analysed between 80 and 150 cells per condition 
for each experiment. The experiments were repeated 3 times.   
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5.3 Results 
To investigate the effects of P2X4R and P2X7R on autophagy and autophagic flux, I 
used HeLa cells that were stably expressing mRFP-tagged LC3 protein. Cells were 
transfected with rP2X4R-EGFP and rP2X7R, either alone or together. 48h post-
transfection, confocal images were taken of live cells to assess the distribution and 
fluorescence intensity of mRFP-tagged LC3 proteins. In the normal, nutrient rich 
medium, a low level of LC3 intensity was observed in all cells suggesting that basal 
autophagy was unaffected by the expression of rP2X4R and rP2X7R (Fig. 5.1). I 
tested the effect of incubating cells with 300 µM NaATP for 30 minutes on the 
expression of LC3-II and saw no change in mRFP-LC3 fluorescence, either in control 
cells or cells co-expressing rP2X4R and rP2X7R (Fig. 5.2A). Thus, stimulation of 
rP2X7R was insufficient to induce autophagy, at least over this time period. Similarly, 
the incubation of control cells in a nutrient rich medium with an inhibitor of the 
lysosome H+ ATPase, Baf-A1 (100 nM) for 3 h had no effect on LC3 fluorescence 
(Fig. 5.2B). Baf-A1 is known to inhibit autophagic flux by alkalinisation of the 
lysosome, which inhibits the activity of lysosomal proteases.  
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Fig. 5.1 Low expression of LC3-II proteins in nutrient rich conditions in mRFP-LC3-
HeLa cells. (A-B) Representative confocal images of mRFP-LC3-HeLa cells 
expressing EGFP, co-expressing rP2X4R-EGFP with rP2X7R, expressing 
rP2X4R-EGFP alone or co-expressing rP2X7R + EGFP. All cells were incubated 
in nutrient fed media (control; A). All scale bars, 10 µm.  
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Fig. 5.2 Low expression of LC3-II proteins after NaATP and Baf-A1 treatments in 
mRFP-LC3-HeLa cells. (A-B) Representative confocal images of mRFP-LC3-HeLa 
cells either expressing EGFP or co-expressing rP2X4R-EGFP and rP2X7R. Cells 
were incubated in a nutrient fed medium either with 0.3 mM of NaATP for 30 
minutes (A), or with 100 nM Baf-A1 for 3 h (B). All scale bars, 10 µm.  
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The classical way to induce autophagy is by nutrient starvation and to achieve this I 
used EBSS, which is a glucose-containing medium that is devoid of amino acids and 
some growth factors (Boland et al., 2008). Cells expressing different combinations of 
rP2X4R and rP2X7R were incubated in EBSS for 3 h, but this was insufficient to 
increase the intensity of LC3-II puncta, which suggests that either autophagy was not 
induced during this time or that autophagic flux was rapid so that the LC3-II puncta 
that formed during the 3 h incubation period were rapidly degraded (Fig. 5.3A). To 
discriminate between these two possibilities, cells were treated with EBSS for 3 h 
plus Baf-A1 (100 nM for 3 h). This combination produced an approximately 2.4-fold 
increase in LC3-II puncta intensity (Fig. 5.3B and Fig. 5.5), which indicates that 
EBSS is sufficient to induce autophagy and that the LC3-II puncta accumulates when 
autophagic flux is blocked by the alkalinisation of the lysosome.  
Next I tested the effect of incubating cells with 300 µM NaATP for the final 30 
minutes of the 3 h incubation with EBSS to see if this had any effect on the 
autophagic flux. A longer incubation with NaATP was avoided because of the 
noticeably compromised the health of the cells. Only in cells co-expressing rP2X4R 
and rP2X7R was there an increase in the LC3-II puncta intensity following NaATP 
plus EBSS treatment (Fig. 5.4A). In cells expressing just one of the two receptor 
types, there was no change in puncta intensity compared to EBSS alone. Finally, I 
tested a combination of EBSS, NaATP and Baf-A1 treatment on all cell groups and 
saw enhanced fluorescence of LC3-II puncta, which was similar to EBSS and Baf-A1 
treatment alone, independent of the expression of rP2X4R and rP2X7R. (Fig. 5.4B 
and Fig. 5.5). These results suggest NaATP can inhibit autophagic flux leading to 
the accumulation of LC3-II, but only when rP2X4R and rP2X7R are co-expressed 
and following the induction of autophagy.  
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Fig. 5.3 Baf-A1 treatment in EBSS media induced LC3-II protein accumulation in 
mRFP-LC3-HeLa cells. (A-B) Representative confocal images of mRFP-LC3-HeLa 
cells expressing EGFP, co-expressing rP2X4R-EGFP with rP2X7R, expressing 
rP2X4R-EGFP alone or co-expressing rP2X7R + EGFP. All cells were incubated 
for 3 h in an amino acid-free medium: EBSS (A), or EBSS with Baf-A1 (100 nM for 
3 h) (B). All scale bars, 10 µm.  
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Fig. 5.4 Synergistic effect of rP2X4R and rP2X7R in LC3-II protein accumulation 
following NaATP treatments in EBSS. (A-B) Representative confocal images of 
mRFP-LC3-HeLa cells expressing EGFP, co-expressing rP2X4R-EGFP with 
rP2X7R, expressing rP2X4R-EGFP alone or co-expressing rP2X7R + EGFP. All 
cells were incubated for 3 h in EBSS with 0.3 mM of NaATP treatment for the final 
0.5 h, either without Baf-A1 (A) or with Baf-A1 (100 nM for 3 h) (B). All scale bars, 
10 µm.  
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Fig. 5.5 Histogram showing the fluorescence intensity of mRFP-LC3 proteins in 
mRFP-LC3-HeLa cells expressing EGFP, rP2X4R-EGFP or rP2X7R, or cells co-
expressing rP2X4R-EGFP and rP2X7R. All results are mean ± s.e.m. from at least 
3 independent experiments. ***P < 0.001, one-way ANOVA followed by Tukey’s 
analysis.  
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Autophagic flux is known to require fusion of lysosomes with autophagosomes to 
generate autophagolysosomes. Delivery of lysosomal proteolytic enzymes to the 
autophagosome then triggers degradation of the engulfed cellular constituents plus 
the accumulated LC3-II proteins. My results suggest that in cells co-expressing 
rP2X4R and rP2X7R, treatment with NaATP either inhibits the activity of lysosomal 
proteases or inhibits the fusion of lysosomes with autophagosomes. To discriminate 
between these two possibilities, I compared the distribution of rP2X4-EGFP, which I 
know is in lysosomes, with the distribution of the LC3-II puncta after treatment with 
EBSS + NaATP. In cells co-expressing rP2X4R and rP2X7R there was extensive co-
localisation between rP2X4R-EGFP and mRFP-LC3 indicating that lysosomes have 
fused with autophagosomes (Fig. 5.6A). The co-localisation was very similar to that 
seen after treatment with EBSS + NaATP + Baf-A1 in cells co-expressing both 
receptors or just expressing rP2X4-EGFP. Altogether these results suggest that 
when rP2X4R and rP2X7R are both present, the activation of rP2X7R inhibits 
autophagic flux, in a similar way to Baf-A1, by inhibiting the activity of lysosomal 
enzymes.  
 
146 
 
 
EBSS + NaATP
rP2X4R
rP2X4R
+ 
rP2X7R
P2X4R-EGFP mRFP-LC3
A
Overlay
EBSS + NaATP+ Baf-A1
P2X4R-EGFP mRFP-LC3
B
Overlay
rP2X4R
rP2X4R 
+ 
rP2X7R
 
Fig. 5.6 Co-localisation of rP2X4R-EGFP with mRFP-LC3 suggests the fusion of 
lysosomes and autophagosomes. (A-B) Confocal images of mRFP-LC3-HeLa 
cells either expressing rP2X4R-EGFP or co-expressing rP2X4R-EGFP and 
rP2X7R. Cells were treated as follows: (A) 3 h incubation of EBSS with NaATP 
(0.3 mM) treatment for the final 0.5 h, or (B) 3 h incubation of EBSS with NaATP 
(0.3 mM) treatment for the final 0.5 h and Baf-A1 (100 nM) for 3 h. Red boxes 
depict the area of interest for higher magnification images. All scale bars, 10 µm.  
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5.4 Discussion 
The results presented in this Chapter, and the previous Chapter, are consistent in 
providing evidence that activation of P2X7R reduces the acidity of lysosomes. This 
has consequences for homotypic lysosome fusion mediated by P2X4R and it also 
has consequences for the rate at which autophagic flux progresses. What was 
surprising about my autophagy results was that activation of P2X7R in the absence 
of P2X4R was insufficient to see a significant increase in LC3-II fluorescence. I 
expected inhibition of autophagic flux to be dependent upon lysosome alkalinisation 
rather than a subsequent step mediated by lysosomal P2X4Rs. This suggests that 
P2X4R might play a role in the regulation of lysosome or autophagolysosome pH 
and that perhaps Ca2+ or Na+ flux mediated by lysosomal P2X4R feeds back to 
affect H+ flux. Alternatively, there might be other mechanisms involved in the 
regulation of degradation by P2X4R. 
The previous studies showing an effect of P2X7R in autophagy were both carried out 
in cell types where I expect P2X4R to also be expressed, namely microglial cells 
(Takenouchi et al., 2009), and retinal-pigmented epithelium (RPE) cells (Guha et al., 
2013). Therefore, although the focus of these studies was P2X7R, there may have 
been a contribution from endogenous P2X4R. In addition, the ability of Baf-A1 
treatment to induce lysosomes alkalinisation and inhibit autophagic clearance as 
measured by the accumulation of LC3 proteins has been shown previously (Fass et 
al., 2006, Takenouchi et al., 2009 and Guha et al., 2013). This suggests that 
lysosome pH is essential for the degradation of autophagolysosomes and the effect 
of P2X7R in lysosome alkalinisation, which activates P2X4R, are likely to inhibit this 
process in the similar manner as Baf-A1.  
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An effect of NaATP on LC3 accumulation was only seen in combination with EBSS, 
suggesting that P2X4R and P2X7R do not affect the initiation of autophagy, at least 
in a nutrient rich environment. This result contrasts with the findings by Takenouchi 
et al. (2009) that the application of ATP in nutrient rich medium is sufficient to induce 
LC3-II accumulation in microglial cells. One possible explanation for the discrepancy 
is the different cell types. Microglial cells may exhibit a relatively higher basal 
autophagy activity compared to stable cell line, mRFP-LC3-HeLa cells. There is 
evidence suggested that the turnover of LC3 proteins differs in cell types alongside 
with different basal activity, for example in cells with neuronal origins has a higher 
ratio of LC3-I to LC3-II is a common finding (Klionsky et al., 2016). Alternatively, this 
study utilised endogenous P2X7R in microglial cells, a different experimental system 
from my study which employed the transient expression of P2X4R and P2X7R.  
Overall, my results demonstrate that the stimulation of heterologous expression of 
P2X4R and P2X7R is sufficient to inhibit autophagic flux such that LC3-II proteins 
are accumulated. This suggests that both receptors are negatively regulating the 
autophagic clearance due to lysosome alkalinisation at least under such 
experimental setup, a similar effect induced by Baf-A1 treatment.  
However, autophagy is a complex, dynamic, and multistep process, and multiple 
assays are recommended to permit a correct interpretation of the result. Having 
shown the effect of P2X4R and P2X7R in the accumulation of LC3 proteins, further 
examination is required to be sure of the effect of P2X4R and P2X7R in impairment 
of the autophagy degradation process. The accumulation of LC3 proteins in the 
autophagosome usually arises from either the upregulation of induction, impairment 
of autophagosome fusion or inefficient autophagic clearance. However, my result 
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has ruled out the possibility of autophagy initiation and autophagosome-lysosome 
fusion, but further assays in addition to confocal imaging are preferable. For example, 
application of PI3K inhibitor 3-methyladenine (3-MA), which inhibits autophagy 
initiation (Yang et al., 2013), or vinblastine, a reagent that depolymerises 
microtubules, are necessary to rule out autophagy initiation and autophagosome-
lysosome fusion, respectively. Furthermore, I have shown the effect of P2X4R and 
P2X7R in inefficient lysosome degradation by measuring the rate of accumulation of 
LC3 proteins at a static time point using confocal microscopy. In addition to this, one 
complementary approach can be conducted which is the measurement in the rate of 
degradation. The measurement of the rate of general degradation by autophagy 
process can be achieved by measuring the time-dependent decrease of an 
autophagy-degradable proteins, for example p62 using western blot or confocal 
imaging. However, the changes in p62 has a caveat where there is a potential 
contribution of the increase in protein synthesis, where one can address by 
experimental inhibition such as protein synthesis inhibitor, cycloheximide (Klionsky et 
al., 2012, 2016).  
The regulation of autophagy is tightly associated with cellular function; therefore it is 
important to understand regulators and channels involved in autophagy. Autophagy 
is primarily known to be stimulated by cellular stress conditions like nutrient 
starvation. This leads to the general understanding that autophagy serves as an 
energy-generating mechanism under metabolic stress conditions. In addition, 
autophagy mediates turnover of old and damaged organelles to ensure desirable 
intracellular conditions and supply metabolic precursor for minimal growth 
requirement. However, excessive activation of autophagy is undesirable as it 
involves large-scale degradation of the cytoplasm, protein complexes and organelles 
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that are necessary for cell growth. There is evidence that an adequate level of 
autophagy activity maintains cell viability in Caenorhabditis elegans, but low level or 
excessively high level of autophagy can promote cell death (Kang et al., 2007). 
Therefore, tight regulation of autophagy is essential for cell viability such that most 
cells maintain a low basal level of autophagy under normal nutrient fed conditions, 
but stimulated by various stimuli including protein aggregation, pathogen invasion, 
inflammation, and damaged organelles (Van Limbergen et al., 2009).  
In addition to increasing cell viability under metabolic stress conditions, autophagy 
maintains cell homeostasis and provides an intracellular quality control by recycling 
and regenerating metabolic precursor via degradation of intracellular debris and 
organelles. For example, autophagy is a housekeeping mechanism in heart and 
muscle cells that mediate the turnover of cytoplasmic constituents like mitochondria. 
There is a study showing that depletion of LAMP2 proteins resulted in ineffective 
autophagic degradation in myopathy and cardiomyopathy patients (Nishino et al., 
2000; Tanaka et al., 2000). LAMP2 has been suggested to contribute to lysosome 
acidification and deficiency in LAMP2 induced lysosome alkalinisation (Mindell, 
2012). This suggests a possible contribution of active P2X4R and P2X7R upon 
alkalinisation of lysosomes such that the active P2X4R and P2X7R impaired 
degradation of autophagolysosomes.  
Autophagy has also been shown to participate in the regulation of immunity and 
inflammation. First, autophagy functions as an effector that eliminates intracellular 
pathogen invasion. One example is that bacterial infection triggers activation of 
NLRs and that can direct ATG16L1 to the site of bacterial entry at the plasma 
membrane to eliminate bacteria by autophagy (Travassos et al., 2010). In addition, 
151 
 
autophagy has been implicated in the regulation of cytokine production. One 
example is that autophagy has been shown to control the level of cytokine release, 
such that the production of IL-1β and IL-18 increased in the autophagy-deficient 
macrophages (ATG16-/-) (Saitoh et al., 2008). These evidences suggest the effect of 
autophagy in inflammation could be associated with P2X4R and P2X7R because 
these receptors have also been shown to mediate the release of IL-1β and IL-18 
(Sakaki et al., 2013). The similar downstream effect in an increase IL-1β and IL-18 
production following autophagy-depletion and activation of P2X4R and P2X7R may 
suggest that the role of autophagy in cytokine release is mediated via these 
receptors, but further examination is required to understand the role of autophagy in 
immunity. 
Apart from P2X4R, there is evidence demonstrating an effect of another lysosomal 
Ca2+ release channel, TPC2 in autophagy (Lu et al., 2013). Over expression of TPC2 
was shown to induce an impairment in autophagic degradation due to defective 
autophagosome-lysosome fusion. Both genetic knockdown of TPC2 and 
pharmacological inhibition of NAADP (TPC2 agonist) using the NAADP-antagonist, 
Ned-19 abolished the impairment of autophagosome-lysosome fusion and facilitated 
the progression of autophagy by promoting the formation of autophagolysosomes. In 
addition, the study demonstrated that NAADP stimulates TPC2-induced Ca2+ release 
and this alkalinises lysosomes, thereby disrupting autophagosome-lysosome fusion. 
In line with this finding, my results agree that the manipulation of lysosome pH and 
lysosome Ca2+ signals could disrupt the progression of autophagy, thereby 
accumulating LC3 proteins. However, my study demonstrates an effect of P2X4R 
and P2X7R in autophagy degradation, which was only observed under stress 
conditions, without a significant impact on autophagosome-lysosome fusion. 
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Together, the study by Lu et al. (2013) and my result suggest that the manipulation 
of different lysosome Ca2+ channels may contribute to different stages of autophagy 
progression. Therefore, it is of interest to understand the signalling of lysosomal Ca2+ 
channels in autophagy under basal and stimulated conditions. Given that autophagy 
is involved in a variety of cellular processes and dysfunction of autophagy is 
implicated in many diseases, it is important to further understand the role of P2X4R 
signalling to identify novel regulator in this pathway.  
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6 Characterisation of the subcellular distribution of human and rat P2X4R 
6.1 Introduction  
My project has focused mainly on the study of rat P2X4R (rP2X4R), but I also 
compared the subcellular distribution of human P2X4R (hP2X4R) with that of the rat 
receptor. These two isoforms share 87 % amino acid sequence identity with the most 
variability found in the extracellular loop (Abdelrahman et al., 2017; Garcia-Guzman 
et al., 1997). These differences in amino acid sequence in the extracellular loop have 
been implicated in differences in antagonist sensitivity. For example, P2XR 
antagonists, suramin and PPADS were shown to inhibit hP2X4R, but are relatively 
ineffective at rP2X4R. Previously, the motifs identified as targeting P2X4 to 
lysosomes included an N-terminal dileucine-like motif (L22I23) and two adjacent C-
terminal tyrosine-based motifs (Y372 and Y378). All of these motifs are conserved in 
hP2X4R and therefore my expectation was that the trafficking of hP2X4 would be 
indistinguishable from rP2X4 (Qureshi et al., 2007; Royle et al., 2002, 2005). The 
aim of this study was to investigate any species difference in the trafficking 
behaviour of the receptor.  
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6.2 Results 
A comparison was made of the subcellular distribution of hP2X4R with that of the 
rP2X4R following their heterologous expression in HeLa cells.  LAMP1-mCherry was 
expressed to label lysosomes and the EGFP-tagged P2X4Rs were transfected into 
cells and imaged 48 h later. There was extensive co-localisation of LAMP1-mCherry 
with both rP2X4R-EGFP and hP2X4R-EGFP, but for many cells expressing 
hP2X4R-EGFP there were also clear plasma membrane localisation, which was not 
apparent for rP2X4R-EGFP (Fig. 6.1A-B). A similar experiment was carried out 
using DR to label lysosomes with the standard protocol (incubation for 5 h followed 
by a 2 h chase). Co-localisation between hP2X4-EGFP and DR was less than for 
LAMP1-mCherry, and it was less than for rP2X4-EGFP and DR and this was 
reflected in the relatively low value for the Pearson’s coefficient (Fig. 6.1C-D). This 
suggests that there is some isoform dependence on the distribution of the receptor. 
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Fig. 6.1 The subcellular distribution of human and rat P2X4R in HeLa cells. (A-B) 
Confocal images of HeLa cells co-expressing LAMP1-mCherry as lysosomes, with 
rat (A) or human (B) isoforms of P2X4R-EGFP. (C-D) Confocal images showing 
cells expressing rat (C) or human (D) isoforms of P2X4R-EGFP with lysosomes 
labelled by Texas Red 10-kDa Dextran (DR). (E) Histogram showing the co-
localisation measured by Pearson’s coefficients of LAMP1-mCherry or DR with 
human and rat orthologues of P2X4R-EGFP. All results are mean ± s.e.m. 
obtained from the total number of cells, n as indicated. ***P < 0.001, one-way 
ANOVA followed by Tukey’s analysis. All scale bars, 10 µm.  
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The experiment was repeated, but using NRK cells, and comparing the distribution of 
both EGFP-tagged and un-tagged P2X4Rs, labelled by immunofluorescence (Fig. 
6.2). Again, the plasma membrane expression of hP2X4R was more evident than for 
the rP2X4R and the degree of co-localisation with LAMP1-mCherry was lower for the 
human versus the rat receptor.  
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Fig. 6.2 Human P2X4Rs are localised to lysosomes and the plasma membrane in 
NRK cells. (A-B) Representative confocal images of cells co-expressing LAMP1-
mCherry as lysosomes, with rat (A) or human (B) isoforms of P2X4R-EGFP. (C-D) 
Confocal images of NRK cells expressing rat (C) and human (D) orthologues of 
P2X4R, immunostained with α-P2X4R antibody (Alexa Fluor 488) and lysosomes 
marked by LAMP1-mCherry. (E-F) A summary of the results showing Pearson’s 
coefficients for co-localisation of LAMP1-mCherry with either P2X4R-EGFP (E) or 
α-P2X4R antibody (F) in rat P2X4R (rP2X4R) and human P2X4R (hP2X4R) 
expressing NRK cells. (E) Results are mean ± s.e.m. obtained from 3 independent 
experiments, N = 3. (F) Results are mean ± s.e.m. obtained from total number of 
cells, n as indicated. (E-F) *P < 0.05 and ***P < 0.001, Student’s t test. All scale 
bars, 10 µm.  
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To further investigate if hP2X4R has a higher expression at the plasma membrane 
compared to rP2X4R, I used a different approach in which surface receptors were 
labelled using biotin, purified and then the amount at the cell surface was compared 
with the total receptor population by western blot analysis. This experiment was 
carried out using a modified HEK293 cells line that is suited to biochemical assays 
because of high expression of recombinant proteins. The total expression of P2X4Rs 
was normalised to a loading control (β-actin) and the purified surface receptor 
samples were loaded in the same proportion (Fig. 6.3). It is clear from this blot and 
the quantification shown in the histogram, that the intensity of the band representing 
surface hP2X4R was greater than for the band that represents surface rP2X4R even 
when one takes into account that total hP2X4R had a slightly higher intensity than 
total rP2X4R. There is one caveat with this data, which is that β-actin should not 
appear in the biotin-purified sample given that it is an intracellular protein. Its 
appearance in lanes 3 and 4 indicates that some cells were permeabilised enabling 
biotin to gain access to intracellular proteins. However, the band intensity is relatively 
faint compared to the total bands and these samples were highly concentrated 
(which the concentration factor is 5 times) compared to the total samples. Therefore, 
those bands that are supposed to represent the cell surface P2X4R are likely to have 
a small component contributed by intracellular receptors. Unfortunately, this 
experiment was carried out only once, but the results are consistent with the 
confocal images, which show elevated hP2X4-EGFP versus rP2X4-EGFP at the cell 
surface.  
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Fig. 6.3 Surface expression of hP2X4R and rP2X4R in HEK293 cells. (A) 
Immunoblot showing the input and proteins detected after surface avidin 
purification in cells expressing rat or human isoforms of P2X4R. (B) Histogram 
showing the total amount of P2X4R normalised to β-actin. (C) Histogram showing 
the amount of P2X4R detected on the cell surface via the avidin pull-downs, 
normalised by the total amount of P2X4R.  
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The higher plasma membrane expression of hP2X4R compared to rP2X4R was 
surprising because this receptor contains the endocytic and lysosome targeting 
motifs that were identified in rP2X4R, namely Y372 and Y378-based endocytic 
motifs within the C-terminus and the dileucine-like motif within the N-terminus (L22, 
I23) (Fig. 6.4) (Qureshi et al., 2007). However, there are some sequence differences 
between the two isoforms in the vicinity of these motifs. Also, there is a second in-
frame methionine at position 31 and I was interested in the possibility that this was 
being utilised in the translation of hP2X4R thereby generating an N-terminally 
truncated variant of hP2X4 lacking the L22, I23 motif. I carried out some limited 
mutagenesis of residues in hP2X4R-EGFP to see if I could identify what was 
responsible for its higher plasma membrane expression. Within the N-terminus of 
hP2X4R, alanine at position 6 was mutated to serine and alanine at position 7 to 
valine (hP2X4R-A6S-A7V), which are homologous residues in rP2X4R. Additionally, 
I mutated methionine 31 to alanine (hP2X4R-M31A) to remove the possibility of 
expression of a truncated variant.  
These mutants were expressed in NRK cells and lysosomes were labelled using 
LAMP1-mCherry. Confocal images showed that the mutant hP2X4R-A6S-A7V-
EGFP (0.52 ± 0.02 A.U., p < 0.01) concentrated within the intracellular 
compartments that co-localised with LAMP1-mCherry with a reduction in the 
peripheral membrane expression (Fig. 6.5C). The mutant M31A, however exhibited 
the same subcellular distribution as hP2X4R WT with receptors targeted to 
lysosomes, but still showing clear expression at the cell surface (Fig. 6.5). A similar 
experiment was conducted to assess the targeting of WT and mutant receptors in 
HeLa cells, but this time lysosomes were marked with DR. Confocal images showed 
greater co-localisation of hP2X4R-A6S-A7V-EGFP within the DR-loaded 
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compartments than for WT and mutant M31A receptors and this was reflected in the 
value of the Pearson’s coefficient, which was significantly higher for the hP2X4R-
A6S-A7V-EGFP mutant than WT and mutant M31A receptors (p < 0.001) (Fig. 6.6). 
Again, the mutant hP2X4R-A6S-A7V-EGFP appeared to decrease the expression at 
the plasma membrane. Fig. 6.7 shows a comparison of a selection of images taken 
either from cells expressing the wild type hP2X4 receptor or the A6S-A7V mutant. 
The results are not completely clear cut, but there do seem to be fewer cells showing 
detectable plasma membrane expression in the mutant hP2X4R-A6S-A7V-EGFP 
compared to WT hP2X4R-EGFP. These results suggest that the nature of the 
residues at positions 6 and 7 in P2X4R have some influence on the proportion of 
receptors within lysosomes versus at the cell surface.  
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Fig. 6.4 Amino acid sequence alignment for human and rat isoforms of P2X4R. 
Red boxes with asterisks represent the mutations, hP2X4R-A6S-A7V and 
hP2X4R-M31A, constructed for the study. Open boxes depict the non-conserved 
residues. M1 and M2 represent transmembrane domain 1 and 2. Image with 
modification is adapted from Garcia-Guzman et al., 1997.    
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Fig. 6.5 The mutant hP2X4R-A6S-A7V reduced the plasma membrane expression 
in NRK cells.  (A-C) Confocal images of NRK cells transiently transfected with WT 
hP2X4R-EGFP (A), hP2X4R-M31A-EGFP (B) and hP2X4R-A6S-A7V-EGFP (C), 
with lysosomes labelled by LAMP1-mCherry. (D) Summary of results showing 
Pearson’s coefficients for the co-localisation of LAMP1-mCherry with WT and 
mutants of P2X4R-EGFP, as indicated. All results are mean ± s.e.m. obtained 
from total number of cells, n, as indicated. *P < 0.05 and ***P < 0.001, one-way 
ANOVA followed by Tukey’s analysis. All scale bars, 10 µm.  
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Fig. 6.6 The mutant hP2X4R-A6S-A7V reduced plasma membrane localisation in 
HeLa cells. (A-C) Confocal images showing the subcellular distribution of EGFP-
tagged constructs of WT hP2X4R (A), hP2X4R-M31A (B) and hP2X4R-A6S-A7V 
(C) in HeLa cells; lysosomes were marked by DR. All scale bars, 10 µm. (D) 
Histogram showing the Pearson’s coefficients of DR with either WT or mutants of 
P2X4R-EGFP (hP2X4R-M31A and hP2X4R-A6S-A7V). All results are mean ± 
s.e.m. obtained from total number of cells, n, as indicated. ***P < 0.001, one-way 
ANOVA followed by Tukey’s analysis.  
 
 
165 
 
 
hP2X4R-EGFP WTA
hP2X4R-EGFP-A6S-A7VB
 
Fig. 6.7 The mutant hP2X4R-A6S-A7V reduced the plasma membrane labelling in 
NRK cells.  (A-B) A series of NRK cells transiently transfected with WT hP2X4R-
EGFP (A) and hP2X4R-A6S-A7V-EGFP (B). Confocal images demonstrate 
lysosomes labelled by EGFP-tagged P2X4Rs with some cells showing the plasma 
membrane labelling. All scale bars, 10 µm.  
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6.3 Discussion 
My results show that there are many similarities in the distribution of rP2X4R and 
hP2X4R, but also some differences. Both receptors show localisation to lysosomes, 
but there is more obvious expression of hP2X4R at the cell surface compared to 
rP2X4R. This was clearly seen in the confocal images and the western blot results 
following biotinylation of surface proteins, which agree with these confocal images. 
Also, measurements of co-localisation by calculating the Pearson’s coefficient 
indicated that there was higher co-localisation between rP2X4R and lysosomal 
makers than for hP2X4R. Interestingly, this was particularly apparent when 
comparing with DR labelling rather than LAMP1-mCherry. One explanation is that 
the labelling of LAMP1-mCherry marks both active and quiescence populations of 
lysosomes whereas DR-loaded compartments are active by virtue of recently 
receiving endocytosed materials.  
I carried out some preliminary investigation of the sequence differences between 
rP2X4R and hP2X4R that might be responsible for the difference in receptor 
targeting. It was previously shown that both N-terminus dileucine motif (L22I23) and 
two tyrosine motifs (Y372 and Y378) in the C-terminus of P2X4R are involved in 
lysosomal targeting (Qureshi et al., 2007). However, these are both conserved in rat 
and human isoforms, which does not explain the plasma membrane expression of 
hP2X4R. I investigated both mutations of the non-conserved residues A6S-A7V and 
the second open reading frame M31A of hP2X4R, which are juxtaposed to the 
lysosomal targeting motifs. Confocal studies suggested that the distribution of 
hP2X4R-A6S-A7V was more similar to rP2X4R than wild type hP2X4R. However, 
further experiments are required to be sure these findings are robust and to test for 
the functionality of the mutant receptor. Both rP2X4R and hP2X4R contain an in-
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frame methionine at position 31 suggesting that an N-terminally truncated variant 
might also be expressed, but have slightly reduced targeting to lysosomes. 
Mutagenesis of hP2X4R-M31A was carried out to investigate whether the first 
methionine is skipped as the start of translation in preference for the second 
methionine. This mutation removes this possibility and yet it had no obvious effect on 
either the expression level of the receptor or its distribution which suggests that the 
truncated variant may not be the dominant form expressed. There was a difference 
in the distribution of the A6S-A7V mutant compared to wild type hP2X7R, but further 
work needs to be carried out to characterise this mutant in more detail. Co-
localisation between the mutant receptor and lysosomal markers was increased 
compared to wild type hP2X4R. One possible explanation for the differences seen in 
P2X4R targeting is that the accessibility of the L22I23 motif is reduced in the human 
isoform and that this has something to do with the nature of the residues at positions 
6 and 7. Perhaps this affects the folding of the N-terminus or an interaction with 
another protein that restricts accessibility. 
The higher expression of hP2X4R on the cell surface is completely unexpected given 
that the lysosome targeting motifs are conserved in human isoforms. Previously it 
has been suggested that dileucine like motifs are more important for directly 
targeting proteins to lysosomes from the trans Golgi network whereas tyrosine-based 
motifs are more involved in targeting to lysosomes via retrieval of the protein from 
the plasma membrane (Qureshi et al., 2007; Royle et al., 2002). To ensure this is the 
case for hP2X4R, further investigation can be implemented to assess the trafficking 
behaviour of hP2X4R by generating chimeras between rP2X4R and hP2X4R in 
which the C-termini are switched. Similarly, chimeras where the N-termini are 
switched between rP2X4R and hP2X4R. These chimeras with a GFP-tag can be 
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visualised by confocal microscopy to determine whether the N-terminus or the C-
terminus is dominant in determining the surface expression of hP2X4R. After having 
determined which terminal region is largely regulating the targeting of hP2X4R, 
series of sequential mutagenesis closed to the targeting motif can generate to 
identify the important region for trafficking. Certainly, P2X4R is known to undergo 
constitutive endocytosis from the cell surface and that this requires the C-terminal 
tyrosines 372 and 378. Thus, a series of individual substitution of the 7 non-
conserved amino acid residues in hP2X4R with the homologue residue in rP2X4R, 
which is juxtaposed to the tyrosine motifs, can identify the important residue in the 
endocytosis of hP2X4R (Garcia-Guzman et al., 1997). These 7 non-conserved 
amino acids may contribute to the binding of adaptor proteins alongside with the 
tyrosine motif for endocytosis.  
Recently other experiments carried out in the RML lab have examined the 
distribution of endogenous P2X4R in highly invasive human breast cancer cells, 
including MDA-MB-435 cells and MDA-MB-231 cells. In both cases the 
immunostaining has shown a lysosomal localisation of P2X4R with no clear staining 
at the cell surface. Thus understanding a role for the lysosomal receptors is likely to 
be important for both the human as well as the rodent isoforms. 
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7. Conclusion 
The lysosome is recognised as an organelle that modulates many cellular processes, 
including degradation, recycling of intracellular organelles and cell death. Essentially, 
lysosomes mediate these cellular functions via the distribution and delivery of acidic 
hydrolases. Delivery of these hydrolases via fusion and fission are essential for the 
main mode of lysosome function.  
The high concentration of hydrolases with low pH within lysosomes suggests a 
perfect degradative environment. However, my results (alongside others - Qureshi et 
al., 2007; Royle et al., 2002, 2005) have demonstrated the stable localisation of 
P2X4R in lysosomes. There is evidence demonstrating that P2X4R retains its 
functional integrity in lysosomes and can be activated following lysosomal 
alkalinisation, using pharmacological reagents like Baf-A1 and MA (Cao et al., 2015; 
Huang et al., 2014). This matches with my results demonstrating P2X4R-dependent 
lysosome fusion following lysosome alkalinisation. Mediation of lysosome fusion has 
been shown to be dependent on Ca2+ release from lysosomes (Morgan et al., 2011; 
Pryor et al., 2000). Correspondingly, my results match with the proposed mechanism 
such that the activation of P2X4R mediates lysosome Ca2+ efflux, thereby mediating 
lysosome fusion. This result is consistent with that of others (Cao et al., 2015; Huang 
et al., 2014), however neither of the studies demonstrate a role for P2X4R under 
physiological or pathophysiological conditions.  
In my studies I identified two physiological regulators of P2X4R, namely P2X7R and 
Gq-coupled GPCRs. P2X7R-induced lysosome alkalinisation was previously shown 
in microglial cells, which led to my investigation of the potential interaction between 
P2X4R and P2X7R in lysosome function. My results suggest that the activation of 
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P2X7R increases the pH of lysosomes in a manner that is dependent upon Ca2+ 
entry into the cell. Similarly P2X4-dependent lysosome fusion was dependent upon 
Ca2+ entry into the cell via P2X7R. The activation of P2X4Rs mediates lysosome 
functions, specifically lysosome Ca2+ efflux and lysosome fusion. The P2X4R-
mediated Ca2+ signal was only detectable using LAMP1-GECO, but not the 
cytoplasmic Ca2+ indicator G-GECO, following the activation of P2X7R. The slow 
desensitisation rate of P2X7R and over expression of the receptor is likely to 
generate a sustained Ca2+ influx from the extracellular space and that is likely to 
saturate G-GECO signals. This provides evidence of the synergistic effect of P2X7R 
and P2X4R in Ca2+ signalling such that P2X4R triggered a localised surge of the 
cytoplasmic [Ca2+], mediated by lysosome Ca2+ efflux. This Ca2+ signal is likely to be 
the stimulus for lysosome fusion, only when P2X4R and P2X7R are co-expressed.  
My results also showed that the activation of the Gq-coupled GPCR, H1R, triggered 
Ca2+ release from the ER that alkalinised the pH of lysosomes in HeLa cells. The 
alkalinised lysosomes relieved the acidic inhibition of P2X4R and enabled lysosome 
Ca2+ efflux. This was confirmed by three different Ca2+ indicators, namely LAMP1-
GECO, G-GECO and Fluo4. These Ca2+ indicators showed that P2X4R potentiated 
the histamine-induced Ca2+ signal via lysosome Ca2+ release, indicative of the 
functional crosstalk between lysosomes and ER. This is different from the Ca2+ 
signal recorded by G-GECO where it does not resolve any Ca2+ signal derived from 
lysosomes in NRK cells. The discrepancy can be explained based on the different 
experimental setups. A more physiological setup was used in HeLa cells to monitor 
the P2X4R-mediated Ca2+ signal from intra-organelle Ca2+ stores compared to the 
mobilisation of Ca2+ influx from the extracellular space via P2X7R, an ion channel 
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with prolonged pore opening. Similarly, the Gq-coupled P2Y2R also recruited the 
activity of lysosomal P2X4R in the same manner as H1R, via the release of ER Ca2+. 
I have also demonstrated that P2X7R-induced lysosome alkalinisation impacts upon 
the rate at which autophagic flux progresses. The heterologous expression of P2X4R 
and P2X7R was sufficient to inhibit autophagic flux. This effect is only observed after 
autophagy initiation, providing evidence that the receptors are involved in the later 
stages of autophagy. The accumulation of LC3 proteins that co-localised with 
lysosomes confirmed the effect of P2X4R and P2X7R in the degradation of 
autophagolysosome, without significant impact on the fusion between 
autophagosomes and lysosomes. Altogether, these results suggest that both 
receptors are negatively regulating the autophagic clearance due to lysosome 
alkalinisation, a similar effect induced by Baf-A1 treatment.  
Having shown the physiological regulators of P2X4R in lysosome function and the 
effect of P2X4R in autophagy, the depletion of P2X4R is expected to confer an 
impact in lysosome phenotype. Nonetheless, the depletion of P2X4R in BMDMs 
derived from P2X4R-/- mice did not exhibit any gross change in lysosome phenotype 
under control conditions. This rules out the role of P2X4R in lysosome function under 
basal conditions but it should be noted that I did not have a chance to repeat this 
preliminary data. However, pharmacological reagents that alkalinise lysosomes 
reduced the rate of lysosome fusion. This suggests that P2X4R in lysosomes is likely 
to be stimulated under circumstances where the pH of lysosomes is increased. 
Nonetheless, the effect of P2X4R has been shown to mediate regulated lysosome 
fusion in ATII cells. P2X4R modulates the secretory fusion of LBs with plasma 
membrane such that the activation of P2X4R mediates a localised Ca2+ signal, 
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facilitating the complete fusion and secretion of surfactants (Miklavc et al., 2010).  
Therefore, P2X4R is likely to be stimulated under specific cell types and 
circumstances where the pH of lysosomes is elevated. 
Lastly, I have demonstrated the difference in the trafficking behaviour of hP2X4R 
and rP2X4R. Both receptors exhibit many similarities in the subcellular distribution 
such that both hP2X4R and rP2X4R are localised to lysosomes at the perinuclear 
region. However, hP2X4Rs display a higher plasma membrane distribution than the 
rat isoform. My preliminary study has shown that the non-conserved residues at 
position A6 and A7 in hP2X4R may have some influence in the plasma membrane 
labelling. This difference in receptor targeting may imply that the human isoforms are 
more sensitive towards the extracellular milieu due to its enhanced expression on 
the plasma membrane, thereby positively regulating the activity of P2X4R in 
lysosomes. Collectively, my results provide the first evidence of physiological 
regulators of lysosomal P2X4Rs.  
7.1. Potential effects of P2X4R in health and diseases 
My results demonstrate the effect of P2X4R and P2X7R in autophagic flux suggests 
the effect of P2X4R in lysosome function is likely to mediate under cellular stress 
conditions, complementing the explanation of the lack of lysosome phenotype in 
P2X4R-/- mice. Thus far, no research has examined the effect of P2X4R in 
autophagy in P2X4R knockout mice. Given my results demonstrating the negative 
regulation of P2X4R and P2X7R in autophagy, it is possible that cells in P2X4R 
knockout mice may have the positive consequence in improving autophagy 
clearance under stressful conditions. In addition to the effect of P2X4R and P2X7R 
on the accumulation of LC3 proteins, there is evidence showing effects of P2X7R on 
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autophagy and subsequently enhanced the exocytosis of the autophagolysosomes 
in microglial cells (Takenouchi et al., 2009). This increases the extracellular 
undigested metabolites and may have toxic consequences due to the secretion of 
acidic hydrolytic enzymes. Again, such conditions suggest an effect of P2X4R in the 
exocytosis of autophagolysosomes, given P2X7R as a regulator of P2X4R. 
Therefore, P2X4R knockout mice may exhibit a positive effect following nutrient 
starvation conditions as compared to wildtype.  
Research has demonstrated the physiological importance of autophagy in neuronal 
biogenesis and dysfunction has been implicated in neurodegenerative diseases. 
Most neurodegenerative diseases present with abnormality of lysosome trafficking, 
accumulation of autophagic vacuoles, lysosomal hydrolysis impairment and 
aggregation of misfolded proteins, which arises from the impairment in autophagy 
(Nixon, 2013). One example for autophagy-related disease is familial Alzheimer’s 
disease (AD), which arises from mutations in presenilin1 (PS1). AD is characterised 
by the loss of neurons, the formation of intracellular neurofibrillary tangles and 
extracellular plaque of amyloid β (Aβ). The aggregation of Aβ is associated with the 
rate of autophagy such that the upregulation of autophagy decreases Aβ level 
(Menzies et al., 2017). Furthermore, there is evidence demonstrating an increase in 
lysosome pH in fibroblasts with Alzheimer-associated PS1 mutation (Coffey et al., 
2014; Lee et al., 2010). This is because PS1 serves as a chaperone in the ER for the 
essential maturation of lysosomal V-ATPase subunit, V0a1. The mutation in PS1 
therefore prevents formation and delivery of the mature V-ATPase, resulting in 
increase in lysosome pH. In addition, there is evidence showing that the loss of V0a1 
subunit increases the susceptibility of neurons to Aβ and tau-induced toxicity, only in 
the context of stress conditions (Williamson and Hiesinger, 2010). Consistent with 
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my finding that the effect of P2X4R and P2X7R in autophagic flux was only observed 
following nutrient starvation, this suggests P2X4R may contribute to the progression 
of AD. Interesting, there is evidence showing an enhanced Ca2+ release from 
lysosomes, which is mediated by TRPML1 in the knockout of PS1 blastocysts (Lee 
et al., 2015). However, the study does not demonstrate a role for P2X4R, which may 
contribute to the enhanced Ca2+ release from lysosomes. Therefore, it can be 
explained based on the assumption that lysosome pH modulates the balance in 
lysosome Ca2+ release mediated by both TRPML1 and P2X4R, and the disruption in 
lysosome pH disrupts the balance of this regulation. Altogether, an increase in 
lysosome pH in AD is likely to stimulate P2X4R-mediated Ca2+ signals and facilitate 
lysosome fusion followed by exocytosis. My results demonstrate the anterograde 
movement of lysosomes towards the plasma membrane, indicative of lysosome 
exocytosis. Therefore, understanding of P2X4R in lysosome function is important 
and the inhibition of P2X4R could serve as an alternative target for lysosome defects 
and may alleviate phenotypes of autophagy-related neurodegenerative diseases 
(Colacurcio and Nixon, 2016; McBrayer and Nixon, 2013; Menzies et al., 2017).  
Having shown that P2X7R is a regulator of P2X4R in lysosomes, P2X4R in 
lysosomes may have an effect in inflammation given the role of P2X7R in 
inflammation. Indeed, a study has demonstrated the expression of P2X4R in 
neurons was upregulated after spinal cord injury (Vaccari et al., 2012). The depletion 
of P2X4R reduced the level of caspase-1 activation and IL-1β cleavage, suggesting 
an effect of P2X4R in the release of active cytokines. P2X4Rs in neurons are 
constitutively shuttled between lysosomes and plasma membrane (Bobanovic et al., 
2002; Royle et al., 2002, 2005), therefore P2X4R in lysosomes may contribute in the 
upregulation of plasma membrane expression via lysosome exocytosis. However, 
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this study did not demonstrate a function of P2X4R in lysosomes in such an 
inflammatory response. Furthermore, there is evidence demonstrating that the 
activation of P2X7R upregulates lysosome exocytosis to release IL-1β in primary 
bone marrow-derived macrophages (Qu et al., 2007; 2009). This supports the 
hypothesis that P2X7R recruits the activity of P2X4R in lysosomes to mediate Ca2+-
dependent lysosome exocytosis. In addition, the synergistic effect of P2X4R and 
P2X7R in IL-1β and IL-18 release has been demonstrated in dendritic cells (Sakaki 
et al., 2013). Collectively, these observations suggest a potential effect of P2X4R in 
lysosome exocytosis; releasing cytokines and ATP, and upregulating P2X4R could 
potentially provide a positive feedback effect in inflammatory responses. 
In addition to inflammation, lysosome-mediated cell death may be a condition where 
P2X4R activity is stimulated. A critical step in this process is the release of 
cathepsins, protons and lysosomal constituents to the cytoplasm and/or the 
extracellular space via lysosome membrane permeabilisation (LMP). Specifically, the 
escape of lysosome protons will result in an increase in lysosome pH. This 
alkalinisation favours the activation of P2X4R and this is likely to mediate lysosome 
fusion and subsequently lysosome secretion of cathepsins for LMP-induced cell 
death. The leakage of cathepsins has been implicated in apoptosis because most of 
the cathepsin substrate is Bid (BH3-interacting domain death agonist), leading to the 
activation of apoptosis signalling. In addition, cancer is highly dependent on 
lysosome function and the changes in lysosome composition, number and 
localisation have been implicated in cancers (Appelqvist et al., 2013). There is 
evidence suggesting an increase in the secretion of cathepsins in cancer cells. In 
addition, the upregulation of extracellular cathepsins was shown to trigger the 
stimulation of angiogenesis, tumour growth and invasion (Gocheva et al., 2006). 
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Moreover, there is evidence demonstrating the release of lysosomal glycosidases. 
For example β-NAG facilitates the extracellular matrix (ECM) degradation, resulting 
in the cancer invagination (Ramessur et al., 2010). P2X7R, which is often referred to 
as the “death receptor” for its ability to induce apoptosis, is highly expressed in 
cancer cells. There is evidence demonstrating that HEK293 tumour cells expressing 
P2X7R grew more rapidly and had a more developed vascular network, suggesting 
the effect of P2X7R in the upregulation of cancer progression (Adinolfi et al., 2012). 
Having shown the P2X7R as the regulator of P2X4R in lysosomes, a functional 
interaction between P2X4R and P2X7R could be possible to contribute an effect in 
cancer progression.  
A full understanding of lysosome-related and autophagy-related diseases remain, to 
a large extent, unclear and this impedes the development of effective therapy. 
However, there are great number of research findings suggesting that these 
diseases are highly associated with the impairment in lysosome homeostasis, for 
example lysosome acidity. Therefore, the manipulation of lysosome function and 
inhibition of P2X4R might be an alternative therapeutic target given the effect of 
P2X4R in lysosome function. Therefore the detailed molecular mechanism of P2X4R 
in lysosome under pathological conditions should be examined as this would permit 
the development of an alternative therapeutic target. 
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8. Future Directions  
8.1. The effect of lysosomal P2X4Rs in exocytosis  
Having shown that the activation of P2X4R and P2X7R promotes Ca2+ dependent 
lysosome fusion and the evidence of lysosome translocation to the cell periphery 
(Chapter 4), lysosome exocytosis could be one of the downstream effects mediated 
by P2X4R and P2X7R. To study lysosome exocytosis, the activity of the lysosome 
enzyme, β-hexosaminidase and lysosomal cathepsins can be assayed in the culture 
medium of cells co-expressing P2X4R and P2X7R following P2X7R stimulation. The 
activity of β-hexosaminidase can be measured by incubating the culture medium with 
4-nitrophenyl N-acetyl-ß-D-glucosaminide, which acts as a chromogenic substrate, 
for 1 h and measures its cleaved product at absorbance 405 nm. Additionally, the 
biotinylation of LAMP1 on the plasma membrane can determine the degree of 
lysosome exocytosis in response to BzATP treatment in cells expressing P2X4R and 
P2X7R. Together, this will be able to determine a role for P2X4R in lysosome 
exocytosis.  
8.2.  The effect of P2X4/7Rs in autophagy  
I have demonstrated the effect of P2X4R and P2X7R in autophagy flux where the 
activation of both P2X4R and P2X7R increases the accumulation of LC3 proteins. 
However, several issues remain unresolved and below is a list of potential 
experiments for future investigation.  
8.2.1. The effect of P2X4/7Rs in autophagolysosome degradation 
To further consolidate the effect of P2X4R and P2X7R in disrupting the degradation 
steps of autophagy process, experiments using western blot can be conducted. 
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Western blot can be used to determine the changes of LC3-I and LC3-II proteins 
during the activation of P2X7R. Under nutrient rich conditions, western blot bands 
representing LC3-I and LC3-II are expected to be low in intensity. The incubation of 
EBSS, which is sufficient to trigger autophagy, is expected to reduce LC3-II proteins. 
This is because the dynamic autophagy process promotes the fusion of 
autophagosomes, where LC3-II proteins are localised, with lysosomes into 
autophagolysosomes thereby degrading LC3-II proteins. However, the presence of 
Baf-A1 in EBSS inhibits degradation of autophagolysosomes, thereby the band 
intensity that represents LC3-II proteins is expected to increase. To support the 
negative regulation of P2X4R and P2X7R in autophagic degradation, the LC3-II 
proteins are expected to accumulate to the same extend as Baf-A1 treatment. This 
will confirm that P2X4/7Rs are negatively regulating the autophagic degradation, in a 
similar effect as Baf-A1 treatment, through lysosome alkalinisation.  
To consolidate the synergistic effect of P2X4R and P2X7R in the inhibition of 
autophagolysosome degradation, the level of p62, also known as sequestosome 1 
(SQSTM1), could be used as a protein marker to examine autophagy and 
autophagic flux. Initiation of autophagy is associated with a decrease in the p62 level, 
whilst the inhibition of autophagic flux using Baf-A1 correlates with an increase in 
p62 level due to the impairment in autophagolysosome degradation, and thus p62 
serves as a readout for autophagic degradation (Bjørkøy et al., 2005). NaATP 
treatment with EBSS is expected to increase p62 level to a similar extend as Baf-A1 
treatment in EBSS, in cells heterologous expression of P2X4R and P2X7R. 
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8.2.2. Determining the Ca2+ dependence of LC3-II accumulation 
The effect of P2X7R in LC3-II protein accumulation was shown to be dependent on 
P2X7R-mediated Ca2+ influx (Takenouchi et al., 2009). My results in Chapter 4 also 
demonstrate that the Ca2+ influx via P2X7R increased the pH of lysosomes and 
thereby activated P2X4R in lysosomes. Further experiments could be conducted to 
assess whether the effect of P2X7R and P2X4R in autophagic flux is dependent on 
the upregulation of the cytoplasmic [Ca2+]. To examine this, NaATP could be added 
to Ca2+-free EBSS to determine the changes of LC3-II intensity using either confocal 
microscope or western blot. LC3-II aggregation will not be observed if Ca2+ influx is 
required for autophagosome turnover. Given the evidence of H1R in lysosome 
alkalinisation and H1R as the physiological regulator of P2X4R, further experiments 
can be conducted to determine whether the stimulation of H1R is sufficient to 
stimulate P2X4R to induce LC3-II accumulation.  
8.3. The sub-cellular distribution of human and rat P2X4R 
I have identified that hP2X4R localises in both lysosomes and plasma membrane 
and that is likely to be mediated by the non-conserved amino acid residues at A6 
and A7 of hP2X4R. To consolidate the finding that hP2X4R-A6S-A7V is involved in 
lysosome localisation, a biotinylation assay could be conducted to examine the 
expression level of this mutant on the plasma membrane and compared with WT 
hP2X4R and rP2X4R.  The cell surface expression level of hP2X4R-A6S-A7V is 
expected to reduce to a level comparable to rP2X4R and that will support my results 
that hP2X4R-A6S-A7V is predominantly localised to lysosomes.  To ensure that 
hP2X4R-A6S-A7V does not negatively impact functional activity, analysis of 
hP2X4R-A6S-A7V can be conducted using patch clamp. This can examine the 
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receptor activity of hP2X4R-A6S-A7V by measuring the current in response to ATP 
stimulation and compared to WT hP2X4R.  A dose response curve can then be 
produced to examine the ATP-sensitivity of WT hP2X4R and hP2X4R-A6S-A7V. To 
further validate this, the effect of a P2X4R antagonist, TNP-ATP can be utilised to 
determine the functional activity of WT hP2X4R and hP2X4R-A6S-A7V.  
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